{
  "doc_id": "37",
  "paragraphs": [
    {
      "paragraph_id": "0",
      "paragraph": "中国糖尿病足诊治指南 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "中国糖尿病足诊治指南 ",
          "start_idx": 0,
          "end_idx": 11,
          "entities": [
            {
              "entity_id": "T0",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 2,
              "end_idx": 6,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T1",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 5,
              "end_idx": 6,
              "entity_en": "foot"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R0",
              "head_entity_id": "T1",
              "tail_entity_id": "T0"
            }
          ],
          "sentence_en": "Guidelines for the diagnosis and treatment of diabetic foot in China"
        }
      ],
      "paragraph_en": "Guidelines for the diagnosis and treatment of diabetic foot in China"
    },
    {
      "paragraph_id": "1",
      "paragraph": "糖尿病足是导致我国糖尿病患者致残、致死的严重慢性并发症之一，其发病率高，治疗困难，花费巨大目前我国主要是参考国际足病工作者与美国糖尿病足病学组制定的指南。但是，由于我国糖尿病足具有自身的特点，因此，中国医疗保健国际交流促进会组织全国足病相关专家起草了糖尿病足诊治指南。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "糖尿病足是导致我国糖尿病患者致残、致死的严重慢性并发症之一，其发病率高，治疗困难，花费巨大目前我国主要是参考国际足病工作者与美国糖尿病足病学组制定的指南。",
          "start_idx": 0,
          "end_idx": 77,
          "entities": [
            {
              "entity_id": "T2",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 0,
              "end_idx": 4,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T3",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 3,
              "end_idx": 4,
              "entity_en": "foot"
            },
            {
              "entity_id": "T4",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 9,
              "end_idx": 12,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T5",
              "entity": "足病",
              "entity_type": "Disease",
              "start_idx": 56,
              "end_idx": 58,
              "entity_en": "Podiatry"
            },
            {
              "entity_id": "T6",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 56,
              "end_idx": 57,
              "entity_en": "foot"
            },
            {
              "entity_id": "T7",
              "entity": "糖尿病足病",
              "entity_type": "Disease",
              "start_idx": 64,
              "end_idx": 69,
              "entity_en": "Diabetic foot disease"
            },
            {
              "entity_id": "T8",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 67,
              "end_idx": 68,
              "entity_en": "foot"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R1",
              "head_entity_id": "T3",
              "tail_entity_id": "T2"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R2",
              "head_entity_id": "T6",
              "tail_entity_id": "T5"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R3",
              "head_entity_id": "T8",
              "tail_entity_id": "T7"
            }
          ],
          "sentence_en": "Diabetic foot is one of the serious chronic complications that causes disability and death in diabetic patients in my country. It has a high incidence rate, is difficult to treat, and is very expensive. Currently, my country mainly refers to the guidelines developed by international podiatry workers and the American Diabetic Podiatry Group."
        },
        {
          "sentence_id": "1",
          "sentence": "但是，由于我国糖尿病足具有自身的特点，因此，中国医疗保健国际交流促进会组织全国足病相关专家起草了糖尿病足诊治指南。",
          "start_idx": 77,
          "end_idx": 134,
          "entities": [
            {
              "entity_id": "T9",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 7,
              "end_idx": 11,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T10",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 10,
              "end_idx": 11,
              "entity_en": "foot"
            },
            {
              "entity_id": "T11",
              "entity": "足病",
              "entity_type": "Disease",
              "start_idx": 39,
              "end_idx": 41,
              "entity_en": "Podiatry"
            },
            {
              "entity_id": "T12",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 39,
              "end_idx": 40,
              "entity_en": "foot"
            },
            {
              "entity_id": "T13",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 48,
              "end_idx": 52,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T14",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 51,
              "end_idx": 52,
              "entity_en": "foot"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R4",
              "head_entity_id": "T10",
              "tail_entity_id": "T9"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R5",
              "head_entity_id": "T12",
              "tail_entity_id": "T11"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R6",
              "head_entity_id": "T14",
              "tail_entity_id": "T13"
            }
          ],
          "sentence_en": "However, since diabetic foot in my country has its own characteristics, the China Medical and Health International Exchange Promotion Association organized national foot disease experts to draft guidelines for the diagnosis and treatment of diabetic foot."
        },
        {
          "sentence_id": "2",
          "sentence": " ",
          "start_idx": 134,
          "end_idx": 135,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "Diabetic foot is one of the serious chronic complications that cause disability and death in Chinese diabetic patients. It has a high incidence rate, is difficult to treat, and is very expensive. At present, my country mainly refers to the guidelines developed by international podiatric workers and the American Diabetic Podiatry Group. However, due to the unique characteristics of diabetic foot in my country, the China Medical and Health International Exchange Promotion Association organized national podiatry experts to draft a guideline for the diagnosis and treatment of diabetic foot."
    },
    {
      "paragraph_id": "2",
      "paragraph": "一、糖尿病足及高危足的概念 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "一、糖尿病足及高危足的概念 ",
          "start_idx": 0,
          "end_idx": 14,
          "entities": [
            {
              "entity_id": "T15",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 2,
              "end_idx": 6,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T16",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 5,
              "end_idx": 6,
              "entity_en": "foot"
            },
            {
              "entity_id": "T17",
              "entity": "高危足",
              "entity_type": "Disease",
              "start_idx": 7,
              "end_idx": 10,
              "entity_en": "High-risk foot"
            },
            {
              "entity_id": "T18",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 9,
              "end_idx": 10,
              "entity_en": "foot"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R7",
              "head_entity_id": "T16",
              "tail_entity_id": "T15"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R8",
              "head_entity_id": "T18",
              "tail_entity_id": "T17"
            }
          ],
          "sentence_en": "1. The concept of diabetic foot and high-risk foot"
        }
      ],
      "paragraph_en": "1. The concept of diabetic foot and high-risk foot"
    },
    {
      "paragraph_id": "3",
      "paragraph": "糖尿病足：糖尿病患者因下肢远端神经异常和不同程度的血管病变导致的足部感染、溃疡和(或) 深层组织破坏。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "糖尿病足：糖尿病患者因下肢远端神经异常和不同程度的血管病变导致的足部感染、溃疡和(或) 深层组织破坏。",
          "start_idx": 0,
          "end_idx": 51,
          "entities": [
            {
              "entity_id": "T19",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 0,
              "end_idx": 4,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T20",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 3,
              "end_idx": 4,
              "entity_en": "foot"
            },
            {
              "entity_id": "T21",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 5,
              "end_idx": 8,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T22",
              "entity": "下肢远端神经异常",
              "entity_type": "Reason",
              "start_idx": 11,
              "end_idx": 19,
              "entity_en": "Distal lower extremity nerve abnormalities"
            },
            {
              "entity_id": "T23",
              "entity": "不同程度的血管病变",
              "entity_type": "Reason",
              "start_idx": 20,
              "end_idx": 29,
              "entity_en": "Vascular disease of varying degrees"
            },
            {
              "entity_id": "T24",
              "entity": "足部感染",
              "entity_type": "Symptom",
              "start_idx": 32,
              "end_idx": 36,
              "entity_en": "Foot infection"
            },
            {
              "entity_id": "T25",
              "entity": "溃疡",
              "entity_type": "Symptom",
              "start_idx": 37,
              "end_idx": 39,
              "entity_en": "ulcer"
            },
            {
              "entity_id": "T26",
              "entity": "深层组织破坏",
              "entity_type": "Symptom",
              "start_idx": 44,
              "end_idx": 50,
              "entity_en": "Deep tissue damage"
            },
            {
              "entity_id": "T27",
              "entity": "下肢远端神经",
              "entity_type": "Anatomy",
              "start_idx": 11,
              "end_idx": 17,
              "entity_en": "Distal nerves of lower limbs"
            },
            {
              "entity_id": "T28",
              "entity": "足部",
              "entity_type": "Anatomy",
              "start_idx": 32,
              "end_idx": 34,
              "entity_en": "Foot"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R9",
              "head_entity_id": "T20",
              "tail_entity_id": "T19"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R10",
              "head_entity_id": "T22",
              "tail_entity_id": "T19"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R11",
              "head_entity_id": "T23",
              "tail_entity_id": "T19"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R12",
              "head_entity_id": "T27",
              "tail_entity_id": "T19"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R13",
              "head_entity_id": "T28",
              "tail_entity_id": "T19"
            }
          ],
          "sentence_en": "Diabetic foot: foot infection, ulcers and/or deep tissue destruction caused by distal nerve abnormalities and varying degrees of vascular lesions in diabetic patients."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 51,
          "end_idx": 52,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "Diabetic foot: foot infection, ulcers and/or deep tissue destruction caused by distal nerve abnormalities and varying degrees of vascular lesions in diabetic patients."
    },
    {
      "paragraph_id": "4",
      "paragraph": "糖尿病高危足糖尿病患者未出现足溃疡但存在周围神经病变，不管是否存在足畸形或周围动脉病变或足溃疡史或截肢(趾)史。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "糖尿病高危足糖尿病患者未出现足溃疡但存在周围神经病变，不管是否存在足畸形或周围动脉病变或足溃疡史或截肢(趾)史。",
          "start_idx": 0,
          "end_idx": 56,
          "entities": [
            {
              "entity_id": "T29",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 6,
              "end_idx": 9,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T30",
              "entity": "足溃疡",
              "entity_type": "Symptom",
              "start_idx": 14,
              "end_idx": 17,
              "entity_en": "Foot ulcer"
            },
            {
              "entity_id": "T31",
              "entity": "周围神经病变",
              "entity_type": "Disease",
              "start_idx": 20,
              "end_idx": 26,
              "entity_en": "Peripheral neuropathy"
            },
            {
              "entity_id": "T32",
              "entity": "周围神经",
              "entity_type": "Anatomy",
              "start_idx": 20,
              "end_idx": 24,
              "entity_en": "Peripheral nerves"
            },
            {
              "entity_id": "T33",
              "entity": "足畸形",
              "entity_type": "Disease",
              "start_idx": 33,
              "end_idx": 36,
              "entity_en": "Foot deformity"
            },
            {
              "entity_id": "T34",
              "entity": "周围动脉病变",
              "entity_type": "Disease",
              "start_idx": 37,
              "end_idx": 43,
              "entity_en": "Peripheral arterial disease"
            },
            {
              "entity_id": "T35",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 33,
              "end_idx": 34,
              "entity_en": "foot"
            },
            {
              "entity_id": "T36",
              "entity": "周围动脉",
              "entity_type": "Anatomy",
              "start_idx": 37,
              "end_idx": 41,
              "entity_en": "Peripheral arteries"
            },
            {
              "entity_id": "T37",
              "entity": "足溃疡",
              "entity_type": "Disease",
              "start_idx": 44,
              "end_idx": 47,
              "entity_en": "Foot ulcer"
            },
            {
              "entity_id": "T38",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 44,
              "end_idx": 45,
              "entity_en": "foot"
            },
            {
              "entity_id": "T39",
              "entity": "糖尿病高危足",
              "entity_type": "Disease",
              "start_idx": 0,
              "end_idx": 6,
              "entity_en": "Diabetic high risk foot"
            },
            {
              "entity_id": "T40",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 5,
              "end_idx": 6,
              "entity_en": "foot"
            },
            {
              "entity_id": "T41",
              "entity": "截肢(趾)",
              "entity_type": "Operation",
              "start_idx": 49,
              "end_idx": 54,
              "entity_en": "Amputation (toe)"
            }
          ],
          "relations": [
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R14",
              "head_entity_id": "T30",
              "tail_entity_id": "T29"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R15",
              "head_entity_id": "T32",
              "tail_entity_id": "T31"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R16",
              "head_entity_id": "T35",
              "tail_entity_id": "T33"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R17",
              "head_entity_id": "T36",
              "tail_entity_id": "T34"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R18",
              "head_entity_id": "T38",
              "tail_entity_id": "T37"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R19",
              "head_entity_id": "T40",
              "tail_entity_id": "T39"
            }
          ],
          "sentence_en": "High-risk diabetic foot patients with diabetes do not have foot ulcers but have peripheral neuropathy, regardless of whether they have foot deformities or peripheral arterial disease or a history of foot ulcers or amputation (toe)."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 56,
          "end_idx": 57,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "High-risk diabetic foot patients with diabetes do not have foot ulcers but have peripheral neuropathy, regardless of whether they have foot deformities or peripheral arterial disease or a history of foot ulcers or amputation (toe)."
    },
    {
      "paragraph_id": "5",
      "paragraph": "二、糖尿病足与下肢动脉病变的流行病学 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "二、糖尿病足与下肢动脉病变的流行病学 ",
          "start_idx": 0,
          "end_idx": 19,
          "entities": [
            {
              "entity_id": "T42",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 2,
              "end_idx": 6,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T43",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 5,
              "end_idx": 6,
              "entity_en": "foot"
            },
            {
              "entity_id": "T44",
              "entity": "下肢动脉病变",
              "entity_type": "Disease",
              "start_idx": 7,
              "end_idx": 13,
              "entity_en": "Lower extremity arterial disease"
            },
            {
              "entity_id": "T45",
              "entity": "下肢动脉",
              "entity_type": "Anatomy",
              "start_idx": 7,
              "end_idx": 11,
              "entity_en": "Lower limb arteries"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R20",
              "head_entity_id": "T43",
              "tail_entity_id": "T42"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R21",
              "head_entity_id": "T45",
              "tail_entity_id": "T44"
            }
          ],
          "sentence_en": "2. Epidemiology of diabetic foot and lower extremity arterial disease"
        }
      ],
      "paragraph_en": "2. Epidemiology of diabetic foot and lower extremity arterial disease"
    },
    {
      "paragraph_id": "6",
      "paragraph": "国外资料显示在所有的非外伤性低位截肢手术中，糖尿病患者占40%~60%，在糖尿病相关的低位远端截肢中，有85%是发生在足部溃疡后。糖尿病患者中足部溃疡的患病率为4%~10%。国内多中心研究资料显示我国50岁以上糖尿病患者下肢动脉病变的比例为19.5%。单中心研究显示60岁以上糖尿病患者下肢动脉病变的比例为3 5.4%。我国糖尿病患者1年内新发溃疡发生率为8.1%，糖尿病足溃疡患者1年内新发溃疡发生率为31.6%",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "国外资料显示在所有的非外伤性低位截肢手术中，糖尿病患者占40%~60%，在糖尿病相关的低位远端截肢中，有85%是发生在足部溃疡后。",
          "start_idx": 0,
          "end_idx": 65,
          "entities": [
            {
              "entity_id": "T46",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 22,
              "end_idx": 25,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T47",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 37,
              "end_idx": 40,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T48",
              "entity": "足部溃疡",
              "entity_type": "Disease",
              "start_idx": 59,
              "end_idx": 63,
              "entity_en": "Foot ulcers"
            },
            {
              "entity_id": "T49",
              "entity": "足部",
              "entity_type": "Anatomy",
              "start_idx": 59,
              "end_idx": 61,
              "entity_en": "Foot"
            },
            {
              "entity_id": "T65",
              "entity": "非外伤性低位截肢手术",
              "entity_type": "Operation",
              "start_idx": 10,
              "end_idx": 20,
              "entity_en": "Non-traumatic low amputation"
            },
            {
              "entity_id": "T66",
              "entity": "低位远端截肢",
              "entity_type": "Operation",
              "start_idx": 43,
              "end_idx": 49,
              "entity_en": "Low distal amputation"
            }
          ],
          "relations": [
            {
              "relation_type": "Operation_Disease",
              "relation_id": "R22",
              "head_entity_id": "T65",
              "tail_entity_id": "T46"
            },
            {
              "relation_type": "Operation_Disease",
              "relation_id": "R23",
              "head_entity_id": "T66",
              "tail_entity_id": "T46"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R24",
              "head_entity_id": "T49",
              "tail_entity_id": "T48"
            }
          ],
          "sentence_en": "Foreign data show that among all non-traumatic low amputation surgeries, diabetic patients account for 40% to 60%, and among diabetes-related low distal amputations, 85% occur after foot ulcers."
        },
        {
          "sentence_id": "1",
          "sentence": "糖尿病患者中足部溃疡的患病率为4%~10%。",
          "start_idx": 65,
          "end_idx": 87,
          "entities": [
            {
              "entity_id": "T50",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 0,
              "end_idx": 3,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T51",
              "entity": "足部溃疡",
              "entity_type": "Disease",
              "start_idx": 6,
              "end_idx": 10,
              "entity_en": "Foot ulcers"
            },
            {
              "entity_id": "T52",
              "entity": "足部",
              "entity_type": "Anatomy",
              "start_idx": 6,
              "end_idx": 8,
              "entity_en": "Foot"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R25",
              "head_entity_id": "T52",
              "tail_entity_id": "T51"
            }
          ],
          "sentence_en": "The prevalence of foot ulcers in diabetic patients is 4% to 10%."
        },
        {
          "sentence_id": "2",
          "sentence": "国内多中心研究资料显示我国50岁以上糖尿病患者下肢动脉病变的比例为19.5%。",
          "start_idx": 87,
          "end_idx": 126,
          "entities": [
            {
              "entity_id": "T53",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 18,
              "end_idx": 21,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T54",
              "entity": "下肢动脉病变",
              "entity_type": "Disease",
              "start_idx": 23,
              "end_idx": 29,
              "entity_en": "Lower extremity arterial disease"
            },
            {
              "entity_id": "T55",
              "entity": "下肢动脉",
              "entity_type": "Anatomy",
              "start_idx": 23,
              "end_idx": 27,
              "entity_en": "Lower limb arteries"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R26",
              "head_entity_id": "T55",
              "tail_entity_id": "T54"
            }
          ],
          "sentence_en": "Domestic multi-center research data show that the proportion of lower limb artery disease in diabetic patients over 50 years old in my country is 19.5%."
        },
        {
          "sentence_id": "3",
          "sentence": "单中心研究显示60岁以上糖尿病患者下肢动脉病变的比例为3 5.4%。",
          "start_idx": 126,
          "end_idx": 160,
          "entities": [
            {
              "entity_id": "T56",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 12,
              "end_idx": 15,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T57",
              "entity": "下肢动脉病变",
              "entity_type": "Disease",
              "start_idx": 17,
              "end_idx": 23,
              "entity_en": "Lower extremity arterial disease"
            },
            {
              "entity_id": "T58",
              "entity": "下肢动脉",
              "entity_type": "Anatomy",
              "start_idx": 17,
              "end_idx": 21,
              "entity_en": "Lower limb arteries"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R27",
              "head_entity_id": "T58",
              "tail_entity_id": "T57"
            }
          ],
          "sentence_en": "A single-center study showed that the proportion of lower limb arterial disease in diabetic patients over 60 years old was 35.4%."
        },
        {
          "sentence_id": "4",
          "sentence": "我国糖尿病患者1年内新发溃疡发生率为8.1%，糖尿病足溃疡患者1年内新发溃疡发生率为31.6%",
          "start_idx": 160,
          "end_idx": 207,
          "entities": [
            {
              "entity_id": "T59",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 2,
              "end_idx": 5,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T60",
              "entity": "溃疡",
              "entity_type": "Disease",
              "start_idx": 12,
              "end_idx": 14,
              "entity_en": "ulcer"
            },
            {
              "entity_id": "T61",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 23,
              "end_idx": 26,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T62",
              "entity": "足溃疡",
              "entity_type": "Disease",
              "start_idx": 26,
              "end_idx": 29,
              "entity_en": "Foot ulcer"
            },
            {
              "entity_id": "T63",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 26,
              "end_idx": 27,
              "entity_en": "foot"
            },
            {
              "entity_id": "T64",
              "entity": "溃疡",
              "entity_type": "Disease",
              "start_idx": 36,
              "end_idx": 38,
              "entity_en": "ulcer"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R28",
              "head_entity_id": "T63",
              "tail_entity_id": "T62"
            }
          ],
          "sentence_en": "The incidence of new ulcers in diabetic patients in my country within one year is 8.1%, and the incidence of new ulcers in diabetic foot ulcer patients within one year is 31.6%."
        }
      ],
      "paragraph_en": "Foreign data show that among all non-traumatic low amputations, 40% to 60% occur in patients with diabetes, and 85% of diabetes-related low distal amputations occur after foot ulcers. The prevalence of foot ulcers in diabetic patients is 4% to 10%. Domestic multicenter research data show that the proportion of lower limb arterial disease in diabetic patients over 50 years old in my country is 19.5%. A single-center study showed that the proportion of lower limb arterial disease in diabetic patients over 60 years old is 35.4%. The incidence of new ulcers in diabetic patients in my country within one year is 8.1%, and the incidence of new ulcers in patients with diabetic foot ulcers within one year is 31.6%."
    },
    {
      "paragraph_id": "7",
      "paragraph": "三、糖尿病足的临床表现 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "三、糖尿病足的临床表现 ",
          "start_idx": 0,
          "end_idx": 12,
          "entities": [
            {
              "entity_id": "T67",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 2,
              "end_idx": 6,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T68",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 5,
              "end_idx": 6,
              "entity_en": "foot"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R29",
              "head_entity_id": "T68",
              "tail_entity_id": "T67"
            }
          ],
          "sentence_en": "Clinical manifestations of diabetic foot"
        }
      ],
      "paragraph_en": "Clinical manifestations of diabetic foot"
    },
    {
      "paragraph_id": "8",
      "paragraph": "神经病变表现：患肢皮肤干而无汗，肢端刺痛、灼痛、麻木、感觉减退或缺失，呈袜套样改变，行走时脚踩棉絮感",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "神经病变表现：患肢皮肤干而无汗，肢端刺痛、灼痛、麻木、感觉减退或缺失，呈袜套样改变，行走时脚踩棉絮感",
          "start_idx": 0,
          "end_idx": 50,
          "entities": [
            {
              "entity_id": "T69",
              "entity": "神经病变",
              "entity_type": "Disease",
              "start_idx": 0,
              "end_idx": 4,
              "entity_en": "Neuropathy"
            },
            {
              "entity_id": "T70",
              "entity": "神经",
              "entity_type": "Anatomy",
              "start_idx": 0,
              "end_idx": 2,
              "entity_en": "nerve"
            },
            {
              "entity_id": "T71",
              "entity": "皮肤干",
              "entity_type": "Symptom",
              "start_idx": 9,
              "end_idx": 12,
              "entity_en": "Dry skin"
            },
            {
              "entity_id": "T72",
              "entity": "无汗",
              "entity_type": "Symptom",
              "start_idx": 13,
              "end_idx": 15,
              "entity_en": "No sweat"
            },
            {
              "entity_id": "T73",
              "entity": "肢端刺痛",
              "entity_type": "Symptom",
              "start_idx": 16,
              "end_idx": 20,
              "entity_en": "Tingling in the extremities"
            },
            {
              "entity_id": "T74",
              "entity": "灼痛",
              "entity_type": "Symptom",
              "start_idx": 21,
              "end_idx": 23,
              "entity_en": "Burning pain"
            },
            {
              "entity_id": "T75",
              "entity": "麻木",
              "entity_type": "Symptom",
              "start_idx": 24,
              "end_idx": 26,
              "entity_en": "numbness"
            },
            {
              "entity_id": "T76",
              "entity": "感觉减退或缺失",
              "entity_type": "Symptom",
              "start_idx": 27,
              "end_idx": 34,
              "entity_en": "Decreased or absent sensation"
            },
            {
              "entity_id": "T77",
              "entity": "呈袜套样改变",
              "entity_type": "Symptom",
              "start_idx": 35,
              "end_idx": 41,
              "entity_en": "Stocking-like changes"
            },
            {
              "entity_id": "T78",
              "entity": "行走时脚踩棉絮感",
              "entity_type": "Symptom",
              "start_idx": 42,
              "end_idx": 50,
              "entity_en": "Feeling of cotton wool underfoot when walking"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R30",
              "head_entity_id": "T70",
              "tail_entity_id": "T69"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R31",
              "head_entity_id": "T71",
              "tail_entity_id": "T69"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R32",
              "head_entity_id": "T72",
              "tail_entity_id": "T69"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R33",
              "head_entity_id": "T73",
              "tail_entity_id": "T69"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R34",
              "head_entity_id": "T74",
              "tail_entity_id": "T69"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R35",
              "head_entity_id": "T75",
              "tail_entity_id": "T69"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R36",
              "head_entity_id": "T76",
              "tail_entity_id": "T69"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R37",
              "head_entity_id": "T77",
              "tail_entity_id": "T69"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R38",
              "head_entity_id": "T78",
              "tail_entity_id": "T69"
            }
          ],
          "sentence_en": "Symptoms of neuropathy: dry skin without sweat, tingling, burning pain, numbness, decreased or absent sensation in the extremities, sock-like changes, and a cotton-wool feeling when walking."
        }
      ],
      "paragraph_en": "Symptoms of neuropathy: dry skin without sweat, tingling, burning pain, numbness, decreased or absent sensation in the extremities, sock-like changes, and a cotton-wool feeling when walking."
    },
    {
      "paragraph_id": "9",
      "paragraph": "下肢缺血表现：皮肤营养不良、肌肉萎缩，皮肤干燥弹性差，皮温下降，色素沉着，肢端动脉搏动减弱或消失，患者可合并有下肢间歇跛行症状。随着病变进展，可出现静息痛，趾端出现坏疽，足跟或跖趾关节受压部位出现溃疡，部分患者可肢体感染。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "下肢缺血表现：皮肤营养不良、肌肉萎缩，皮肤干燥弹性差，皮温下降，色素沉着，肢端动脉搏动减弱或消失，患者可合并有下肢间歇跛行症状。",
          "start_idx": 0,
          "end_idx": 64,
          "entities": [
            {
              "entity_id": "T79",
              "entity": "下肢缺血",
              "entity_type": "Disease",
              "start_idx": 0,
              "end_idx": 4,
              "entity_en": "Lower limb ischemia"
            },
            {
              "entity_id": "T80",
              "entity": "下肢",
              "entity_type": "Anatomy",
              "start_idx": 0,
              "end_idx": 2,
              "entity_en": "Lower limbs"
            },
            {
              "entity_id": "T81",
              "entity": "皮肤营养不良",
              "entity_type": "Symptom",
              "start_idx": 7,
              "end_idx": 13,
              "entity_en": "Skin dystrophy"
            },
            {
              "entity_id": "T82",
              "entity": "肌肉萎缩",
              "entity_type": "Symptom",
              "start_idx": 14,
              "end_idx": 18,
              "entity_en": "Muscle atrophy"
            },
            {
              "entity_id": "T83",
              "entity": "皮肤干燥弹性差",
              "entity_type": "Symptom",
              "start_idx": 19,
              "end_idx": 26,
              "entity_en": "Dry skin with poor elasticity"
            },
            {
              "entity_id": "T84",
              "entity": "皮温下降",
              "entity_type": "Symptom",
              "start_idx": 27,
              "end_idx": 31,
              "entity_en": "Decreased skin temperature"
            },
            {
              "entity_id": "T85",
              "entity": "色素沉着",
              "entity_type": "Symptom",
              "start_idx": 32,
              "end_idx": 36,
              "entity_en": "Pigmentation"
            },
            {
              "entity_id": "T86",
              "entity": "肢端动脉搏动减弱或消失",
              "entity_type": "Symptom",
              "start_idx": 37,
              "end_idx": 48,
              "entity_en": "Weak or absent arterial pulse in the extremities"
            },
            {
              "entity_id": "T87",
              "entity": "下肢间歇跛行",
              "entity_type": "Disease",
              "start_idx": 55,
              "end_idx": 61,
              "entity_en": "Intermittent claudication of lower limbs"
            },
            {
              "entity_id": "T91",
              "entity": "下肢",
              "entity_type": "Anatomy",
              "start_idx": 55,
              "end_idx": 57,
              "entity_en": "Lower limbs"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R39",
              "head_entity_id": "T80",
              "tail_entity_id": "T79"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R40",
              "head_entity_id": "T81",
              "tail_entity_id": "T79"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R41",
              "head_entity_id": "T82",
              "tail_entity_id": "T79"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R42",
              "head_entity_id": "T83",
              "tail_entity_id": "T79"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R43",
              "head_entity_id": "T84",
              "tail_entity_id": "T79"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R44",
              "head_entity_id": "T85",
              "tail_entity_id": "T79"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R45",
              "head_entity_id": "T86",
              "tail_entity_id": "T79"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R46",
              "head_entity_id": "T91",
              "tail_entity_id": "T87"
            }
          ],
          "sentence_en": "Symptoms of lower limb ischemia include: skin malnutrition, muscle atrophy, dry skin with poor elasticity, decreased skin temperature, pigmentation, weakened or disappeared arterial pulsation in the extremities, and patients may also have symptoms of intermittent claudication in the lower limbs."
        },
        {
          "sentence_id": "1",
          "sentence": "随着病变进展，可出现静息痛，趾端出现坏疽，足跟或跖趾关节受压部位出现溃疡，部分患者可肢体感染。",
          "start_idx": 64,
          "end_idx": 111,
          "entities": [
            {
              "entity_id": "T88",
              "entity": "静息痛",
              "entity_type": "Symptom",
              "start_idx": 10,
              "end_idx": 13,
              "entity_en": "Rest pain"
            },
            {
              "entity_id": "T89",
              "entity": "趾端出现坏疽",
              "entity_type": "Symptom",
              "start_idx": 14,
              "end_idx": 20,
              "entity_en": "Gangrene on the toe"
            },
            {
              "entity_id": "T90",
              "entity": "肢体感染",
              "entity_type": "Symptom",
              "start_idx": 42,
              "end_idx": 46,
              "entity_en": "Limb infection"
            },
            {
              "entity_id": "T92",
              "entity": "足跟或跖趾关节受压部位出现溃疡",
              "entity_type": "Symptom",
              "start_idx": 21,
              "end_idx": 36,
              "entity_en": "Ulcers at pressure points on the heel or metatarsophalangeal joints"
            }
          ],
          "relations": [],
          "sentence_en": "As the disease progresses, rest pain, gangrene on the toes, ulcers on the pressure sites of the heel or metatarsophalangeal joints may occur, and some patients may develop limb infections."
        },
        {
          "sentence_id": "2",
          "sentence": " ",
          "start_idx": 111,
          "end_idx": 112,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "Symptoms of lower limb ischemia: skin malnutrition, muscle atrophy, dry and inelastic skin, decreased skin temperature, pigmentation, weakened or absent arterial pulsation at the extremities, and patients may have symptoms of intermittent claudication in the lower limbs. As the lesion progresses, rest pain, gangrene at the toe tips, ulcers at the pressure points of the heel or metatarsophalangeal joints, and some patients may have limb infections."
    },
    {
      "paragraph_id": "10",
      "paragraph": "四、糖尿病足的辅助检查 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "四、糖尿病足的辅助检查 ",
          "start_idx": 0,
          "end_idx": 12,
          "entities": [
            {
              "entity_id": "T93",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 2,
              "end_idx": 6,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T94",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 5,
              "end_idx": 6,
              "entity_en": "foot"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R47",
              "head_entity_id": "T94",
              "tail_entity_id": "T93"
            }
          ],
          "sentence_en": "4. Auxiliary examination of diabetic foot"
        }
      ],
      "paragraph_en": "4. Auxiliary examination of diabetic foot"
    },
    {
      "paragraph_id": "11",
      "paragraph": "(一)神经系统检查 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(一)神经系统检查 ",
          "start_idx": 0,
          "end_idx": 10,
          "entities": [],
          "relations": [],
          "sentence_en": "(I) Neurological examination"
        }
      ],
      "paragraph_en": "(I) Neurological examination"
    },
    {
      "paragraph_id": "12",
      "paragraph": "糖尿病周围神经病变(diabetic peripheral neuropathy，DPN）可以通过以下几种方法得到诊断。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "糖尿病周围神经病变(diabetic peripheral neuropathy，DPN）可以通过以下几种方法得到诊断。",
          "start_idx": 0,
          "end_idx": 60,
          "entities": [
            {
              "entity_id": "T95",
              "entity": "糖尿病周围神经病变(diabetic peripheral neuropathy，DPN）",
              "entity_type": "Disease",
              "start_idx": 0,
              "end_idx": 45,
              "entity_en": "Diabetic peripheral neuropathy (DPN)"
            },
            {
              "entity_id": "T96",
              "entity": "周围神经",
              "entity_type": "Anatomy",
              "start_idx": 3,
              "end_idx": 7,
              "entity_en": "Peripheral nerves"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R48",
              "head_entity_id": "T96",
              "tail_entity_id": "T95"
            }
          ],
          "sentence_en": "Diabetic peripheral neuropathy (DPN) can be diagnosed in several ways."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 60,
          "end_idx": 61,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "Diabetic peripheral neuropathy (DPN) can be diagnosed in several ways."
    },
    {
      "paragraph_id": "13",
      "paragraph": "1.10g尼龙丝检查法：该方法是较为简便的感觉神经检测方法，要具备一根特制的尼龙丝(其弯曲45°能够产生10g的压力)。检查开始前，通常在患者手掌或前臂试用该尼龙丝2~3次，让患者感受1 0g尼龙丝产生压力的正常感觉。测试应对双侧足部进行检查；每个检查点施压时间约2-3s，时间不宜过长；检查部位应避开胼胝、水疱和溃疡面等；建议检测点为第1、3、5趾腹，第1、3、5跖骨头处，足心，足掌外侧，足跟及足背第1、2跖骨间共10个点，患者有2个或2个以上感觉异常点则视为异常。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "1.10g尼龙丝检查法：该方法是较为简便的感觉神经检测方法，要具备一根特制的尼龙丝(其弯曲45°能够产生10g的压力)。",
          "start_idx": 0,
          "end_idx": 60,
          "entities": [
            {
              "entity_id": "T97",
              "entity": "10g尼龙丝检查",
              "entity_type": "Test",
              "start_idx": 2,
              "end_idx": 10,
              "entity_en": "10g nylon yarn inspection"
            }
          ],
          "relations": [],
          "sentence_en": "1.10g nylon thread inspection method: This method is a relatively simple sensory nerve detection method, which requires a special nylon thread (which can generate 10g of pressure when bent at 45°)."
        },
        {
          "sentence_id": "1",
          "sentence": "检查开始前，通常在患者手掌或前臂试用该尼龙丝2~3次，让患者感受1 0g尼龙丝产生压力的正常感觉。",
          "start_idx": 60,
          "end_idx": 109,
          "entities": [],
          "relations": [],
          "sentence_en": "Before the examination begins, the nylon thread is usually tried on the patient's palm or forearm 2 to 3 times to let the patient feel the normal feeling of pressure produced by 10g of nylon thread."
        },
        {
          "sentence_id": "2",
          "sentence": "测试应对双侧足部进行检查；每个检查点施压时间约2-3s，时间不宜过长；检查部位应避开胼胝、水疱和溃疡面等；建议检测点为第1、3、5趾腹，第1、3、5跖骨头处，足心，足掌外侧，足跟及足背第1、2跖骨间共10个点，患者有2个或2个以上感觉异常点则视为异常。",
          "start_idx": 109,
          "end_idx": 235,
          "entities": [
            {
              "entity_id": "T98",
              "entity": "胼胝",
              "entity_type": "Symptom",
              "start_idx": 42,
              "end_idx": 44,
              "entity_en": "Callus"
            },
            {
              "entity_id": "T99",
              "entity": "水疱",
              "entity_type": "Symptom",
              "start_idx": 45,
              "end_idx": 47,
              "entity_en": "Blisters"
            },
            {
              "entity_id": "T100",
              "entity": "溃疡面",
              "entity_type": "Symptom",
              "start_idx": 48,
              "end_idx": 51,
              "entity_en": "Ulcer surface"
            }
          ],
          "relations": [],
          "sentence_en": "The test should be performed on both sides of the feet; pressure should be applied for about 2-3 seconds at each inspection point, and the time should not be too long; calluses, blisters and ulcers should be avoided; the recommended inspection points are the 1st, 3rd, and 5th toe webs, the 1st, 3rd, and 5th metatarsal heads, the center of the foot, the outside of the sole, the heel, and between the 1st and 2nd metatarsal bones on the dorsum of the foot, a total of 10 points. If the patient has 2 or more abnormal sensory points, it is considered abnormal."
        },
        {
          "sentence_id": "3",
          "sentence": " ",
          "start_idx": 235,
          "end_idx": 236,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "1.10g nylon thread inspection method: This method is a relatively simple sensory nerve detection method. It requires a special nylon thread (which can generate 10g pressure when bent at 45°). Before the inspection begins, the nylon thread is usually tried 2 to 3 times on the patient's palm or forearm to let the patient feel the normal feeling of pressure generated by the 10g nylon thread. The test should be performed on both feet; the pressure time for each inspection point is about 2-3s, and the time should not be too long; the inspection site should avoid calluses, blisters and ulcers; the recommended inspection points are the 1st, 3rd, and 5th toe webs, the 1st, 3rd, and 5th metatarsal heads, the sole of the foot, the outside of the sole, the heel, and the dorsum of the foot between the 1st and 2nd metatarsal bones, a total of 10 points. If the patient has 2 or more abnormal sensory points, it is considered abnormal."
    },
    {
      "paragraph_id": "14",
      "paragraph": "2.震动觉：该检查是对深部组织感觉的半定量检查。在进行前，首先将振动的音叉柄置于患者乳突处让其感受音叉的振动，然后分别置于双足的骨性凸起部位进行比较检查(第1跖趾关节内侧，内外踝)。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.震动觉：该检查是对深部组织感觉的半定量检查。",
          "start_idx": 0,
          "end_idx": 24,
          "entities": [
            {
              "entity_id": "T101",
              "entity": "震动觉",
              "entity_type": "Test",
              "start_idx": 2,
              "end_idx": 5,
              "entity_en": "Vibration Sense"
            }
          ],
          "relations": [],
          "sentence_en": "2. Vibration sense: This test is a semi-quantitative test of deep tissue sensation."
        },
        {
          "sentence_id": "1",
          "sentence": "在进行前，首先将振动的音叉柄置于患者乳突处让其感受音叉的振动，然后分别置于双足的骨性凸起部位进行比较检查(第1跖趾关节内侧，内外踝)。",
          "start_idx": 24,
          "end_idx": 91,
          "entities": [],
          "relations": [],
          "sentence_en": "Before the test, first place the handle of the vibrating tuning fork on the patient's mastoid process so that the patient can feel the vibration of the tuning fork, and then place it on the bony protrusions of both feet for comparative examination (inside the first metatarsophalangeal joint, inner and outer ankles)."
        },
        {
          "sentence_id": "2",
          "sentence": " ",
          "start_idx": 91,
          "end_idx": 92,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "2. Vibration sense: This test is a semi-quantitative test of deep tissue sensation. Before the test, first place the handle of a vibrating tuning fork on the patient's mastoid process to let the patient feel the vibration of the tuning fork, and then place it on the bony protrusions of both feet for comparative examination (the medial side of the first metatarsophalangeal joint, the medial and lateral malleolus)."
    },
    {
      "paragraph_id": "15",
      "paragraph": "3.踝反射、痛觉、温度觉：这3种检查方法，也可以应用于糖尿病周围神经病变的诊断。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "3.踝反射、痛觉、温度觉：这3种检查方法，也可以应用于糖尿病周围神经病变的诊断。",
          "start_idx": 0,
          "end_idx": 40,
          "entities": [
            {
              "entity_id": "T102",
              "entity": "踝反射",
              "entity_type": "Test",
              "start_idx": 2,
              "end_idx": 5,
              "entity_en": "Ankle reflex"
            },
            {
              "entity_id": "T103",
              "entity": "痛觉",
              "entity_type": "Test",
              "start_idx": 6,
              "end_idx": 8,
              "entity_en": "Pain"
            },
            {
              "entity_id": "T104",
              "entity": "温度觉",
              "entity_type": "Test",
              "start_idx": 9,
              "end_idx": 12,
              "entity_en": "Temperature sense"
            },
            {
              "entity_id": "T105",
              "entity": "糖尿病周围神经病变",
              "entity_type": "Disease",
              "start_idx": 27,
              "end_idx": 36,
              "entity_en": "Diabetic peripheral neuropathy"
            },
            {
              "entity_id": "T106",
              "entity": "周围神经",
              "entity_type": "Anatomy",
              "start_idx": 30,
              "end_idx": 34,
              "entity_en": "Peripheral nerves"
            }
          ],
          "relations": [
            {
              "relation_type": "Test_Disease",
              "relation_id": "R49",
              "head_entity_id": "T102",
              "tail_entity_id": "T105"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R50",
              "head_entity_id": "T103",
              "tail_entity_id": "T105"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R51",
              "head_entity_id": "T104",
              "tail_entity_id": "T105"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R52",
              "head_entity_id": "T106",
              "tail_entity_id": "T105"
            }
          ],
          "sentence_en": "3. Ankle reflex, pain sensation, and temperature sensation: These three examination methods can also be used in the diagnosis of diabetic peripheral neuropathy."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 40,
          "end_idx": 41,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "3. Ankle reflex, pain sensation, and temperature sensation: These three examination methods can also be used in the diagnosis of diabetic peripheral neuropathy."
    },
    {
      "paragraph_id": "16",
      "paragraph": "4.神经传导速度(nerve conduction velocity，NCV) ：过去被认为是DPN诊断的“金标准”，通常认为有两项或以上NCV减慢者结合其他症状体征及辅助检查可考虑存在DPN。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "4.神经传导速度(nerve conduction velocity，NCV) ：过去被认为是DPN诊断的“金标准”，通常认为有两项或以上NCV减慢者结合其他症状体征及辅助检查可考虑存在DPN。",
          "start_idx": 0,
          "end_idx": 97,
          "entities": [
            {
              "entity_id": "T107",
              "entity": "神经传导速度(nerve conduction velocity，NCV)",
              "entity_type": "Test",
              "start_idx": 2,
              "end_idx": 39,
              "entity_en": "Nerve conduction velocity (NCV)"
            },
            {
              "entity_id": "T108",
              "entity": "DPN",
              "entity_type": "Disease",
              "start_idx": 47,
              "end_idx": 50,
              "entity_en": "DPN"
            },
            {
              "entity_id": "T109",
              "entity": "NCV",
              "entity_type": "Test",
              "start_idx": 69,
              "end_idx": 72,
              "entity_en": "NCV"
            },
            {
              "entity_id": "T110",
              "entity": "DPN",
              "entity_type": "Disease",
              "start_idx": 93,
              "end_idx": 96,
              "entity_en": "DPN"
            }
          ],
          "relations": [
            {
              "relation_type": "Test_Disease",
              "relation_id": "R53",
              "head_entity_id": "T107",
              "tail_entity_id": "T108"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R54",
              "head_entity_id": "T109",
              "tail_entity_id": "T108"
            }
          ],
          "sentence_en": "4. Nerve conduction velocity (NCV): In the past, it was considered the \"gold standard\" for the diagnosis of DPN. It is generally believed that patients with two or more slowed NCVs combined with other symptoms, signs and auxiliary examinations may be considered to have DPN."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 97,
          "end_idx": 98,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "4. Nerve conduction velocity (NCV): In the past, it was considered the \"gold standard\" for the diagnosis of DPN. It is generally believed that patients with two or more slowed NCVs combined with other symptoms, signs and auxiliary examinations may be considered to have DPN."
    },
    {
      "paragraph_id": "17",
      "paragraph": "(二)血管病变检查 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(二)血管病变检查 ",
          "start_idx": 0,
          "end_idx": 10,
          "entities": [
            {
              "entity_id": "T111",
              "entity": "血管病变",
              "entity_type": "Disease",
              "start_idx": 3,
              "end_idx": 7,
              "entity_en": "Vascular disease"
            },
            {
              "entity_id": "T112",
              "entity": "血管",
              "entity_type": "Anatomy",
              "start_idx": 3,
              "end_idx": 5,
              "entity_en": "Blood vessel"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R55",
              "head_entity_id": "T112",
              "tail_entity_id": "T111"
            }
          ],
          "sentence_en": "(II) Vascular lesion examination"
        }
      ],
      "paragraph_en": "(II) Vascular lesion examination"
    },
    {
      "paragraph_id": "18",
      "paragraph": "1.体检：通过触诊，扪及股、腘、足背动脉和 (或) 胫后动脉搏动了解下肢血管病变；通过Buerger 试验了解下肢缺血情况。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "1.体检：通过触诊，扪及股、腘、足背动脉和 (或) 胫后动脉搏动了解下肢血管病变；通过Buerger 试验了解下肢缺血情况。",
          "start_idx": 0,
          "end_idx": 62,
          "entities": [
            {
              "entity_id": "T113",
              "entity": "体检",
              "entity_type": "Test",
              "start_idx": 2,
              "end_idx": 4,
              "entity_en": "Physical examination"
            },
            {
              "entity_id": "T114",
              "entity": "触诊",
              "entity_type": "Test",
              "start_idx": 7,
              "end_idx": 9,
              "entity_en": "palpation"
            },
            {
              "entity_id": "T115",
              "entity": "下肢血管病变",
              "entity_type": "Disease",
              "start_idx": 34,
              "end_idx": 40,
              "entity_en": "Lower extremity vascular disease"
            },
            {
              "entity_id": "T116",
              "entity": "下肢血管",
              "entity_type": "Anatomy",
              "start_idx": 34,
              "end_idx": 38,
              "entity_en": "Lower limb blood vessels"
            },
            {
              "entity_id": "T117",
              "entity": "Buerger 试验",
              "entity_type": "Test",
              "start_idx": 43,
              "end_idx": 53,
              "entity_en": "Buerger test"
            },
            {
              "entity_id": "T118",
              "entity": "下肢缺血",
              "entity_type": "Disease",
              "start_idx": 55,
              "end_idx": 59,
              "entity_en": "Lower limb ischemia"
            },
            {
              "entity_id": "T119",
              "entity": "下肢",
              "entity_type": "Anatomy",
              "start_idx": 55,
              "end_idx": 57,
              "entity_en": "Lower limbs"
            }
          ],
          "relations": [
            {
              "relation_type": "Test_Disease",
              "relation_id": "R56",
              "head_entity_id": "T113",
              "tail_entity_id": "T115"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R57",
              "head_entity_id": "T114",
              "tail_entity_id": "T115"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R58",
              "head_entity_id": "T116",
              "tail_entity_id": "T115"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R59",
              "head_entity_id": "T117",
              "tail_entity_id": "T118"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R60",
              "head_entity_id": "T119",
              "tail_entity_id": "T118"
            }
          ],
          "sentence_en": "1. Physical examination: palpate the femoral, popliteal, dorsalis pedis and/or posterior tibial artery pulsations to understand lower limb vascular lesions; perform the Buerger test to understand lower limb ischemia."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 62,
          "end_idx": 63,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "1. Physical examination: palpate the femoral, popliteal, dorsalis pedis and/or posterior tibial artery pulsations to understand lower limb vascular lesions; perform the Buerger test to understand lower limb ischemia."
    },
    {
      "paragraph_id": "19",
      "paragraph": "2.皮肤温度检查：红外线皮肤温度检查是一种简单、实用的评估局部血供的方法，最好采用温度差判断肢体血供。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.皮肤温度检查：红外线皮肤温度检查是一种简单、实用的评估局部血供的方法，最好采用温度差判断肢体血供。",
          "start_idx": 0,
          "end_idx": 51,
          "entities": [
            {
              "entity_id": "T120",
              "entity": "皮肤温度检查",
              "entity_type": "Test",
              "start_idx": 2,
              "end_idx": 8,
              "entity_en": "Skin temperature check"
            },
            {
              "entity_id": "T121",
              "entity": "红外线皮肤温度检查",
              "entity_type": "Test",
              "start_idx": 9,
              "end_idx": 18,
              "entity_en": "Infrared skin temperature test"
            }
          ],
          "relations": [],
          "sentence_en": "2. Skin temperature check: Infrared skin temperature check is a simple and practical method to evaluate local blood supply. It is best to use temperature difference to judge limb blood supply."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 51,
          "end_idx": 52,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "2. Skin temperature check: Infrared skin temperature check is a simple and practical method to evaluate local blood supply. It is best to use temperature difference to judge limb blood supply."
    },
    {
      "paragraph_id": "20",
      "paragraph": "3.踝动脉-肱动脉血压比值，又称踝肱指数(ankle brachial index，ABI) ：ABI反映的是肢体的血运状况，正常值为0.9~1.3，0.71~0.89为轻度缺血，0.5-0.7为中度缺血，<0.5为重度缺血，重度缺血的患者容易发生下肢(趾)坏疽。如果踝动脉收缩压过高，如高于200mmHg(1mmHg= 0.133kPa) 或ABI>1.3，则应高度怀疑患者有下肢动脉钙化，部分ABI正常患者，可能存在假阴性，可采用平板运动试验或趾臂指数(TBI）测定来纠正。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "3.踝动脉-肱动脉血压比值，又称踝肱指数(ankle brachial index，ABI) ：ABI反映的是肢体的血运状况，正常值为0.9~1.3，0.71~0.89为轻度缺血，0.5-0.7为中度缺血，<0.5为重度缺血，重度缺血的患者容易发生下肢(趾)坏疽。如果踝动脉收缩压过高，如高于200mmHg(1mmHg= 0.133kPa) 或ABI>1.3，则应高度怀疑患者有下肢动脉钙化，部分ABI正常患者，可能存在假阴性，可采用平板运动试验或趾臂指数(TBI）测定来纠正。",
          "start_idx": 0,
          "end_idx": 239,
          "entities": [
            {
              "entity_id": "T122",
              "entity": "缺血",
              "entity_type": "Disease",
              "start_idx": 87,
              "end_idx": 89,
              "entity_en": "Ischemia"
            },
            {
              "entity_id": "T123",
              "entity": "轻度",
              "entity_type": "Level",
              "start_idx": 85,
              "end_idx": 87,
              "entity_en": "Mild"
            },
            {
              "entity_id": "T124",
              "entity": "中度",
              "entity_type": "Level",
              "start_idx": 98,
              "end_idx": 100,
              "entity_en": "Moderate"
            },
            {
              "entity_id": "T125",
              "entity": "缺血",
              "entity_type": "Disease",
              "start_idx": 100,
              "end_idx": 102,
              "entity_en": "Ischemia"
            },
            {
              "entity_id": "T126",
              "entity": "重度",
              "entity_type": "Level",
              "start_idx": 108,
              "end_idx": 110,
              "entity_en": "Severe"
            },
            {
              "entity_id": "T127",
              "entity": "缺血",
              "entity_type": "Disease",
              "start_idx": 110,
              "end_idx": 112,
              "entity_en": "Ischemia"
            },
            {
              "entity_id": "T128",
              "entity": "重度",
              "entity_type": "Level",
              "start_idx": 113,
              "end_idx": 115,
              "entity_en": "Severe"
            },
            {
              "entity_id": "T129",
              "entity": "缺血",
              "entity_type": "Disease",
              "start_idx": 115,
              "end_idx": 117,
              "entity_en": "Ischemia"
            },
            {
              "entity_id": "T130",
              "entity": "下肢(趾)坏疽",
              "entity_type": "Symptom",
              "start_idx": 124,
              "end_idx": 131,
              "entity_en": "Gangrene of lower limbs (toes)"
            },
            {
              "entity_id": "T131",
              "entity": "下肢(趾)",
              "entity_type": "Anatomy",
              "start_idx": 124,
              "end_idx": 129,
              "entity_en": "Lower limbs (toes)"
            },
            {
              "entity_id": "T132",
              "entity": "踝动脉收缩压",
              "entity_type": "Test_items",
              "start_idx": 134,
              "end_idx": 140,
              "entity_en": "Ankle artery systolic pressure"
            },
            {
              "entity_id": "T133",
              "entity": "过高",
              "entity_type": "Test_Value",
              "start_idx": 140,
              "end_idx": 142,
              "entity_en": "Too high"
            },
            {
              "entity_id": "T134",
              "entity": "高于200mmHg(1mmHg= 0.133kPa)",
              "entity_type": "Test_Value",
              "start_idx": 144,
              "end_idx": 170,
              "entity_en": "Higher than 200mmHg (1mmHg = 0.133kPa)"
            },
            {
              "entity_id": "T135",
              "entity": "ABI",
              "entity_type": "Test",
              "start_idx": 172,
              "end_idx": 175,
              "entity_en": "ABI"
            },
            {
              "entity_id": "T136",
              "entity": "下肢动脉钙化",
              "entity_type": "Disease",
              "start_idx": 189,
              "end_idx": 195,
              "entity_en": "Lower extremity arterial calcification"
            },
            {
              "entity_id": "T137",
              "entity": "下肢动脉",
              "entity_type": "Anatomy",
              "start_idx": 189,
              "end_idx": 193,
              "entity_en": "Lower limb arteries"
            },
            {
              "entity_id": "T138",
              "entity": "平板运动试验",
              "entity_type": "Test",
              "start_idx": 217,
              "end_idx": 223,
              "entity_en": "Treadmill exercise test"
            },
            {
              "entity_id": "T139",
              "entity": ">1.3",
              "entity_type": "Test_Value",
              "start_idx": 175,
              "end_idx": 179,
              "entity_en": ">1.3"
            }
          ],
          "relations": [
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R61",
              "head_entity_id": "T130",
              "tail_entity_id": "T122"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R62",
              "head_entity_id": "T132",
              "tail_entity_id": "T136"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R63",
              "head_entity_id": "T135",
              "tail_entity_id": "T136"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R64",
              "head_entity_id": "T137",
              "tail_entity_id": "T136"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R65",
              "head_entity_id": "T138",
              "tail_entity_id": "T136"
            }
          ],
          "sentence_en": "3. Ankle artery-brachial artery blood pressure ratio, also known as ankle brachial index (ABI): ABI reflects the blood flow of the limbs. The normal value is 0.9~1.3, 0.71~0.89 is mild ischemia, 0.5-0.7 is moderate ischemia, and <0.5 is severe ischemia. Patients with severe ischemia are prone to lower limb (toe) gangrene. If the ankle artery systolic pressure is too high, such as higher than 200mmHg (1mmHg= 0.133kPa) or ABI>1.3, the patient should be highly suspected of lower limb artery calcification. Some patients with normal ABI may have false negatives, which can be corrected by treadmill exercise test or toe brachial index (TBI) measurement."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 239,
          "end_idx": 240,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "3. Ankle artery-brachial artery blood pressure ratio, also known as ankle brachial index (ABI): ABI reflects the blood flow of the limbs. The normal value is 0.9~1.3, 0.71~0.89 is mild ischemia, 0.5-0.7 is moderate ischemia, and <0.5 is severe ischemia. Patients with severe ischemia are prone to lower limb (toe) gangrene. If the ankle artery systolic pressure is too high, such as higher than 200mmHg (1mmHg= 0.133kPa) or ABI>1.3, the patient should be highly suspected of lower limb artery calcification. Some patients with normal ABI may have false negatives, which can be corrected by treadmill exercise test or toe brachial index (TBI) measurement."
    },
    {
      "paragraph_id": "21",
      "paragraph": "4.经皮氧分压(transcutaneous oxygenpressure，TcPO2)：正常人足背TcPO2>40 mmHg；如<30mmHg提示周围血液供应不足，足部易发生溃疡，或已有的溃疡难以愈合；如TcPO2<20mmHg，足溃疡几乎没有愈合的可能。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "4.经皮氧分压(transcutaneous oxygenpressure，TcPO2)：正常人足背TcPO2>40 mmHg；如<30mmHg提示周围血液供应不足，足部易发生溃疡，或已有的溃疡难以愈合；如TcPO2<20mmHg，足溃疡几乎没有愈合的可能。",
          "start_idx": 0,
          "end_idx": 129,
          "entities": [
            {
              "entity_id": "T140",
              "entity": "经皮氧分压(transcutaneous oxygenpressure，TcPO2)",
              "entity_type": "Test",
              "start_idx": 2,
              "end_idx": 44,
              "entity_en": "Transcutaneous oxygen pressure (TcPO2)"
            },
            {
              "entity_id": "T141",
              "entity": "TcPO2",
              "entity_type": "Test",
              "start_idx": 50,
              "end_idx": 55,
              "entity_en": "TcPO2"
            },
            {
              "entity_id": "T142",
              "entity": "周围血液供应不足",
              "entity_type": "Disease",
              "start_idx": 74,
              "end_idx": 82,
              "entity_en": "Inadequate peripheral blood supply"
            },
            {
              "entity_id": "T143",
              "entity": "溃疡",
              "entity_type": "Symptom",
              "start_idx": 88,
              "end_idx": 90,
              "entity_en": "ulcer"
            },
            {
              "entity_id": "T144",
              "entity": "足部",
              "entity_type": "Anatomy",
              "start_idx": 83,
              "end_idx": 85,
              "entity_en": "Foot"
            },
            {
              "entity_id": "T145",
              "entity": "溃疡难以愈合",
              "entity_type": "Symptom",
              "start_idx": 95,
              "end_idx": 101,
              "entity_en": "Ulcers that are difficult to heal"
            },
            {
              "entity_id": "T146",
              "entity": "足溃疡",
              "entity_type": "Symptom",
              "start_idx": 116,
              "end_idx": 119,
              "entity_en": "Foot ulcer"
            },
            {
              "entity_id": "T147",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 116,
              "end_idx": 117,
              "entity_en": "foot"
            },
            {
              "entity_id": "T148",
              "entity": "TcPO2",
              "entity_type": "Test",
              "start_idx": 103,
              "end_idx": 108,
              "entity_en": "TcPO2"
            },
            {
              "entity_id": "T149",
              "entity": "<30mmHg",
              "entity_type": "Test_Value",
              "start_idx": 65,
              "end_idx": 72,
              "entity_en": "<30 mmHg"
            },
            {
              "entity_id": "T150",
              "entity": "<20mmHg",
              "entity_type": "Test_Value",
              "start_idx": 108,
              "end_idx": 115,
              "entity_en": "<20 mmHg"
            },
            {
              "entity_id": "T151",
              "entity": ">40 mmHg",
              "entity_type": "Test_Value",
              "start_idx": 55,
              "end_idx": 63,
              "entity_en": ">40 mmHg"
            }
          ],
          "relations": [
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R66",
              "head_entity_id": "T143",
              "tail_entity_id": "T142"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R67",
              "head_entity_id": "T145",
              "tail_entity_id": "T142"
            }
          ],
          "sentence_en": "4. Transcutaneous oxygen pressure (TcPO2): In normal people, TcPO2 on the dorsum of the foot is >40 mmHg; if it is <30 mmHg, it indicates insufficient peripheral blood supply, the foot is prone to ulcers, or existing ulcers are difficult to heal; if TcPO2 is <20 mmHg, there is almost no possibility of healing of foot ulcers."
        }
      ],
      "paragraph_en": "4. Transcutaneous oxygen pressure (TcPO2): In normal people, TcPO2 on the dorsum of the foot is >40 mmHg; if it is <30 mmHg, it indicates insufficient peripheral blood supply, the foot is prone to ulcers, or existing ulcers are difficult to heal; if TcPO2 is <20 mmHg, there is almost no possibility of healing of foot ulcers."
    },
    {
      "paragraph_id": "23",
      "paragraph": "五、糖尿病足的诊断 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "五、糖尿病足的诊断 ",
          "start_idx": 0,
          "end_idx": 10,
          "entities": [
            {
              "entity_id": "T152",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 2,
              "end_idx": 6,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T153",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 5,
              "end_idx": 6,
              "entity_en": "foot"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R68",
              "head_entity_id": "T153",
              "tail_entity_id": "T152"
            }
          ],
          "sentence_en": "5. Diagnosis of diabetic foot"
        }
      ],
      "paragraph_en": "5. Diagnosis of diabetic foot"
    },
    {
      "paragraph_id": "24",
      "paragraph": "(一)? 糖尿病下肢血管病变的诊断",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(一)? 糖尿病下肢血管病变的诊断",
          "start_idx": 0,
          "end_idx": 17,
          "entities": [
            {
              "entity_id": "T154",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 5,
              "end_idx": 8,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T155",
              "entity": "下肢血管病变",
              "entity_type": "Disease",
              "start_idx": 8,
              "end_idx": 14,
              "entity_en": "Lower extremity vascular disease"
            },
            {
              "entity_id": "T156",
              "entity": "下肢血管",
              "entity_type": "Anatomy",
              "start_idx": 8,
              "end_idx": 12,
              "entity_en": "Lower limb blood vessels"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R69",
              "head_entity_id": "T156",
              "tail_entity_id": "T155"
            }
          ],
          "sentence_en": "(I) Diagnosis of diabetic lower limb vascular disease"
        }
      ],
      "paragraph_en": "(I) Diagnosis of diabetic lower limb vascular disease"
    },
    {
      "paragraph_id": "25",
      "paragraph": "诊断依据：(1)符合糖尿病诊断；(2)具有下肢缺血的临床表现；(3)辅助检查提示下肢血管病变。静息时ABI<0.9，或静息时ABI>0.9，但运动时出现下肢不适症状，行踏车平板试验后ABI降低1 5%-20%或影像学提示血管存在狭窄。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "诊断依据：(1)符合糖尿病诊断；(2)具有下肢缺血的临床表现；(3)辅助检查提示下肢血管病变。",
          "start_idx": 0,
          "end_idx": 47,
          "entities": [
            {
              "entity_id": "T157",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 10,
              "end_idx": 13,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T158",
              "entity": "下肢缺血",
              "entity_type": "Symptom",
              "start_idx": 21,
              "end_idx": 25,
              "entity_en": "Lower limb ischemia"
            },
            {
              "entity_id": "T159",
              "entity": "下肢血管病变",
              "entity_type": "Disease",
              "start_idx": 40,
              "end_idx": 46,
              "entity_en": "Lower extremity vascular disease"
            },
            {
              "entity_id": "T160",
              "entity": "下肢血管",
              "entity_type": "Anatomy",
              "start_idx": 40,
              "end_idx": 44,
              "entity_en": "Lower limb blood vessels"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R70",
              "head_entity_id": "T160",
              "tail_entity_id": "T159"
            }
          ],
          "sentence_en": "Diagnostic basis: (1) meeting the diagnosis of diabetes; (2) having clinical manifestations of lower limb ischemia; (3) auxiliary examinations indicating lower limb vascular disease."
        },
        {
          "sentence_id": "1",
          "sentence": "静息时ABI<0.9，或静息时ABI>0.9，但运动时出现下肢不适症状，行踏车平板试验后ABI降低1 5%-20%或影像学提示血管存在狭窄。",
          "start_idx": 47,
          "end_idx": 117,
          "entities": [
            {
              "entity_id": "T161",
              "entity": "运动",
              "entity_type": "Reason",
              "start_idx": 24,
              "end_idx": 26,
              "entity_en": "sports"
            },
            {
              "entity_id": "T162",
              "entity": "下肢不适",
              "entity_type": "Symptom",
              "start_idx": 29,
              "end_idx": 33,
              "entity_en": "Lower limb discomfort"
            },
            {
              "entity_id": "T163",
              "entity": "踏车平板试验",
              "entity_type": "Test",
              "start_idx": 37,
              "end_idx": 43,
              "entity_en": "Treadmill test"
            },
            {
              "entity_id": "T164",
              "entity": "影像学",
              "entity_type": "Test",
              "start_idx": 58,
              "end_idx": 61,
              "entity_en": "Imaging"
            },
            {
              "entity_id": "T165",
              "entity": "血管存在狭窄",
              "entity_type": "Symptom",
              "start_idx": 63,
              "end_idx": 69,
              "entity_en": "Stenosis of blood vessels"
            }
          ],
          "relations": [],
          "sentence_en": "ABI < 0.9 at rest, or ABI > 0.9 at rest, but lower limb discomfort symptoms occur during exercise, ABI decreases by 15%-20% after the treadmill test, or imaging suggests vascular stenosis."
        },
        {
          "sentence_id": "2",
          "sentence": " ",
          "start_idx": 117,
          "end_idx": 118,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "Diagnostic basis: (1) meeting the diagnosis of diabetes; (2) having clinical manifestations of lower limb ischemia; (3) auxiliary examinations indicating lower limb vascular disease. ABI < 0.9 at rest, or ABI > 0.9 at rest, but lower limb discomfort symptoms during exercise, ABI decreases by 15%-20% after treadmill test, or imaging indicates vascular stenosis."
    },
    {
      "paragraph_id": "26",
      "paragraph": "(二)糖尿病周围神经病变的诊断 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(二)糖尿病周围神经病变的诊断 ",
          "start_idx": 0,
          "end_idx": 16,
          "entities": [
            {
              "entity_id": "T166",
              "entity": "周围神经病变",
              "entity_type": "Disease",
              "start_idx": 6,
              "end_idx": 12,
              "entity_en": "Peripheral neuropathy"
            },
            {
              "entity_id": "T167",
              "entity": "周围神经",
              "entity_type": "Anatomy",
              "start_idx": 6,
              "end_idx": 10,
              "entity_en": "Peripheral nerves"
            },
            {
              "entity_id": "T168",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 3,
              "end_idx": 6,
              "entity_en": "diabetes"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R71",
              "head_entity_id": "T167",
              "tail_entity_id": "T166"
            }
          ],
          "sentence_en": "2. Diagnosis of diabetic peripheral neuropathy"
        }
      ],
      "paragraph_en": "2. Diagnosis of diabetic peripheral neuropathy"
    },
    {
      "paragraph_id": "27",
      "paragraph": "明确的糖尿病病史；在诊断糖尿病时或之后出现的神经病变；临床症状和体征与DPN的表现相符；以下5项检查中如果有2项或2项以上异常则诊断为DPN：(1) 温度觉异常； (2) 尼龙丝检查，足部感觉减退或消失；(3)振动觉异常；(4)踝反射消失； (5) NCV有2项或2项以上减慢。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "明确的糖尿病病史；在诊断糖尿病时或之后出现的神经病变；临床症状和体征与DPN的表现相符；以下5项检查中如果有2项或2项以上异常则诊断为DPN：(1) 温度觉异常； (2) 尼龙丝检查，足部感觉减退或消失；(3)振动觉异常；(4)踝反射消失； (5) NCV有2项或2项以上减慢。",
          "start_idx": 0,
          "end_idx": 139,
          "entities": [
            {
              "entity_id": "T169",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 3,
              "end_idx": 6,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T170",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 12,
              "end_idx": 15,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T171",
              "entity": "神经病变",
              "entity_type": "Disease",
              "start_idx": 22,
              "end_idx": 26,
              "entity_en": "Neuropathy"
            },
            {
              "entity_id": "T172",
              "entity": "神经",
              "entity_type": "Anatomy",
              "start_idx": 22,
              "end_idx": 24,
              "entity_en": "nerve"
            },
            {
              "entity_id": "T173",
              "entity": "DPN",
              "entity_type": "Disease",
              "start_idx": 35,
              "end_idx": 38,
              "entity_en": "DPN"
            },
            {
              "entity_id": "T174",
              "entity": "DPN",
              "entity_type": "Disease",
              "start_idx": 67,
              "end_idx": 70,
              "entity_en": "DPN"
            },
            {
              "entity_id": "T175",
              "entity": "温度觉",
              "entity_type": "Test",
              "start_idx": 75,
              "end_idx": 78,
              "entity_en": "Temperature sense"
            },
            {
              "entity_id": "T176",
              "entity": "异常",
              "entity_type": "Test_Value",
              "start_idx": 78,
              "end_idx": 80,
              "entity_en": "abnormal"
            },
            {
              "entity_id": "T177",
              "entity": "尼龙丝检查",
              "entity_type": "Test",
              "start_idx": 86,
              "end_idx": 91,
              "entity_en": "Nylon thread inspection"
            },
            {
              "entity_id": "T178",
              "entity": "足部感觉减退或消失",
              "entity_type": "Symptom",
              "start_idx": 92,
              "end_idx": 101,
              "entity_en": "Decreased or absent sensation in the feet"
            },
            {
              "entity_id": "T179",
              "entity": "振动觉",
              "entity_type": "Test",
              "start_idx": 105,
              "end_idx": 108,
              "entity_en": "Vibration Sense"
            },
            {
              "entity_id": "T180",
              "entity": "异常",
              "entity_type": "Test_Value",
              "start_idx": 108,
              "end_idx": 110,
              "entity_en": "abnormal"
            },
            {
              "entity_id": "T181",
              "entity": "踝反射",
              "entity_type": "Test",
              "start_idx": 114,
              "end_idx": 117,
              "entity_en": "Ankle reflexes"
            },
            {
              "entity_id": "T182",
              "entity": "消失",
              "entity_type": "Test_Value",
              "start_idx": 117,
              "end_idx": 119,
              "entity_en": "disappear"
            },
            {
              "entity_id": "T183",
              "entity": "NCV",
              "entity_type": "Test",
              "start_idx": 125,
              "end_idx": 128,
              "entity_en": "NCV"
            },
            {
              "entity_id": "T184",
              "entity": "2项或2项以上减慢",
              "entity_type": "Test_Value",
              "start_idx": 129,
              "end_idx": 138,
              "entity_en": "2 or more items slow down"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R72",
              "head_entity_id": "T172",
              "tail_entity_id": "T171"
            }
          ],
          "sentence_en": "A clear history of diabetes; neuropathy that develops at or after the diagnosis of diabetes; clinical symptoms and signs consistent with DPN; and DPN is diagnosed if two or more of the following five tests are abnormal: (1) abnormal temperature sensation; (2) decreased or absent foot sensation on nylon thread examination; (3) abnormal vibration sensation; (4) absent ankle reflexes; and (5) slowing of two or more NCV items."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 139,
          "end_idx": 140,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "A clear history of diabetes; neuropathy that develops at or after the diagnosis of diabetes; clinical symptoms and signs consistent with DPN; and a diagnosis of DPN if two or more of the following five tests are abnormal: (1) abnormal temperature sensation; (2) decreased or absent foot sensation on nylon thread examination; (3) abnormal vibration sensation; (4) absent ankle reflexes; and (5) slowing of two or more NCV items."
    },
    {
      "paragraph_id": "28",
      "paragraph": "排除其他病变如颈腰椎病变(神经根压迫、椎管狭窄、颈腰椎退行性变)、脑梗死、格林-巴利综合征、严重动静脉血管性病变(静脉栓塞、淋巴管炎)等，尚需鉴别药物尤其是化疗药物引起的神经毒性作用以及肾功能不全引起的代谢毒物对神经的损伤。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "排除其他病变如颈腰椎病变(神经根压迫、椎管狭窄、颈腰椎退行性变)、脑梗死、格林-巴利综合征、严重动静脉血管性病变(静脉栓塞、淋巴管炎)等，尚需鉴别药物尤其是化疗药物引起的神经毒性作用以及肾功能不全引起的代谢毒物对神经的损伤。",
          "start_idx": 0,
          "end_idx": 112,
          "entities": [
            {
              "entity_id": "T185",
              "entity": "颈腰椎病变",
              "entity_type": "Disease",
              "start_idx": 7,
              "end_idx": 12,
              "entity_en": "Cervical and lumbar spine disease"
            },
            {
              "entity_id": "T186",
              "entity": "颈腰椎",
              "entity_type": "Anatomy",
              "start_idx": 7,
              "end_idx": 10,
              "entity_en": "Cervical and Lumbar Spine"
            },
            {
              "entity_id": "T187",
              "entity": "神经根压迫",
              "entity_type": "Disease",
              "start_idx": 13,
              "end_idx": 18,
              "entity_en": "Nerve root compression"
            },
            {
              "entity_id": "T188",
              "entity": "神经根",
              "entity_type": "Anatomy",
              "start_idx": 13,
              "end_idx": 16,
              "entity_en": "Nerve roots"
            },
            {
              "entity_id": "T189",
              "entity": "椎管狭窄",
              "entity_type": "Disease",
              "start_idx": 19,
              "end_idx": 23,
              "entity_en": "Spinal stenosis"
            },
            {
              "entity_id": "T190",
              "entity": "椎管",
              "entity_type": "Anatomy",
              "start_idx": 19,
              "end_idx": 21,
              "entity_en": "Spinal canal"
            },
            {
              "entity_id": "T191",
              "entity": "颈腰椎退行性变",
              "entity_type": "Disease",
              "start_idx": 24,
              "end_idx": 31,
              "entity_en": "Degeneration of cervical and lumbar spine"
            },
            {
              "entity_id": "T192",
              "entity": "颈腰椎",
              "entity_type": "Anatomy",
              "start_idx": 24,
              "end_idx": 27,
              "entity_en": "Cervical and Lumbar Spine"
            },
            {
              "entity_id": "T193",
              "entity": "脑梗死",
              "entity_type": "Disease",
              "start_idx": 33,
              "end_idx": 36,
              "entity_en": "Cerebral infarction"
            },
            {
              "entity_id": "T194",
              "entity": "脑",
              "entity_type": "Anatomy",
              "start_idx": 33,
              "end_idx": 34,
              "entity_en": "brain"
            },
            {
              "entity_id": "T195",
              "entity": "格林-巴利综合征",
              "entity_type": "Disease",
              "start_idx": 37,
              "end_idx": 45,
              "entity_en": "Guillain-Barré syndrome"
            },
            {
              "entity_id": "T196",
              "entity": "严重",
              "entity_type": "Level",
              "start_idx": 46,
              "end_idx": 48,
              "entity_en": "serious"
            },
            {
              "entity_id": "T197",
              "entity": "动静脉血管性病变",
              "entity_type": "Disease",
              "start_idx": 48,
              "end_idx": 56,
              "entity_en": "Arteriovenous vascular disease"
            },
            {
              "entity_id": "T198",
              "entity": "动静脉",
              "entity_type": "Anatomy",
              "start_idx": 48,
              "end_idx": 51,
              "entity_en": "Arteries and veins"
            },
            {
              "entity_id": "T199",
              "entity": "静脉栓塞",
              "entity_type": "Disease",
              "start_idx": 57,
              "end_idx": 61,
              "entity_en": "Venous thrombosis"
            },
            {
              "entity_id": "T200",
              "entity": "静脉",
              "entity_type": "Anatomy",
              "start_idx": 57,
              "end_idx": 59,
              "entity_en": "vein"
            },
            {
              "entity_id": "T201",
              "entity": "淋巴管炎",
              "entity_type": "Disease",
              "start_idx": 62,
              "end_idx": 66,
              "entity_en": "Lymphangitis"
            },
            {
              "entity_id": "T202",
              "entity": "淋巴管",
              "entity_type": "Anatomy",
              "start_idx": 62,
              "end_idx": 65,
              "entity_en": "Lymphatic vessels"
            },
            {
              "entity_id": "T203",
              "entity": "肾功能不全",
              "entity_type": "Disease",
              "start_idx": 93,
              "end_idx": 98,
              "entity_en": "Renal insufficiency"
            },
            {
              "entity_id": "T204",
              "entity": "肾",
              "entity_type": "Anatomy",
              "start_idx": 93,
              "end_idx": 94,
              "entity_en": "kidney"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R73",
              "head_entity_id": "T188",
              "tail_entity_id": "T187"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R74",
              "head_entity_id": "T190",
              "tail_entity_id": "T189"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R75",
              "head_entity_id": "T192",
              "tail_entity_id": "T191"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R76",
              "head_entity_id": "T194",
              "tail_entity_id": "T193"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R77",
              "head_entity_id": "T198",
              "tail_entity_id": "T197"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R78",
              "head_entity_id": "T200",
              "tail_entity_id": "T199"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R79",
              "head_entity_id": "T202",
              "tail_entity_id": "T201"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R80",
              "head_entity_id": "T204",
              "tail_entity_id": "T203"
            }
          ],
          "sentence_en": "Other diseases such as cervical and lumbar spine diseases (nerve root compression, spinal stenosis, cervical and lumbar degeneration), cerebral infarction, Guillain-Barré syndrome, severe arteriovenous vascular diseases (venous thrombosis, lymphangitis), etc. should be excluded. It is also necessary to identify the neurotoxic effects caused by drugs, especially chemotherapy drugs, and the damage to the nerves caused by metabolic toxins caused by renal insufficiency."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 112,
          "end_idx": 113,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "Other diseases such as cervical and lumbar spine diseases (nerve root compression, spinal stenosis, cervical and lumbar degeneration), cerebral infarction, Guillain-Barré syndrome, severe arteriovenous vascular diseases (venous thrombosis, lymphangitis), etc. should be excluded. It is also necessary to identify the neurotoxic effects caused by drugs, especially chemotherapy drugs, and the damage to the nerves caused by metabolic toxins caused by renal insufficiency."
    },
    {
      "paragraph_id": "29",
      "paragraph": "个别学者对DPN诊断进行分层，第1层指有DPN的症状或体征(踝反射、压力觉、振动觉、针刺觉、温度觉任意1项体征为阳性)，同时存在神经传导功能异常，可确诊；第2层指有DPN的症状及1项体征为阳性，或无症状但有2项及以上体征为阳性，可临床诊断；第3层指有DPN的症状但无体征或无症状但有1项体征阳性，为疑似诊断；第4层指无症状和体征，仅存在神经传导功能异常，为亚临床诊断。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "个别学者对DPN诊断进行分层，第1层指有DPN的症状或体征(踝反射、压力觉、振动觉、针刺觉、温度觉任意1项体征为阳性)，同时存在神经传导功能异常，可确诊；第2层指有DPN的症状及1项体征为阳性，或无症状但有2项及以上体征为阳性，可临床诊断；第3层指有DPN的症状但无体征或无症状但有1项体征阳性，为疑似诊断；第4层指无症状和体征，仅存在神经传导功能异常，为亚临床诊断。",
          "start_idx": 0,
          "end_idx": 184,
          "entities": [
            {
              "entity_id": "T205",
              "entity": "DPN",
              "entity_type": "Disease",
              "start_idx": 5,
              "end_idx": 8,
              "entity_en": "DPN"
            },
            {
              "entity_id": "T206",
              "entity": "DPN",
              "entity_type": "Disease",
              "start_idx": 20,
              "end_idx": 23,
              "entity_en": "DPN"
            },
            {
              "entity_id": "T207",
              "entity": "踝反射",
              "entity_type": "Test",
              "start_idx": 30,
              "end_idx": 33,
              "entity_en": "Ankle reflexes"
            },
            {
              "entity_id": "T208",
              "entity": "压力觉",
              "entity_type": "Test",
              "start_idx": 34,
              "end_idx": 37,
              "entity_en": "Pressure sensation"
            },
            {
              "entity_id": "T209",
              "entity": "振动觉",
              "entity_type": "Test",
              "start_idx": 38,
              "end_idx": 41,
              "entity_en": "Vibration Sense"
            },
            {
              "entity_id": "T210",
              "entity": "针刺觉",
              "entity_type": "Test",
              "start_idx": 42,
              "end_idx": 45,
              "entity_en": "Pinprick sensation"
            },
            {
              "entity_id": "T211",
              "entity": "温度觉",
              "entity_type": "Test",
              "start_idx": 46,
              "end_idx": 49,
              "entity_en": "Temperature sense"
            },
            {
              "entity_id": "T212",
              "entity": "神经传导功能异常",
              "entity_type": "Symptom",
              "start_idx": 64,
              "end_idx": 72,
              "entity_en": "Nerve conduction dysfunction"
            },
            {
              "entity_id": "T213",
              "entity": "神经",
              "entity_type": "Anatomy",
              "start_idx": 64,
              "end_idx": 66,
              "entity_en": "nerve"
            },
            {
              "entity_id": "T214",
              "entity": "DPN",
              "entity_type": "Disease",
              "start_idx": 82,
              "end_idx": 85,
              "entity_en": "DPN"
            },
            {
              "entity_id": "T215",
              "entity": "DPN",
              "entity_type": "Disease",
              "start_idx": 125,
              "end_idx": 128,
              "entity_en": "DPN"
            },
            {
              "entity_id": "T216",
              "entity": "神经传导功能异常",
              "entity_type": "Symptom",
              "start_idx": 168,
              "end_idx": 176,
              "entity_en": "Nerve conduction dysfunction"
            },
            {
              "entity_id": "T217",
              "entity": "神经",
              "entity_type": "Anatomy",
              "start_idx": 168,
              "end_idx": 170,
              "entity_en": "nerve"
            }
          ],
          "relations": [
            {
              "relation_type": "Test_Disease",
              "relation_id": "R81",
              "head_entity_id": "T207",
              "tail_entity_id": "T205"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R82",
              "head_entity_id": "T208",
              "tail_entity_id": "T205"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R83",
              "head_entity_id": "T209",
              "tail_entity_id": "T205"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R84",
              "head_entity_id": "T210",
              "tail_entity_id": "T205"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R85",
              "head_entity_id": "T211",
              "tail_entity_id": "T205"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R86",
              "head_entity_id": "T212",
              "tail_entity_id": "T205"
            }
          ],
          "sentence_en": "Some scholars have stratified the diagnosis of DPN. The first level refers to the presence of symptoms or signs of DPN (any one of the signs of ankle reflex, pressure sensation, vibration sensation, pinprick sensation, and temperature sensation is positive) and abnormal nerve conduction function, which can be confirmed; the second level refers to the presence of symptoms of DPN and one positive sign, or no symptoms but two or more positive signs, which can be clinically diagnosed; the third level refers to the presence of symptoms of DPN but no signs, or no symptoms but one positive sign, which is a suspected diagnosis; the fourth level refers to the absence of symptoms and signs, and only abnormal nerve conduction function, which is a subclinical diagnosis."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 184,
          "end_idx": 185,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "Some scholars have stratified the diagnosis of DPN. The first level refers to the presence of symptoms or signs of DPN (any one of the signs of ankle reflex, pressure sensation, vibration sensation, pinprick sensation, and temperature sensation is positive) and abnormal nerve conduction function, which can be confirmed; the second level refers to the presence of symptoms of DPN and one positive sign, or no symptoms but two or more positive signs, which can be clinically diagnosed; the third level refers to the presence of symptoms of DPN but no signs, or no symptoms but one positive sign, which is a suspected diagnosis; the fourth level refers to the absence of symptoms and signs, and only abnormal nerve conduction function, which is a subclinical diagnosis."
    },
    {
      "paragraph_id": "30",
      "paragraph": "(三)糖尿病足感染 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(三)糖尿病足感染 ",
          "start_idx": 0,
          "end_idx": 10,
          "entities": [
            {
              "entity_id": "T218",
              "entity": "糖尿病足感染",
              "entity_type": "Disease",
              "start_idx": 3,
              "end_idx": 9,
              "entity_en": "Diabetic foot infection"
            },
            {
              "entity_id": "T219",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 6,
              "end_idx": 7,
              "entity_en": "foot"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R87",
              "head_entity_id": "T219",
              "tail_entity_id": "T218"
            }
          ],
          "sentence_en": "3. Diabetic foot infection"
        }
      ],
      "paragraph_en": "3. Diabetic foot infection"
    },
    {
      "paragraph_id": "31",
      "paragraph": "糖尿病患者足踝以下部位的感染，糖尿病足感染依据感染范围和症状分为轻中重度(表1)。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "糖尿病患者足踝以下部位的感染，糖尿病足感染依据感染范围和症状分为轻中重度(表1)。",
          "start_idx": 0,
          "end_idx": 41,
          "entities": [
            {
              "entity_id": "T220",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 0,
              "end_idx": 3,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T221",
              "entity": "足踝以下部位的感染",
              "entity_type": "Symptom",
              "start_idx": 5,
              "end_idx": 14,
              "entity_en": "Infections below the ankle"
            },
            {
              "entity_id": "T222",
              "entity": "足踝以下部位",
              "entity_type": "Anatomy",
              "start_idx": 5,
              "end_idx": 11,
              "entity_en": "Below the ankle"
            },
            {
              "entity_id": "T223",
              "entity": "糖尿病足感染",
              "entity_type": "Disease",
              "start_idx": 15,
              "end_idx": 21,
              "entity_en": "Diabetic foot infection"
            },
            {
              "entity_id": "T224",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 18,
              "end_idx": 19,
              "entity_en": "foot"
            },
            {
              "entity_id": "T225",
              "entity": "轻中重度",
              "entity_type": "Level",
              "start_idx": 32,
              "end_idx": 36,
              "entity_en": "Mild, moderate and severe"
            }
          ],
          "relations": [
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R88",
              "head_entity_id": "T221",
              "tail_entity_id": "T220"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R89",
              "head_entity_id": "T224",
              "tail_entity_id": "T223"
            }
          ],
          "sentence_en": "Diabetic foot infections below the ankle are classified into mild, moderate and severe levels according to the extent of infection and symptoms (Table 1)."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 41,
          "end_idx": 42,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "Diabetic foot infections below the ankle are classified into mild, moderate and severe levels according to the extent of infection and symptoms (Table 1)."
    },
    {
      "paragraph_id": "32",
      "paragraph": "(四)糖尿病足的分类、分级 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(四)糖尿病足的分类、分级 ",
          "start_idx": 0,
          "end_idx": 14,
          "entities": [
            {
              "entity_id": "T226",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 3,
              "end_idx": 7,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T227",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 6,
              "end_idx": 7,
              "entity_en": "foot"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R90",
              "head_entity_id": "T227",
              "tail_entity_id": "T226"
            }
          ],
          "sentence_en": "4. Classification and grading of diabetic foot"
        }
      ],
      "paragraph_en": "4. Classification and grading of diabetic foot"
    },
    {
      "paragraph_id": "33",
      "paragraph": "糖尿病足的表现为感染、溃疡和坏疽。溃疡依据病因可分为神经性、缺血性和混合性溃疡；坏疽的性质可分为湿性坏疽、干性坏疽和混合性坏疽3种类型。治疗前对糖尿病足患者进行正确的分类和分级，有助于选择合理的治疗方案和判断预后。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "糖尿病足的表现为感染、溃疡和坏疽。溃疡依据病因可分为神经性、缺血性和混合性溃疡；坏疽的性质可分为湿性坏疽、干性坏疽和混合性坏疽3种类型。",
          "start_idx": 0,
          "end_idx": 68,
          "entities": [
            {
              "entity_id": "T228",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 0,
              "end_idx": 4,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T229",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 3,
              "end_idx": 4,
              "entity_en": "foot"
            },
            {
              "entity_id": "T230",
              "entity": "感染",
              "entity_type": "Symptom",
              "start_idx": 8,
              "end_idx": 10,
              "entity_en": "Infect"
            },
            {
              "entity_id": "T231",
              "entity": "溃疡",
              "entity_type": "Symptom",
              "start_idx": 11,
              "end_idx": 13,
              "entity_en": "ulcer"
            },
            {
              "entity_id": "T232",
              "entity": "坏疽",
              "entity_type": "Symptom",
              "start_idx": 14,
              "end_idx": 16,
              "entity_en": "gangrene"
            },
            {
              "entity_id": "T233",
              "entity": "溃疡",
              "entity_type": "Disease",
              "start_idx": 17,
              "end_idx": 19,
              "entity_en": "ulcer"
            },
            {
              "entity_id": "T234",
              "entity": "坏疽",
              "entity_type": "Disease",
              "start_idx": 40,
              "end_idx": 42,
              "entity_en": "gangrene"
            },
            {
              "entity_id": "T235",
              "entity": "湿性坏疽",
              "entity_type": "Disease",
              "start_idx": 48,
              "end_idx": 52,
              "entity_en": "Wet gangrene"
            },
            {
              "entity_id": "T236",
              "entity": "干性坏疽",
              "entity_type": "Disease",
              "start_idx": 53,
              "end_idx": 57,
              "entity_en": "Dry gangrene"
            },
            {
              "entity_id": "T237",
              "entity": "混合性坏疽",
              "entity_type": "Disease",
              "start_idx": 58,
              "end_idx": 63,
              "entity_en": "Mixed gangrene"
            },
            {
              "entity_id": "T240",
              "entity": "混合性溃疡",
              "entity_type": "Disease",
              "start_idx": 34,
              "end_idx": 39,
              "entity_en": "Mixed ulcer"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R91",
              "head_entity_id": "T229",
              "tail_entity_id": "T228"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R92",
              "head_entity_id": "T230",
              "tail_entity_id": "T228"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R93",
              "head_entity_id": "T231",
              "tail_entity_id": "T228"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R94",
              "head_entity_id": "T232",
              "tail_entity_id": "T228"
            }
          ],
          "sentence_en": "The manifestations of diabetic foot are infection, ulcers and gangrene. Ulcers can be divided into neuropathic, ischemic and mixed ulcers according to the cause; the nature of gangrene can be divided into three types: wet gangrene, dry gangrene and mixed gangrene."
        },
        {
          "sentence_id": "1",
          "sentence": "治疗前对糖尿病足患者进行正确的分类和分级，有助于选择合理的治疗方案和判断预后。",
          "start_idx": 68,
          "end_idx": 107,
          "entities": [
            {
              "entity_id": "T238",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 4,
              "end_idx": 8,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T239",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 7,
              "end_idx": 8,
              "entity_en": "foot"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R95",
              "head_entity_id": "T239",
              "tail_entity_id": "T238"
            }
          ],
          "sentence_en": "Correct classification and grading of diabetic foot patients before treatment will help choose a reasonable treatment plan and judge the prognosis."
        },
        {
          "sentence_id": "2",
          "sentence": " ",
          "start_idx": 107,
          "end_idx": 108,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "Diabetic foot symptoms include infection, ulcers, and gangrene. Ulcers can be divided into neuropathic, ischemic, and mixed ulcers based on their etiology; gangrene can be divided into three types: wet gangrene, dry gangrene, and mixed gangrene. Correct classification and grading of diabetic foot patients before treatment will help choose a reasonable treatment plan and determine the prognosis."
    },
    {
      "paragraph_id": "34",
      "paragraph": "1.依据溃疡的病因进行分类",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "1.依据溃疡的病因进行分类",
          "start_idx": 0,
          "end_idx": 13,
          "entities": [
            {
              "entity_id": "T241",
              "entity": "溃疡",
              "entity_type": "Disease",
              "start_idx": 4,
              "end_idx": 6,
              "entity_en": "ulcer"
            }
          ],
          "relations": [],
          "sentence_en": "1. Classification based on the cause of ulcer"
        }
      ],
      "paragraph_en": "1. Classification based on the cause of ulcer"
    },
    {
      "paragraph_id": "35",
      "paragraph": "(1)神经性溃疡：神经性溃疡患者通常有患足麻木、感觉异常、皮肤干燥，但皮温正常，足背动脉搏动良好。病情严重者可发展为神经性关节病 (Charcot关节病)。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(1)神经性溃疡：神经性溃疡患者通常有患足麻木、感觉异常、皮肤干燥，但皮温正常，足背动脉搏动良好。病情严重者可发展为神经性关节病 (Charcot关节病)。",
          "start_idx": 0,
          "end_idx": 78,
          "entities": [
            {
              "entity_id": "T242",
              "entity": "神经性溃疡",
              "entity_type": "Disease",
              "start_idx": 3,
              "end_idx": 8,
              "entity_en": "Neuropathic ulcers"
            },
            {
              "entity_id": "T243",
              "entity": "神经性溃疡",
              "entity_type": "Disease",
              "start_idx": 9,
              "end_idx": 14,
              "entity_en": "Neuropathic ulcers"
            },
            {
              "entity_id": "T244",
              "entity": "患足麻木",
              "entity_type": "Symptom",
              "start_idx": 19,
              "end_idx": 23,
              "entity_en": "Numbness in the foot"
            },
            {
              "entity_id": "T245",
              "entity": "感觉异常",
              "entity_type": "Symptom",
              "start_idx": 24,
              "end_idx": 28,
              "entity_en": "Paresthesias"
            },
            {
              "entity_id": "T246",
              "entity": "皮肤干燥",
              "entity_type": "Symptom",
              "start_idx": 29,
              "end_idx": 33,
              "entity_en": "Dry skin"
            },
            {
              "entity_id": "T247",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 20,
              "end_idx": 21,
              "entity_en": "foot"
            },
            {
              "entity_id": "T248",
              "entity": "皮肤",
              "entity_type": "Anatomy",
              "start_idx": 29,
              "end_idx": 31,
              "entity_en": "skin"
            },
            {
              "entity_id": "T249",
              "entity": "严重",
              "entity_type": "Level",
              "start_idx": 51,
              "end_idx": 53,
              "entity_en": "serious"
            },
            {
              "entity_id": "T250",
              "entity": "神经性关节病 (Charcot关节病)",
              "entity_type": "Disease",
              "start_idx": 58,
              "end_idx": 77,
              "entity_en": "Neuropathic arthropathy (Charcot arthropathy)"
            },
            {
              "entity_id": "T251",
              "entity": "关节",
              "entity_type": "Anatomy",
              "start_idx": 61,
              "end_idx": 63,
              "entity_en": "joint"
            }
          ],
          "relations": [
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R96",
              "head_entity_id": "T244",
              "tail_entity_id": "T242"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R97",
              "head_entity_id": "T245",
              "tail_entity_id": "T242"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R98",
              "head_entity_id": "T246",
              "tail_entity_id": "T242"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R99",
              "head_entity_id": "T251",
              "tail_entity_id": "T250"
            }
          ],
          "sentence_en": "(1) Neuropathic ulcers: Patients with neuropathic ulcers usually experience numbness, paresthesia, and dry skin in the affected foot, but their skin temperature is normal and the dorsalis pedis artery pulse is good. Severe cases may develop into neuropathic arthropathy (Charcot arthropathy)."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 78,
          "end_idx": 79,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "(1) Neuropathic ulcers: Patients with neuropathic ulcers usually experience numbness, paresthesia, and dry skin in the affected foot, but their skin temperature is normal and the dorsalis pedis artery pulse is good. Severe cases may develop into neuropathic arthropathy (Charcot arthropathy)."
    },
    {
      "paragraph_id": "36",
      "paragraph": "(2)神经-缺血性溃疡：同时具有周围神经病变和周围血管病变，糖尿病足患者以此类居多。患者除了有神经性溃疡症状外还有下肢发凉感、间敏性跛行、静息痛等，足背动脉搏动减弱或消失，足部温减低，在进行清创换药时创面渗血少。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(2)神经-缺血性溃疡：同时具有周围神经病变和周围血管病变，糖尿病足患者以此类居多。患者除了有神经性溃疡症状外还有下肢发凉感、间敏性跛行、静息痛等，足背动脉搏动减弱或消失，足部温减低，在进行清创换药时创面渗血少。",
          "start_idx": 0,
          "end_idx": 106,
          "entities": [
            {
              "entity_id": "T252",
              "entity": "神经-缺血性溃疡",
              "entity_type": "Disease",
              "start_idx": 3,
              "end_idx": 11,
              "entity_en": "Neuro-ischemic ulcer"
            },
            {
              "entity_id": "T253",
              "entity": "周围神经病变",
              "entity_type": "Disease",
              "start_idx": 16,
              "end_idx": 22,
              "entity_en": "Peripheral neuropathy"
            },
            {
              "entity_id": "T254",
              "entity": "周围神经",
              "entity_type": "Anatomy",
              "start_idx": 16,
              "end_idx": 20,
              "entity_en": "Peripheral nerves"
            },
            {
              "entity_id": "T255",
              "entity": "周围血管病变",
              "entity_type": "Disease",
              "start_idx": 23,
              "end_idx": 29,
              "entity_en": "Peripheral vascular disease"
            },
            {
              "entity_id": "T256",
              "entity": "周围血管",
              "entity_type": "Anatomy",
              "start_idx": 23,
              "end_idx": 27,
              "entity_en": "Peripheral blood vessels"
            },
            {
              "entity_id": "T257",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 30,
              "end_idx": 34,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T258",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 33,
              "end_idx": 34,
              "entity_en": "foot"
            },
            {
              "entity_id": "T259",
              "entity": "神经性溃疡",
              "entity_type": "Disease",
              "start_idx": 47,
              "end_idx": 52,
              "entity_en": "Neuropathic ulcers"
            },
            {
              "entity_id": "T260",
              "entity": "下肢发凉感",
              "entity_type": "Symptom",
              "start_idx": 57,
              "end_idx": 62,
              "entity_en": "Coolness in lower limbs"
            },
            {
              "entity_id": "T261",
              "entity": "间敏性跛行",
              "entity_type": "Symptom",
              "start_idx": 63,
              "end_idx": 68,
              "entity_en": "Allergic claudication"
            },
            {
              "entity_id": "T262",
              "entity": "静息痛",
              "entity_type": "Symptom",
              "start_idx": 69,
              "end_idx": 72,
              "entity_en": "Rest pain"
            },
            {
              "entity_id": "T263",
              "entity": "足背动脉搏动减弱或消失",
              "entity_type": "Symptom",
              "start_idx": 74,
              "end_idx": 85,
              "entity_en": "The dorsalis pedis artery pulse is weakened or absent"
            },
            {
              "entity_id": "T264",
              "entity": "足部温减低",
              "entity_type": "Symptom",
              "start_idx": 86,
              "end_idx": 91,
              "entity_en": "Reduced foot temperature"
            },
            {
              "entity_id": "T265",
              "entity": "创面渗血少",
              "entity_type": "Symptom",
              "start_idx": 100,
              "end_idx": 105,
              "entity_en": "Less bleeding from wound"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R100",
              "head_entity_id": "T254",
              "tail_entity_id": "T253"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R101",
              "head_entity_id": "T256",
              "tail_entity_id": "T255"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R102",
              "head_entity_id": "T258",
              "tail_entity_id": "T257"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R103",
              "head_entity_id": "T260",
              "tail_entity_id": "T259"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R104",
              "head_entity_id": "T261",
              "tail_entity_id": "T259"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R105",
              "head_entity_id": "T262",
              "tail_entity_id": "T259"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R106",
              "head_entity_id": "T263",
              "tail_entity_id": "T259"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R107",
              "head_entity_id": "T264",
              "tail_entity_id": "T259"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R108",
              "head_entity_id": "T265",
              "tail_entity_id": "T259"
            }
          ],
          "sentence_en": "(2) Neuro-ischemic ulcer: Patients with both peripheral neuropathy and peripheral vascular disease are mostly of this type. In addition to the symptoms of neuropathic ulcer, patients also have lower limb coldness, intermittent claudication, resting pain, etc., dorsalis pedis artery pulsation is weakened or absent, foot temperature is reduced, and there is less bleeding from the wound during debridement and dressing change."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 106,
          "end_idx": 107,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "(2) Neuro-ischemic ulcer: Patients with both peripheral neuropathy and peripheral vascular disease are mostly of this type. In addition to the symptoms of neuropathic ulcer, patients also have lower limb coldness, intermittent claudication, resting pain, etc., dorsalis pedis artery pulsation is weakened or absent, foot temperature is reduced, and there is less bleeding from the wound during debridement and dressing change."
    },
    {
      "paragraph_id": "37",
      "paragraph": "(3)单纯缺血性溃疡：此类患者无周围神经病变，以缺血性改变为主，较少见，需根据症状、体征及相关检查排除周围神经病变后方可诊断。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(3)单纯缺血性溃疡：此类患者无周围神经病变，以缺血性改变为主，较少见，需根据症状、体征及相关检查排除周围神经病变后方可诊断。",
          "start_idx": 0,
          "end_idx": 63,
          "entities": [
            {
              "entity_id": "T266",
              "entity": "单纯缺血性溃疡",
              "entity_type": "Disease",
              "start_idx": 3,
              "end_idx": 10,
              "entity_en": "Simple ischemic ulcer"
            },
            {
              "entity_id": "T267",
              "entity": "周围神经病变",
              "entity_type": "Disease",
              "start_idx": 16,
              "end_idx": 22,
              "entity_en": "Peripheral neuropathy"
            },
            {
              "entity_id": "T268",
              "entity": "周围神经",
              "entity_type": "Anatomy",
              "start_idx": 16,
              "end_idx": 20,
              "entity_en": "Peripheral nerves"
            },
            {
              "entity_id": "T269",
              "entity": "缺血性改变为主",
              "entity_type": "Symptom",
              "start_idx": 24,
              "end_idx": 31,
              "entity_en": "Mainly ischemic changes"
            },
            {
              "entity_id": "T270",
              "entity": "周围神经病变",
              "entity_type": "Disease",
              "start_idx": 51,
              "end_idx": 57,
              "entity_en": "Peripheral neuropathy"
            },
            {
              "entity_id": "T271",
              "entity": "周围神经",
              "entity_type": "Anatomy",
              "start_idx": 51,
              "end_idx": 55,
              "entity_en": "Peripheral nerves"
            }
          ],
          "relations": [
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R109",
              "head_entity_id": "T269",
              "tail_entity_id": "T266"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R110",
              "head_entity_id": "T268",
              "tail_entity_id": "T267"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R111",
              "head_entity_id": "T271",
              "tail_entity_id": "T270"
            }
          ],
          "sentence_en": "(3) Simple ischemic ulcer: This type of patient does not have peripheral neuropathy, but mainly presents ischemic changes, which are relatively rare and can only be diagnosed after peripheral neuropathy is excluded based on symptoms, signs and related examinations."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 63,
          "end_idx": 64,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "(3) Simple ischemic ulcer: This type of patient does not have peripheral neuropathy, but mainly presents ischemic changes. It is relatively rare and can only be diagnosed after peripheral neuropathy is excluded based on symptoms, signs and related examinations."
    },
    {
      "paragraph_id": "38",
      "paragraph": "2.依据坏疽的性质分类 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.依据坏疽的性质分类 ",
          "start_idx": 0,
          "end_idx": 12,
          "entities": [
            {
              "entity_id": "T272",
              "entity": "坏疽",
              "entity_type": "Disease",
              "start_idx": 4,
              "end_idx": 6,
              "entity_en": "gangrene"
            }
          ],
          "relations": [],
          "sentence_en": "2. Classification based on the nature of gangrene"
        }
      ],
      "paragraph_en": "2. Classification based on the nature of gangrene"
    },
    {
      "paragraph_id": "39",
      "paragraph": "(1)湿性坏疽：糖尿病湿性坏疽发病人数较多。多因肢端循环及微循环障碍，常伴周围神经病变和患足感染。局部常有红、肿、热、痛、功能障碍等，严重者常伴有毒血症或败血症等临床表现。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(1)湿性坏疽：糖尿病湿性坏疽发病人数较多。",
          "start_idx": 0,
          "end_idx": 22,
          "entities": [
            {
              "entity_id": "T273",
              "entity": "湿性坏疽",
              "entity_type": "Disease",
              "start_idx": 3,
              "end_idx": 7,
              "entity_en": "Wet gangrene"
            },
            {
              "entity_id": "T274",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 8,
              "end_idx": 11,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T275",
              "entity": "湿性坏疽",
              "entity_type": "Disease",
              "start_idx": 11,
              "end_idx": 15,
              "entity_en": "Wet gangrene"
            }
          ],
          "relations": [],
          "sentence_en": "(1) Wet gangrene: Diabetic wet gangrene is more common."
        },
        {
          "sentence_id": "1",
          "sentence": "多因肢端循环及微循环障碍，常伴周围神经病变和患足感染。",
          "start_idx": 22,
          "end_idx": 49,
          "entities": [
            {
              "entity_id": "T276",
              "entity": "肢端循环及微循环障碍",
              "entity_type": "Reason",
              "start_idx": 2,
              "end_idx": 12,
              "entity_en": "Acrocirculatory and microcirculatory disorders"
            },
            {
              "entity_id": "T277",
              "entity": "周围神经病变",
              "entity_type": "Disease",
              "start_idx": 15,
              "end_idx": 21,
              "entity_en": "Peripheral neuropathy"
            },
            {
              "entity_id": "T278",
              "entity": "周围神经",
              "entity_type": "Anatomy",
              "start_idx": 15,
              "end_idx": 19,
              "entity_en": "Peripheral nerves"
            },
            {
              "entity_id": "T279",
              "entity": "患足感染",
              "entity_type": "Disease",
              "start_idx": 22,
              "end_idx": 26,
              "entity_en": "Foot infection"
            },
            {
              "entity_id": "T280",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 23,
              "end_idx": 24,
              "entity_en": "foot"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R112",
              "head_entity_id": "T278",
              "tail_entity_id": "T277"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R113",
              "head_entity_id": "T280",
              "tail_entity_id": "T279"
            }
          ],
          "sentence_en": "It is mostly caused by limb circulation and microcirculation disorders, often accompanied by peripheral neuropathy and foot infection."
        },
        {
          "sentence_id": "2",
          "sentence": "局部常有红、肿、热、痛、功能障碍等，严重者常伴有毒血症或败血症等临床表现。",
          "start_idx": 49,
          "end_idx": 86,
          "entities": [
            {
              "entity_id": "T281",
              "entity": "局部常有红、肿、热、痛、功能障碍",
              "entity_type": "Symptom",
              "start_idx": 0,
              "end_idx": 16,
              "entity_en": "Local redness, swelling, heat, pain, and dysfunction"
            },
            {
              "entity_id": "T282",
              "entity": "严重",
              "entity_type": "Level",
              "start_idx": 18,
              "end_idx": 20,
              "entity_en": "serious"
            },
            {
              "entity_id": "T283",
              "entity": "毒血症",
              "entity_type": "Disease",
              "start_idx": 24,
              "end_idx": 27,
              "entity_en": "Toxemia"
            },
            {
              "entity_id": "T284",
              "entity": "败血症",
              "entity_type": "Disease",
              "start_idx": 28,
              "end_idx": 31,
              "entity_en": "septicemia"
            }
          ],
          "relations": [],
          "sentence_en": "Local symptoms include redness, swelling, heat, pain, and functional impairment. In severe cases, there are often clinical manifestations such as toxemia or sepsis."
        },
        {
          "sentence_id": "3",
          "sentence": " ",
          "start_idx": 86,
          "end_idx": 87,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "(1) Wet gangrene: Diabetic wet gangrene is common. It is usually caused by circulatory and microcirculatory disorders in the extremities, often accompanied by peripheral neuropathy and foot infection. Local symptoms include redness, swelling, heat, pain, and functional impairment. In severe cases, clinical manifestations include toxemia or sepsis."
    },
    {
      "paragraph_id": "40",
      "paragraph": "(2)干性坏疽：糖尿病干性坏疽发病人数较少，占糖尿病足坏疽的5.0%。多发生在糖尿病患者肢端动脉及小动脉粥样硬化，致管腔狭窄或闭塞，局部血供障碍，最终导致缺血组织发生干性坏疽。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(2)干性坏疽：糖尿病干性坏疽发病人数较少，占糖尿病足坏疽的5.0%。多发生在糖尿病患者肢端动脉及小动脉粥样硬化，致管腔狭窄或闭塞，局部血供障碍，最终导致缺血组织发生干性坏疽。",
          "start_idx": 0,
          "end_idx": 88,
          "entities": [
            {
              "entity_id": "T285",
              "entity": "干性坏疽",
              "entity_type": "Disease",
              "start_idx": 3,
              "end_idx": 7,
              "entity_en": "Dry gangrene"
            },
            {
              "entity_id": "T286",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 8,
              "end_idx": 11,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T287",
              "entity": "干性坏疽",
              "entity_type": "Disease",
              "start_idx": 11,
              "end_idx": 15,
              "entity_en": "Dry gangrene"
            },
            {
              "entity_id": "T288",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 23,
              "end_idx": 26,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T289",
              "entity": "足坏疽",
              "entity_type": "Disease",
              "start_idx": 26,
              "end_idx": 29,
              "entity_en": "Foot gangrene"
            },
            {
              "entity_id": "T290",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 26,
              "end_idx": 27,
              "entity_en": "foot"
            },
            {
              "entity_id": "T291",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 39,
              "end_idx": 42,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T292",
              "entity": "肢端动脉",
              "entity_type": "Anatomy",
              "start_idx": 44,
              "end_idx": 48,
              "entity_en": "Acroarticular arteries"
            },
            {
              "entity_id": "T293",
              "entity": "小动脉粥样硬化",
              "entity_type": "Symptom",
              "start_idx": 49,
              "end_idx": 56,
              "entity_en": "Arteriolar atherosclerosis"
            },
            {
              "entity_id": "T294",
              "entity": "小动脉",
              "entity_type": "Anatomy",
              "start_idx": 49,
              "end_idx": 52,
              "entity_en": "Arterioles"
            },
            {
              "entity_id": "T295",
              "entity": "管腔狭窄或闭塞",
              "entity_type": "Symptom",
              "start_idx": 58,
              "end_idx": 65,
              "entity_en": "Lumen stenosis or occlusion"
            },
            {
              "entity_id": "T296",
              "entity": "管腔",
              "entity_type": "Anatomy",
              "start_idx": 58,
              "end_idx": 60,
              "entity_en": "Lumen"
            },
            {
              "entity_id": "T297",
              "entity": "局部血供障碍",
              "entity_type": "Reason",
              "start_idx": 66,
              "end_idx": 72,
              "entity_en": "Local blood supply disorder"
            },
            {
              "entity_id": "T298",
              "entity": "干性坏疽",
              "entity_type": "Disease",
              "start_idx": 83,
              "end_idx": 87,
              "entity_en": "Dry gangrene"
            },
            {
              "entity_id": "T299",
              "entity": "缺血组织",
              "entity_type": "Anatomy",
              "start_idx": 77,
              "end_idx": 81,
              "entity_en": "Ischemic tissue"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R114",
              "head_entity_id": "T290",
              "tail_entity_id": "T289"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R115",
              "head_entity_id": "T292",
              "tail_entity_id": "T291"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R116",
              "head_entity_id": "T295",
              "tail_entity_id": "T291"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R117",
              "head_entity_id": "T293",
              "tail_entity_id": "T291"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R118",
              "head_entity_id": "T297",
              "tail_entity_id": "T298"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R119",
              "head_entity_id": "T299",
              "tail_entity_id": "T298"
            }
          ],
          "sentence_en": "(2) Dry gangrene: The incidence of diabetic dry gangrene is relatively small, accounting for 5.0% of diabetic foot gangrene. It often occurs in diabetic patients with atherosclerosis of the extremities and arterioles, leading to stenosis or occlusion of the lumen, local blood supply obstruction, and ultimately leading to dry gangrene in ischemic tissues."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 88,
          "end_idx": 89,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "(2) Dry gangrene: The incidence of diabetic dry gangrene is relatively small, accounting for 5.0% of diabetic foot gangrene. It often occurs in diabetic patients with atherosclerosis of the extremities and arterioles, leading to stenosis or occlusion of the lumen, local blood supply obstruction, and ultimately leading to dry gangrene in ischemic tissues."
    },
    {
      "paragraph_id": "41",
      "paragraph": "(3)混合性坏疽：混合性坏疽较干性坏疽稍多见，占糖尿病足坏疽的15.2%。肢端局部血供障碍引起干性坏疽，而病变另一部分合并感染。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(3)混合性坏疽：混合性坏疽较干性坏疽稍多见，占糖尿病足坏疽的15.2%。肢端局部血供障碍引起干性坏疽，而病变另一部分合并感染。",
          "start_idx": 0,
          "end_idx": 64,
          "entities": [
            {
              "entity_id": "T300",
              "entity": "混合性坏疽",
              "entity_type": "Disease",
              "start_idx": 3,
              "end_idx": 8,
              "entity_en": "Mixed gangrene"
            },
            {
              "entity_id": "T301",
              "entity": "混合性坏疽",
              "entity_type": "Disease",
              "start_idx": 9,
              "end_idx": 14,
              "entity_en": "Mixed gangrene"
            },
            {
              "entity_id": "T302",
              "entity": "干性坏疽",
              "entity_type": "Disease",
              "start_idx": 15,
              "end_idx": 19,
              "entity_en": "Dry gangrene"
            },
            {
              "entity_id": "T303",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 24,
              "end_idx": 27,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T304",
              "entity": "足坏疽",
              "entity_type": "Disease",
              "start_idx": 27,
              "end_idx": 30,
              "entity_en": "Foot gangrene"
            },
            {
              "entity_id": "T305",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 27,
              "end_idx": 28,
              "entity_en": "foot"
            },
            {
              "entity_id": "T306",
              "entity": "肢端局部血供障碍",
              "entity_type": "Reason",
              "start_idx": 37,
              "end_idx": 45,
              "entity_en": "Local blood supply disorder of extremities"
            },
            {
              "entity_id": "T307",
              "entity": "干性坏疽",
              "entity_type": "Disease",
              "start_idx": 47,
              "end_idx": 51,
              "entity_en": "Dry gangrene"
            },
            {
              "entity_id": "T308",
              "entity": "感染",
              "entity_type": "Disease",
              "start_idx": 61,
              "end_idx": 63,
              "entity_en": "Infect"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R120",
              "head_entity_id": "T305",
              "tail_entity_id": "T304"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R121",
              "head_entity_id": "T306",
              "tail_entity_id": "T307"
            }
          ],
          "sentence_en": "(3) Mixed gangrene: Mixed gangrene is slightly more common than dry gangrene, accounting for 15.2% of diabetic foot gangrene. Dry gangrene is caused by local blood supply obstruction in the extremities, while another part of the lesion is infected."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 64,
          "end_idx": 65,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "(3) Mixed gangrene: Mixed gangrene is slightly more common than dry gangrene, accounting for 15.2% of diabetic foot gangrene. Dry gangrene is caused by local blood supply obstruction in the extremities, while another part of the lesion is infected."
    },
    {
      "paragraph_id": "42",
      "paragraph": "3.糖尿病足的分级 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "3.糖尿病足的分级 ",
          "start_idx": 0,
          "end_idx": 10,
          "entities": [
            {
              "entity_id": "T309",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 2,
              "end_idx": 6,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T310",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 5,
              "end_idx": 6,
              "entity_en": "foot"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R122",
              "head_entity_id": "T310",
              "tail_entity_id": "T309"
            }
          ],
          "sentence_en": "3. Grading of diabetic foot"
        }
      ],
      "paragraph_en": "3. Grading of diabetic foot"
    },
    {
      "paragraph_id": "43",
      "paragraph": "依据不同的病变程度需要对糖尿病足进行分级，目前临床上广为接受的分级方法主要有Wagner 分级、Texas分级，但因为糖尿病足病情复杂，血管病变、神经病变、感染的程度、软组织及骨质破坏情况等差异大，所以任何一种分级方法都不可能做到十全十美。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "依据不同的病变程度需要对糖尿病足进行分级，目前临床上广为接受的分级方法主要有Wagner 分级、Texas分级，但因为糖尿病足病情复杂，血管病变、神经病变、感染的程度、软组织及骨质破坏情况等差异大，所以任何一种分级方法都不可能做到十全十美。",
          "start_idx": 0,
          "end_idx": 120,
          "entities": [
            {
              "entity_id": "T311",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 12,
              "end_idx": 16,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T312",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 15,
              "end_idx": 16,
              "entity_en": "foot"
            },
            {
              "entity_id": "T313",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 59,
              "end_idx": 63,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T314",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 62,
              "end_idx": 63,
              "entity_en": "foot"
            },
            {
              "entity_id": "T315",
              "entity": "血管病变",
              "entity_type": "Disease",
              "start_idx": 68,
              "end_idx": 72,
              "entity_en": "Vascular disease"
            },
            {
              "entity_id": "T316",
              "entity": "血管",
              "entity_type": "Anatomy",
              "start_idx": 68,
              "end_idx": 70,
              "entity_en": "Blood vessel"
            },
            {
              "entity_id": "T317",
              "entity": "神经病变",
              "entity_type": "Disease",
              "start_idx": 73,
              "end_idx": 77,
              "entity_en": "Neuropathy"
            },
            {
              "entity_id": "T318",
              "entity": "神经",
              "entity_type": "Anatomy",
              "start_idx": 73,
              "end_idx": 75,
              "entity_en": "nerve"
            },
            {
              "entity_id": "T319",
              "entity": "感染",
              "entity_type": "Disease",
              "start_idx": 78,
              "end_idx": 80,
              "entity_en": "Infect"
            },
            {
              "entity_id": "T320",
              "entity": "软组织及骨质破坏",
              "entity_type": "Disease",
              "start_idx": 84,
              "end_idx": 92,
              "entity_en": "Soft tissue and bone destruction"
            },
            {
              "entity_id": "T321",
              "entity": "软组织",
              "entity_type": "Anatomy",
              "start_idx": 84,
              "end_idx": 87,
              "entity_en": "Soft tissue"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R123",
              "head_entity_id": "T312",
              "tail_entity_id": "T311"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R124",
              "head_entity_id": "T314",
              "tail_entity_id": "T313"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R125",
              "head_entity_id": "T316",
              "tail_entity_id": "T315"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R126",
              "head_entity_id": "T318",
              "tail_entity_id": "T317"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R127",
              "head_entity_id": "T321",
              "tail_entity_id": "T320"
            }
          ],
          "sentence_en": "Diabetic foot needs to be graded according to the different degrees of lesions. Currently, the widely accepted grading methods in clinical practice are Wagner grade and Texas grade. However, due to the complexity of diabetic foot, there are great differences in vascular lesions, neuropathy, degree of infection, soft tissue and bone destruction, so no grading method can be perfect."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 120,
          "end_idx": 121,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "Diabetic foot needs to be graded according to the different degrees of lesions. Currently, the widely accepted grading methods in clinical practice are Wagner grade and Texas grade. However, due to the complexity of diabetic foot, there are great differences in vascular lesions, neuropathy, degree of infection, soft tissue and bone destruction, so no grading method can be perfect."
    },
    {
      "paragraph_id": "44",
      "paragraph": "(1) Wagner分级：此分级方法首先由Meggitt于1976年提出，Wagner后来加以推广，是目前临床及科研中应用最为广泛的分级方法(表2)。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(1) Wagner分级：此分级方法首先由Meggitt于1976年提出，Wagner后来加以推广，是目前临床及科研中应用最为广泛的分级方法(表2)。",
          "start_idx": 0,
          "end_idx": 75,
          "entities": [],
          "relations": [],
          "sentence_en": "(1) Wagner classification: This classification method was first proposed by Meggitt in 1976 and later promoted by Wagner. It is currently the most widely used classification method in clinical and scientific research (Table 2)."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 75,
          "end_idx": 76,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "(1) Wagner classification: This classification method was first proposed by Meggitt in 1976 and later promoted by Wagner. It is currently the most widely used classification method in clinical and scientific research (Table 2)."
    },
    {
      "paragraph_id": "45",
      "paragraph": "(2) Texas分级法：Texas分级法是由美国Texas San Antonio大学Lavery等提出的(表3) ，此分级方法从病变程度和病因两个方面对糖尿病足溃疡及坏疽进行评估，更好地体现了创面感染和缺血的情况，相对于Wagner分级在评价创面的严重性和预测肢体预后情况上更好。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(2) Texas分级法：Texas分级法是由美国Texas San Antonio大学Lavery等提出的(表3) ，此分级方法从病变程度和病因两个方面对糖尿病足溃疡及坏疽进行评估，更好地体现了创面感染和缺血的情况，相对于Wagner分级在评价创面的严重性和预测肢体预后情况上更好。",
          "start_idx": 0,
          "end_idx": 142,
          "entities": [
            {
              "entity_id": "T322",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 78,
              "end_idx": 81,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T323",
              "entity": "足溃疡",
              "entity_type": "Disease",
              "start_idx": 81,
              "end_idx": 84,
              "entity_en": "Foot ulcer"
            },
            {
              "entity_id": "T324",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 81,
              "end_idx": 82,
              "entity_en": "foot"
            },
            {
              "entity_id": "T325",
              "entity": "坏疽",
              "entity_type": "Disease",
              "start_idx": 85,
              "end_idx": 87,
              "entity_en": "gangrene"
            },
            {
              "entity_id": "T326",
              "entity": "创面感染",
              "entity_type": "Symptom",
              "start_idx": 98,
              "end_idx": 102,
              "entity_en": "Wound infection"
            },
            {
              "entity_id": "T327",
              "entity": "缺血",
              "entity_type": "Symptom",
              "start_idx": 103,
              "end_idx": 105,
              "entity_en": "Ischemia"
            },
            {
              "entity_id": "T328",
              "entity": "创面",
              "entity_type": "Symptom",
              "start_idx": 123,
              "end_idx": 125,
              "entity_en": "Wound"
            }
          ],
          "relations": [
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R128",
              "head_entity_id": "T326",
              "tail_entity_id": "T322"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R129",
              "head_entity_id": "T327",
              "tail_entity_id": "T322"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R130",
              "head_entity_id": "T328",
              "tail_entity_id": "T322"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R131",
              "head_entity_id": "T324",
              "tail_entity_id": "T323"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R132",
              "head_entity_id": "T326",
              "tail_entity_id": "T323"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R133",
              "head_entity_id": "T327",
              "tail_entity_id": "T323"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R134",
              "head_entity_id": "T328",
              "tail_entity_id": "T323"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R135",
              "head_entity_id": "T326",
              "tail_entity_id": "T325"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R136",
              "head_entity_id": "T327",
              "tail_entity_id": "T325"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R137",
              "head_entity_id": "T328",
              "tail_entity_id": "T325"
            }
          ],
          "sentence_en": "(2) Texas grading: The Texas grading was proposed by Lavery et al. from the University of Texas San Antonio (Table 3). This grading method evaluates diabetic foot ulcers and gangrene from the two aspects of lesion severity and etiology, better reflecting the infection and ischemia of the wound surface. Compared with the Wagner grading, it is better in evaluating the severity of the wound surface and predicting the prognosis of the limb."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 142,
          "end_idx": 143,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "(2) Texas grading: The Texas grading was proposed by Lavery et al. from the University of Texas San Antonio (Table 3). This grading method evaluates diabetic foot ulcers and gangrene from the two aspects of lesion severity and etiology, better reflecting the infection and ischemia of the wound surface. Compared with the Wagner grading, it is better in evaluating the severity of the wound surface and predicting the prognosis of the limb."
    },
    {
      "paragraph_id": "46",
      "paragraph": "(3)空军总医院分级法：空军总医院内分泌科李仕明主任依据机体组织抗感染能力及坏疽病变的性质、范围、深度作为分级的依据和说明感染严重程度的依据，结合国内外分级标准，将糖尿病足按病变程度划分为0~5级，提出了空军总医院糖尿病足分级方法。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(3)空军总医院分级法：空军总医院内分泌科李仕明主任依据机体组织抗感染能力及坏疽病变的性质、范围、深度作为分级的依据和说明感染严重程度的依据，结合国内外分级标准，将糖尿病足按病变程度划分为0~5级，提出了空军总医院糖尿病足分级方法。",
          "start_idx": 0,
          "end_idx": 116,
          "entities": [
            {
              "entity_id": "T329",
              "entity": "坏疽病变",
              "entity_type": "Disease",
              "start_idx": 38,
              "end_idx": 42,
              "entity_en": "Gangrenous lesions"
            },
            {
              "entity_id": "T330",
              "entity": "感染",
              "entity_type": "Disease",
              "start_idx": 61,
              "end_idx": 63,
              "entity_en": "Infect"
            },
            {
              "entity_id": "T331",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 82,
              "end_idx": 86,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T332",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 85,
              "end_idx": 86,
              "entity_en": "foot"
            },
            {
              "entity_id": "T333",
              "entity": "0~5级",
              "entity_type": "Level",
              "start_idx": 94,
              "end_idx": 98,
              "entity_en": "Level 0~5"
            },
            {
              "entity_id": "T334",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 107,
              "end_idx": 111,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T335",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 110,
              "end_idx": 111,
              "entity_en": "foot"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R138",
              "head_entity_id": "T332",
              "tail_entity_id": "T331"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R139",
              "head_entity_id": "T335",
              "tail_entity_id": "T334"
            }
          ],
          "sentence_en": "(3) Air Force General Hospital Grading Method: Director Li Shiming of the Endocrinology Department of the Air Force General Hospital uses the body's tissue resistance to infection and the nature, scope, and depth of gangrenous lesions as the basis for grading and explaining the severity of infection. In combination with domestic and international grading standards, he divides diabetic foot into grades 0 to 5 according to the severity of the lesions and proposed the Air Force General Hospital's diabetic foot grading method."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 116,
          "end_idx": 117,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "(3) Air Force General Hospital Grading Method: Director Li Shiming of the Endocrinology Department of the Air Force General Hospital uses the body's tissue resistance to infection and the nature, scope, and depth of gangrenous lesions as the basis for grading and explaining the severity of infection. In combination with domestic and international grading standards, he divides diabetic foot into grades 0 to 5 according to the severity of the lesions and proposed the Air Force General Hospital's diabetic foot grading method."
    },
    {
      "paragraph_id": "47",
      "paragraph": "0级：皮肤无开放性病灶。常表现为肢端供血不足、皮温凉、颜色紫绀或苍白、麻木、感觉迟钝或丧失。肢端刺痛或灼痛，常兼有足趾或足的畸形等高危足表现。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "0级：皮肤无开放性病灶。",
          "start_idx": 0,
          "end_idx": 12,
          "entities": [
            {
              "entity_id": "T342",
              "entity": "0级",
              "entity_type": "Level",
              "start_idx": 0,
              "end_idx": 2,
              "entity_en": "Level 0"
            }
          ],
          "relations": [],
          "sentence_en": "Grade 0: No open lesions on the skin."
        },
        {
          "sentence_id": "1",
          "sentence": "常表现为肢端供血不足、皮温凉、颜色紫绀或苍白、麻木、感觉迟钝或丧失。",
          "start_idx": 12,
          "end_idx": 46,
          "entities": [
            {
              "entity_id": "T336",
              "entity": "肢端供血不足",
              "entity_type": "Symptom",
              "start_idx": 4,
              "end_idx": 10,
              "entity_en": "Insufficient blood supply to the extremities"
            },
            {
              "entity_id": "T337",
              "entity": "皮温凉",
              "entity_type": "Symptom",
              "start_idx": 11,
              "end_idx": 14,
              "entity_en": "Skin temperature cool"
            },
            {
              "entity_id": "T338",
              "entity": "颜色紫绀或苍白",
              "entity_type": "Symptom",
              "start_idx": 15,
              "end_idx": 22,
              "entity_en": "Cyanosis or paleness"
            },
            {
              "entity_id": "T339",
              "entity": "麻木",
              "entity_type": "Symptom",
              "start_idx": 23,
              "end_idx": 25,
              "entity_en": "numbness"
            },
            {
              "entity_id": "T340",
              "entity": "感觉迟钝或丧失",
              "entity_type": "Symptom",
              "start_idx": 26,
              "end_idx": 33,
              "entity_en": "Diminished or lost sensation"
            }
          ],
          "relations": [],
          "sentence_en": "Common symptoms include insufficient blood supply to the extremities, cool skin temperature, cyanosis or paleness, numbness, and loss of sensation."
        },
        {
          "sentence_id": "2",
          "sentence": "肢端刺痛或灼痛，常兼有足趾或足的畸形等高危足表现。",
          "start_idx": 46,
          "end_idx": 71,
          "entities": [
            {
              "entity_id": "T341",
              "entity": "肢端刺痛或灼痛",
              "entity_type": "Symptom",
              "start_idx": 0,
              "end_idx": 7,
              "entity_en": "Tingling or burning pain in the extremities"
            },
            {
              "entity_id": "T343",
              "entity": "足趾或足的畸形",
              "entity_type": "Symptom",
              "start_idx": 11,
              "end_idx": 18,
              "entity_en": "Deformities of the toes or feet"
            },
            {
              "entity_id": "T344",
              "entity": "高危足",
              "entity_type": "Symptom",
              "start_idx": 19,
              "end_idx": 22,
              "entity_en": "High-risk foot"
            }
          ],
          "relations": [],
          "sentence_en": "Tingling or burning pain in the extremities, often accompanied by high-risk foot manifestations such as toe or foot deformities."
        },
        {
          "sentence_id": "3",
          "sentence": " ",
          "start_idx": 71,
          "end_idx": 72,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "Grade 0: No open lesions on the skin. Common symptoms include insufficient blood supply to the extremities, cool skin temperature, cyanosis or paleness, numbness, and sensory insensitivity or loss. Tingling or burning pain in the extremities, often accompanied by high-risk foot manifestations such as toe or foot deformities."
    },
    {
      "paragraph_id": "48",
      "paragraph": "1级：肢端皮肤有开放性病灶。水疱、血泡、鸡眼或胼胝、冻伤或烫伤及其他皮肤损伤所引起的浅表溃疡，但病灶尚未波及深部组织。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "1级：肢端皮肤有开放性病灶。",
          "start_idx": 0,
          "end_idx": 14,
          "entities": [
            {
              "entity_id": "T345",
              "entity": "1级",
              "entity_type": "Level",
              "start_idx": 0,
              "end_idx": 2,
              "entity_en": "Level 1"
            },
            {
              "entity_id": "T346",
              "entity": "肢端皮肤有开放性病灶",
              "entity_type": "Symptom",
              "start_idx": 3,
              "end_idx": 13,
              "entity_en": "Open lesions on the skin of the extremities"
            },
            {
              "entity_id": "T347",
              "entity": "肢端皮肤",
              "entity_type": "Anatomy",
              "start_idx": 3,
              "end_idx": 7,
              "entity_en": "Acral skin"
            }
          ],
          "relations": [],
          "sentence_en": "Grade 1: There are open lesions on the skin of the extremities."
        },
        {
          "sentence_id": "1",
          "sentence": "水疱、血泡、鸡眼或胼胝、冻伤或烫伤及其他皮肤损伤所引起的浅表溃疡，但病灶尚未波及深部组织。",
          "start_idx": 14,
          "end_idx": 59,
          "entities": [
            {
              "entity_id": "T348",
              "entity": "水疱",
              "entity_type": "Symptom",
              "start_idx": 0,
              "end_idx": 2,
              "entity_en": "Blisters"
            },
            {
              "entity_id": "T349",
              "entity": "血泡",
              "entity_type": "Symptom",
              "start_idx": 3,
              "end_idx": 5,
              "entity_en": "Blood blisters"
            },
            {
              "entity_id": "T350",
              "entity": "鸡眼",
              "entity_type": "Symptom",
              "start_idx": 6,
              "end_idx": 8,
              "entity_en": "corn"
            },
            {
              "entity_id": "T351",
              "entity": "胼胝",
              "entity_type": "Symptom",
              "start_idx": 9,
              "end_idx": 11,
              "entity_en": "Callus"
            },
            {
              "entity_id": "T352",
              "entity": "浅表溃疡",
              "entity_type": "Symptom",
              "start_idx": 28,
              "end_idx": 32,
              "entity_en": "Superficial ulcer"
            },
            {
              "entity_id": "T353",
              "entity": "冻伤",
              "entity_type": "Symptom",
              "start_idx": 12,
              "end_idx": 14,
              "entity_en": "Frostbite"
            },
            {
              "entity_id": "T354",
              "entity": "烫伤",
              "entity_type": "Symptom",
              "start_idx": 15,
              "end_idx": 17,
              "entity_en": "scald"
            },
            {
              "entity_id": "T355",
              "entity": "皮肤损伤",
              "entity_type": "Symptom",
              "start_idx": 20,
              "end_idx": 24,
              "entity_en": "Skin damage"
            }
          ],
          "relations": [],
          "sentence_en": "Superficial ulcers caused by blisters, blood blisters, corns or calluses, frostbite or burns and other skin injuries, but the lesions have not yet spread to deep tissues."
        },
        {
          "sentence_id": "2",
          "sentence": " ",
          "start_idx": 59,
          "end_idx": 60,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "Grade 1: There are open lesions on the skin of the extremities, such as blisters, blood blisters, corns or calluses, superficial ulcers caused by frostbite or burns and other skin injuries, but the lesions have not yet spread to the deep tissues."
    },
    {
      "paragraph_id": "49",
      "paragraph": "2级：感染病灶已侵犯深部肌肉组织。常有轻度蜂窝织炎，多发性脓灶及窦道形成，或感染延肌间隙扩大，造成足底、足背贯通性溃疡或坏疽，脓性分泌物较多。足或趾皮肤灶性干性坏疽，但肌腱韧带尚无破坏。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2级：感染病灶已侵犯深部肌肉组织。",
          "start_idx": 0,
          "end_idx": 17,
          "entities": [
            {
              "entity_id": "T356",
              "entity": "2级",
              "entity_type": "Level",
              "start_idx": 0,
              "end_idx": 2,
              "entity_en": "Level 2"
            },
            {
              "entity_id": "T357",
              "entity": "感染病灶已侵犯深部肌肉组织",
              "entity_type": "Symptom",
              "start_idx": 3,
              "end_idx": 16,
              "entity_en": "The infection has invaded the deep muscle tissue"
            }
          ],
          "relations": [],
          "sentence_en": "Grade 2: The infected lesion has invaded the deep muscle tissue."
        },
        {
          "sentence_id": "1",
          "sentence": "常有轻度蜂窝织炎，多发性脓灶及窦道形成，或感染延肌间隙扩大，造成足底、足背贯通性溃疡或坏疽，脓性分泌物较多。",
          "start_idx": 17,
          "end_idx": 71,
          "entities": [
            {
              "entity_id": "T358",
              "entity": "蜂窝织炎",
              "entity_type": "Symptom",
              "start_idx": 4,
              "end_idx": 8,
              "entity_en": "cellulitis"
            },
            {
              "entity_id": "T359",
              "entity": "多发性脓灶",
              "entity_type": "Symptom",
              "start_idx": 9,
              "end_idx": 14,
              "entity_en": "Multiple purulent foci"
            },
            {
              "entity_id": "T360",
              "entity": "窦道",
              "entity_type": "Symptom",
              "start_idx": 15,
              "end_idx": 17,
              "entity_en": "Sinus"
            },
            {
              "entity_id": "T361",
              "entity": "感染延肌间隙扩大",
              "entity_type": "Symptom",
              "start_idx": 21,
              "end_idx": 29,
              "entity_en": "Infection with enlarged intermuscular space"
            },
            {
              "entity_id": "T362",
              "entity": "足底、足背贯通性溃疡",
              "entity_type": "Symptom",
              "start_idx": 32,
              "end_idx": 42,
              "entity_en": "Penetrating ulcer on the plantar and dorsum of the foot"
            },
            {
              "entity_id": "T363",
              "entity": "坏疽",
              "entity_type": "Symptom",
              "start_idx": 43,
              "end_idx": 45,
              "entity_en": "gangrene"
            },
            {
              "entity_id": "T364",
              "entity": "脓性分泌物较多",
              "entity_type": "Symptom",
              "start_idx": 46,
              "end_idx": 53,
              "entity_en": "Excessive purulent discharge"
            }
          ],
          "relations": [],
          "sentence_en": "There is often mild cellulitis, multiple purulent foci and sinus formation, or expansion of the infected intermuscular spaces, resulting in penetrating ulcers or gangrene on the sole and dorsum of the foot, with abundant purulent secretions."
        },
        {
          "sentence_id": "2",
          "sentence": "足或趾皮肤灶性干性坏疽，但肌腱韧带尚无破坏。",
          "start_idx": 71,
          "end_idx": 93,
          "entities": [
            {
              "entity_id": "T365",
              "entity": "足或趾皮肤灶性干性坏疽",
              "entity_type": "Symptom",
              "start_idx": 0,
              "end_idx": 11,
              "entity_en": "Focal dry gangrene of the skin of the feet or toes"
            }
          ],
          "relations": [],
          "sentence_en": "Focal dry gangrene of the skin of the feet or toes, but no destruction of the tendons and ligaments."
        },
        {
          "sentence_id": "3",
          "sentence": " ",
          "start_idx": 93,
          "end_idx": 94,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "Grade 2: The infected lesions have invaded deep muscle tissue. There is often mild cellulitis, multiple purulent foci and sinus formation, or the infection of the extended muscle space expands, causing penetrating ulcers or gangrene on the sole and dorsum of the foot, with more purulent secretions. There is focal dry gangrene on the skin of the foot or toes, but the tendons and ligaments are not damaged."
    },
    {
      "paragraph_id": "50",
      "paragraph": "3级：肌健韧带组织破坏。蜂窝织炎融合形成大脓腔，脓性分泌物及坏死组织增多，足或少数趾干性坏疽，但骨质破坏尚不明显。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "3级：肌健韧带组织破坏。",
          "start_idx": 0,
          "end_idx": 12,
          "entities": [
            {
              "entity_id": "T366",
              "entity": "3级",
              "entity_type": "Level",
              "start_idx": 0,
              "end_idx": 2,
              "entity_en": "Level 3"
            },
            {
              "entity_id": "T367",
              "entity": "肌健韧带组织破坏",
              "entity_type": "Symptom",
              "start_idx": 3,
              "end_idx": 11,
              "entity_en": "Destruction of muscle and ligament tissue"
            },
            {
              "entity_id": "T368",
              "entity": "肌健韧带组织",
              "entity_type": "Anatomy",
              "start_idx": 3,
              "end_idx": 9,
              "entity_en": "Muscle and ligament tissue"
            }
          ],
          "relations": [],
          "sentence_en": "Grade 3: Destruction of muscle and ligament tissue."
        },
        {
          "sentence_id": "1",
          "sentence": "蜂窝织炎融合形成大脓腔，脓性分泌物及坏死组织增多，足或少数趾干性坏疽，但骨质破坏尚不明显。",
          "start_idx": 12,
          "end_idx": 57,
          "entities": [
            {
              "entity_id": "T369",
              "entity": "蜂窝织炎",
              "entity_type": "Disease",
              "start_idx": 0,
              "end_idx": 4,
              "entity_en": "cellulitis"
            },
            {
              "entity_id": "T370",
              "entity": "大脓腔",
              "entity_type": "Symptom",
              "start_idx": 8,
              "end_idx": 11,
              "entity_en": "Large abscess"
            },
            {
              "entity_id": "T371",
              "entity": "脓性分泌物及坏死组织增多",
              "entity_type": "Symptom",
              "start_idx": 12,
              "end_idx": 24,
              "entity_en": "Increased purulent secretions and necrotic tissue"
            },
            {
              "entity_id": "T372",
              "entity": "足或少数趾干性坏疽",
              "entity_type": "Disease",
              "start_idx": 25,
              "end_idx": 34,
              "entity_en": "Dry gangrene of the foot or a few toes"
            },
            {
              "entity_id": "T373",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 25,
              "end_idx": 26,
              "entity_en": "foot"
            },
            {
              "entity_id": "T374",
              "entity": "趾",
              "entity_type": "Anatomy",
              "start_idx": 29,
              "end_idx": 30,
              "entity_en": "toe"
            },
            {
              "entity_id": "T375",
              "entity": "骨质破坏",
              "entity_type": "Symptom",
              "start_idx": 36,
              "end_idx": 40,
              "entity_en": "Bone destruction"
            }
          ],
          "relations": [
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R140",
              "head_entity_id": "T370",
              "tail_entity_id": "T369"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R141",
              "head_entity_id": "T371",
              "tail_entity_id": "T369"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R142",
              "head_entity_id": "T373",
              "tail_entity_id": "T372"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R143",
              "head_entity_id": "T374",
              "tail_entity_id": "T372"
            }
          ],
          "sentence_en": "Cellulitis fuses to form a large abscess cavity, with increased purulent secretions and necrotic tissue, and dry gangrene of the foot or a few toes, but bone destruction is not obvious."
        },
        {
          "sentence_id": "2",
          "sentence": " ",
          "start_idx": 57,
          "end_idx": 58,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "Grade 3: Destruction of muscle and ligament tissues. Cellulitis fuses to form a large abscess cavity, with increased purulent secretions and necrotic tissue, dry gangrene of the foot or a few toes, but bone destruction is not obvious."
    },
    {
      "paragraph_id": "51",
      "paragraph": "4级：严重感染已造成骨质破坏，骨髓炎，骨关节破坏或已形成假关节，Charcot关节病，部分足或趾发生湿性或干性严重坏疽或坏死。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "4级：严重感染已造成骨质破坏，骨髓炎，骨关节破坏或已形成假关节，Charcot关节病，部分足或趾发生湿性或干性严重坏疽或坏死。",
          "start_idx": 0,
          "end_idx": 63,
          "entities": [
            {
              "entity_id": "T376",
              "entity": "4级",
              "entity_type": "Level",
              "start_idx": 0,
              "end_idx": 2,
              "entity_en": "Level 4"
            },
            {
              "entity_id": "T377",
              "entity": "严重",
              "entity_type": "Level",
              "start_idx": 3,
              "end_idx": 5,
              "entity_en": "serious"
            },
            {
              "entity_id": "T378",
              "entity": "感染",
              "entity_type": "Reason",
              "start_idx": 5,
              "end_idx": 7,
              "entity_en": "Infect"
            },
            {
              "entity_id": "T379",
              "entity": "骨质破坏",
              "entity_type": "Disease",
              "start_idx": 10,
              "end_idx": 14,
              "entity_en": "Bone destruction"
            },
            {
              "entity_id": "T380",
              "entity": "骨髓炎",
              "entity_type": "Disease",
              "start_idx": 15,
              "end_idx": 18,
              "entity_en": "osteomyelitis"
            },
            {
              "entity_id": "T381",
              "entity": "骨髓",
              "entity_type": "Anatomy",
              "start_idx": 15,
              "end_idx": 17,
              "entity_en": "marrow"
            },
            {
              "entity_id": "T382",
              "entity": "骨关节破坏",
              "entity_type": "Disease",
              "start_idx": 19,
              "end_idx": 24,
              "entity_en": "Bone and joint destruction"
            },
            {
              "entity_id": "T383",
              "entity": "骨关节",
              "entity_type": "Anatomy",
              "start_idx": 19,
              "end_idx": 22,
              "entity_en": "Bone and joint"
            },
            {
              "entity_id": "T384",
              "entity": "假关节",
              "entity_type": "Disease",
              "start_idx": 28,
              "end_idx": 31,
              "entity_en": "Pseudarthrosis"
            },
            {
              "entity_id": "T385",
              "entity": "关节",
              "entity_type": "Anatomy",
              "start_idx": 29,
              "end_idx": 31,
              "entity_en": "joint"
            },
            {
              "entity_id": "T386",
              "entity": "Charcot关节病",
              "entity_type": "Disease",
              "start_idx": 32,
              "end_idx": 42,
              "entity_en": "Charcot arthropathy"
            },
            {
              "entity_id": "T387",
              "entity": "关节",
              "entity_type": "Anatomy",
              "start_idx": 39,
              "end_idx": 41,
              "entity_en": "joint"
            },
            {
              "entity_id": "T388",
              "entity": "足或趾发生湿性或干性严重坏疽或坏死",
              "entity_type": "Disease",
              "start_idx": 45,
              "end_idx": 62,
              "entity_en": "Severe wet or dry gangrene or necrosis of the feet or toes"
            },
            {
              "entity_id": "T389",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 45,
              "end_idx": 46,
              "entity_en": "foot"
            },
            {
              "entity_id": "T390",
              "entity": "趾",
              "entity_type": "Anatomy",
              "start_idx": 47,
              "end_idx": 48,
              "entity_en": "toe"
            },
            {
              "entity_id": "T391",
              "entity": "严重",
              "entity_type": "Level",
              "start_idx": 55,
              "end_idx": 57,
              "entity_en": "serious"
            }
          ],
          "relations": [
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R144",
              "head_entity_id": "T378",
              "tail_entity_id": "T379"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R145",
              "head_entity_id": "T378",
              "tail_entity_id": "T380"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R146",
              "head_entity_id": "T378",
              "tail_entity_id": "T382"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R147",
              "head_entity_id": "T378",
              "tail_entity_id": "T384"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R148",
              "head_entity_id": "T378",
              "tail_entity_id": "T386"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R149",
              "head_entity_id": "T378",
              "tail_entity_id": "T388"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R150",
              "head_entity_id": "T381",
              "tail_entity_id": "T380"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R151",
              "head_entity_id": "T383",
              "tail_entity_id": "T382"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R152",
              "head_entity_id": "T385",
              "tail_entity_id": "T384"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R153",
              "head_entity_id": "T387",
              "tail_entity_id": "T386"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R154",
              "head_entity_id": "T389",
              "tail_entity_id": "T388"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R155",
              "head_entity_id": "T390",
              "tail_entity_id": "T388"
            }
          ],
          "sentence_en": "Grade 4: Severe infection has caused bone destruction, osteomyelitis, bone and joint destruction or formation of pseudoarthrosis, Charcot arthropathy, and severe wet or dry gangrene or necrosis of part of the foot or toes."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 63,
          "end_idx": 64,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "Grade 4: Severe infection has caused bone destruction, osteomyelitis, bone and joint destruction or formation of pseudoarthrosis, Charcot arthropathy, and severe wet or dry gangrene or necrosis of part of the foot or toes."
    },
    {
      "paragraph_id": "52",
      "paragraph": "5级：足的大部分或足的全部感染或缺血，导致严重的湿性或干性坏疽，肢端变黑，尸干，常波及踝关节及小腿。一般多采取大截肢。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "5级：足的大部分或足的全部感染或缺血，导致严重的湿性或干性坏疽，肢端变黑，尸干，常波及踝关节及小腿。一般多采取大截肢。",
          "start_idx": 0,
          "end_idx": 59,
          "entities": [
            {
              "entity_id": "T392",
              "entity": "5级",
              "entity_type": "Level",
              "start_idx": 0,
              "end_idx": 2,
              "entity_en": "Level 5"
            },
            {
              "entity_id": "T393",
              "entity": "严重",
              "entity_type": "Level",
              "start_idx": 21,
              "end_idx": 23,
              "entity_en": "serious"
            },
            {
              "entity_id": "T394",
              "entity": "湿性或干性坏疽",
              "entity_type": "Disease",
              "start_idx": 24,
              "end_idx": 31,
              "entity_en": "Wet or dry gangrene"
            },
            {
              "entity_id": "T395",
              "entity": "足的大部分或足的全部感染或缺血",
              "entity_type": "Reason",
              "start_idx": 3,
              "end_idx": 18,
              "entity_en": "Infection or ischemia of most or all of the foot"
            },
            {
              "entity_id": "T396",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 3,
              "end_idx": 4,
              "entity_en": "foot"
            },
            {
              "entity_id": "T397",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 9,
              "end_idx": 10,
              "entity_en": "foot"
            },
            {
              "entity_id": "T398",
              "entity": "肢端变黑",
              "entity_type": "Symptom",
              "start_idx": 32,
              "end_idx": 36,
              "entity_en": "Darkening of the extremities"
            },
            {
              "entity_id": "T399",
              "entity": "肢端",
              "entity_type": "Anatomy",
              "start_idx": 32,
              "end_idx": 34,
              "entity_en": "Extremities"
            },
            {
              "entity_id": "T400",
              "entity": "尸干",
              "entity_type": "Symptom",
              "start_idx": 37,
              "end_idx": 39,
              "entity_en": "Dried corpse"
            },
            {
              "entity_id": "T401",
              "entity": "踝关节",
              "entity_type": "Anatomy",
              "start_idx": 43,
              "end_idx": 46,
              "entity_en": "Ankle"
            },
            {
              "entity_id": "T402",
              "entity": "小腿",
              "entity_type": "Anatomy",
              "start_idx": 47,
              "end_idx": 49,
              "entity_en": "Calf"
            },
            {
              "entity_id": "T403",
              "entity": "大截肢",
              "entity_type": "Operation",
              "start_idx": 55,
              "end_idx": 58,
              "entity_en": "Major amputation"
            }
          ],
          "relations": [
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R156",
              "head_entity_id": "T395",
              "tail_entity_id": "T394"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R157",
              "head_entity_id": "T398",
              "tail_entity_id": "T394"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R158",
              "head_entity_id": "T400",
              "tail_entity_id": "T394"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R159",
              "head_entity_id": "T401",
              "tail_entity_id": "T394"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R160",
              "head_entity_id": "T402",
              "tail_entity_id": "T394"
            }
          ],
          "sentence_en": "Grade 5: Most or all of the foot is infected or ischemic, leading to severe wet or dry gangrene, blackening of the extremities, dryness, often involving the ankle and calf. Major amputation is usually required."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 59,
          "end_idx": 60,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "Grade 5: Most or all of the foot is infected or ischemic, leading to severe wet or dry gangrene, blackening of the extremities, dryness, often involving the ankle and calf. Major amputation is usually required."
    },
    {
      "paragraph_id": "53",
      "paragraph": "六、糖尿病足预后 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "六、糖尿病足预后 ",
          "start_idx": 0,
          "end_idx": 9,
          "entities": [
            {
              "entity_id": "T404",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 2,
              "end_idx": 6,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T405",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 5,
              "end_idx": 6,
              "entity_en": "foot"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R161",
              "head_entity_id": "T405",
              "tail_entity_id": "T404"
            }
          ],
          "sentence_en": "6. Prognosis of diabetic foot"
        }
      ],
      "paragraph_en": "6. Prognosis of diabetic foot"
    },
    {
      "paragraph_id": "54",
      "paragraph": "糖尿病足的最终结局是：溃疡愈合、截肢和死亡。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "糖尿病足的最终结局是：溃疡愈合、截肢和死亡。 ",
          "start_idx": 0,
          "end_idx": 23,
          "entities": [
            {
              "entity_id": "T406",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 0,
              "end_idx": 4,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T407",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 3,
              "end_idx": 4,
              "entity_en": "foot"
            },
            {
              "entity_id": "T408",
              "entity": "溃疡",
              "entity_type": "Symptom",
              "start_idx": 11,
              "end_idx": 13,
              "entity_en": "ulcer"
            },
            {
              "entity_id": "T409",
              "entity": "截肢",
              "entity_type": "Operation",
              "start_idx": 16,
              "end_idx": 18,
              "entity_en": "Amputation"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R162",
              "head_entity_id": "T407",
              "tail_entity_id": "T406"
            },
            {
              "relation_type": "Operation_Disease",
              "relation_id": "R163",
              "head_entity_id": "T409",
              "tail_entity_id": "T406"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R164",
              "head_entity_id": "T408",
              "tail_entity_id": "T406"
            }
          ],
          "sentence_en": "The ultimate outcome of diabetic foot is: ulcer healing, amputation and death."
        }
      ],
      "paragraph_en": "The ultimate outcome of diabetic foot is: ulcer healing, amputation and death."
    },
    {
      "paragraph_id": "55",
      "paragraph": "七、糖尿病足的治疗 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "七、糖尿病足的治疗 ",
          "start_idx": 0,
          "end_idx": 10,
          "entities": [
            {
              "entity_id": "T410",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 2,
              "end_idx": 6,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T411",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 5,
              "end_idx": 6,
              "entity_en": "foot"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R165",
              "head_entity_id": "T411",
              "tail_entity_id": "T410"
            }
          ],
          "sentence_en": "7. Treatment of diabetic foot"
        }
      ],
      "paragraph_en": "7. Treatment of diabetic foot"
    },
    {
      "paragraph_id": "56",
      "paragraph": "(一)? 糖尿病足的治疗目标及治疗策略 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(一)? 糖尿病足的治疗目标及治疗策略 ",
          "start_idx": 0,
          "end_idx": 20,
          "entities": [
            {
              "entity_id": "T412",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 5,
              "end_idx": 9,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T413",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 8,
              "end_idx": 9,
              "entity_en": "foot"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R166",
              "head_entity_id": "T413",
              "tail_entity_id": "T412"
            }
          ],
          "sentence_en": "(I) Treatment goals and strategies for diabetic foot"
        }
      ],
      "paragraph_en": "(I) Treatment goals and strategies for diabetic foot"
    },
    {
      "paragraph_id": "57",
      "paragraph": "糖尿病足的治疗目标：预防全身动脉粥样硬化疾病的进展，预防心、脑血管事件的发生，降低糖尿病足患者死亡率；预防缺血导致的溃疡和肢端坏疽，预防截肢或降低截肢平面，改善间歇性跛行患者的下肢肤体功能状态。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "糖尿病足的治疗目标：预防全身动脉粥样硬化疾病的进展，预防心、脑血管事件的发生，降低糖尿病足患者死亡率；预防缺血导致的溃疡和肢端坏疽，预防截肢或降低截肢平面，改善间歇性跛行患者的下肢肤体功能状态。",
          "start_idx": 0,
          "end_idx": 97,
          "entities": [
            {
              "entity_id": "T414",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 0,
              "end_idx": 4,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T415",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 3,
              "end_idx": 4,
              "entity_en": "foot"
            },
            {
              "entity_id": "T416",
              "entity": "全身动脉粥样硬化疾病",
              "entity_type": "Disease",
              "start_idx": 12,
              "end_idx": 22,
              "entity_en": "Systemic atherosclerotic disease"
            },
            {
              "entity_id": "T417",
              "entity": "全身动脉",
              "entity_type": "Anatomy",
              "start_idx": 12,
              "end_idx": 16,
              "entity_en": "Systemic arteries"
            },
            {
              "entity_id": "T418",
              "entity": "心、脑血管事件",
              "entity_type": "Disease",
              "start_idx": 28,
              "end_idx": 35,
              "entity_en": "Cardiovascular and cerebrovascular events"
            },
            {
              "entity_id": "T419",
              "entity": "心、脑血管",
              "entity_type": "Anatomy",
              "start_idx": 28,
              "end_idx": 33,
              "entity_en": "Cardiovascular and cerebrovascular"
            },
            {
              "entity_id": "T420",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 41,
              "end_idx": 45,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T421",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 44,
              "end_idx": 45,
              "entity_en": "foot"
            },
            {
              "entity_id": "T422",
              "entity": "缺血",
              "entity_type": "Reason",
              "start_idx": 53,
              "end_idx": 55,
              "entity_en": "Ischemia"
            },
            {
              "entity_id": "T423",
              "entity": "溃疡",
              "entity_type": "Disease",
              "start_idx": 58,
              "end_idx": 60,
              "entity_en": "ulcer"
            },
            {
              "entity_id": "T424",
              "entity": "肢端坏疽",
              "entity_type": "Disease",
              "start_idx": 61,
              "end_idx": 65,
              "entity_en": "Acrogangrene"
            },
            {
              "entity_id": "T425",
              "entity": "肢端",
              "entity_type": "Anatomy",
              "start_idx": 61,
              "end_idx": 63,
              "entity_en": "Extremities"
            },
            {
              "entity_id": "T426",
              "entity": "截肢",
              "entity_type": "Operation",
              "start_idx": 68,
              "end_idx": 70,
              "entity_en": "Amputation"
            },
            {
              "entity_id": "T427",
              "entity": "间歇性跛行",
              "entity_type": "Disease",
              "start_idx": 80,
              "end_idx": 85,
              "entity_en": "Intermittent claudication"
            },
            {
              "entity_id": "T428",
              "entity": "下肢肤体",
              "entity_type": "Anatomy",
              "start_idx": 88,
              "end_idx": 92,
              "entity_en": "Lower limb skin"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R167",
              "head_entity_id": "T415",
              "tail_entity_id": "T414"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R168",
              "head_entity_id": "T417",
              "tail_entity_id": "T416"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R169",
              "head_entity_id": "T419",
              "tail_entity_id": "T418"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R170",
              "head_entity_id": "T421",
              "tail_entity_id": "T420"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R171",
              "head_entity_id": "T422",
              "tail_entity_id": "T423"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R172",
              "head_entity_id": "T422",
              "tail_entity_id": "T424"
            },
            {
              "relation_type": "Operation_Disease",
              "relation_id": "R173",
              "head_entity_id": "T426",
              "tail_entity_id": "T423"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R174",
              "head_entity_id": "T425",
              "tail_entity_id": "T424"
            },
            {
              "relation_type": "Operation_Disease",
              "relation_id": "R175",
              "head_entity_id": "T426",
              "tail_entity_id": "T424"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R176",
              "head_entity_id": "T428",
              "tail_entity_id": "T427"
            }
          ],
          "sentence_en": "The treatment goals of diabetic foot are: to prevent the progression of systemic atherosclerotic diseases, prevent the occurrence of cardiovascular and cerebrovascular events, and reduce the mortality rate of patients with diabetic foot; to prevent ulcers and extremity gangrene caused by ischemia, prevent amputation or reduce the amputation plane, and improve the lower limb skin function status of patients with intermittent claudication."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 97,
          "end_idx": 98,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "The treatment goals of diabetic foot are: to prevent the progression of systemic atherosclerotic diseases, prevent the occurrence of cardiovascular and cerebrovascular events, and reduce the mortality rate of patients with diabetic foot; to prevent ulcers and extremity gangrene caused by ischemia, prevent amputation or reduce the amputation plane, and improve the lower limb skin function status of patients with intermittent claudication."
    },
    {
      "paragraph_id": "58",
      "paragraph": "糖尿病足的治疗策略：一级预防——防止或延缓神经病变、周围血管病变的发生；二级预防——缓解症状，延缓神经病变、周围血管病变的进展；三级预防——血运重建，溃疡综合治疗，降低截肢率和心血管事件发生率。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "糖尿病足的治疗策略：一级预防——防止或延缓神经病变、周围血管病变的发生；二级预防——缓解症状，延缓神经病变、周围血管病变的进展；三级预防——血运重建，溃疡综合治疗，降低截肢率和心血管事件发生率。",
          "start_idx": 0,
          "end_idx": 97,
          "entities": [
            {
              "entity_id": "T429",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 0,
              "end_idx": 4,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T430",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 3,
              "end_idx": 4,
              "entity_en": "foot"
            },
            {
              "entity_id": "T431",
              "entity": "神经病变",
              "entity_type": "Disease",
              "start_idx": 21,
              "end_idx": 25,
              "entity_en": "Neuropathy"
            },
            {
              "entity_id": "T432",
              "entity": "神经",
              "entity_type": "Anatomy",
              "start_idx": 21,
              "end_idx": 23,
              "entity_en": "nerve"
            },
            {
              "entity_id": "T433",
              "entity": "周围血管病变",
              "entity_type": "Disease",
              "start_idx": 26,
              "end_idx": 32,
              "entity_en": "Peripheral vascular disease"
            },
            {
              "entity_id": "T434",
              "entity": "周围血管",
              "entity_type": "Anatomy",
              "start_idx": 26,
              "end_idx": 30,
              "entity_en": "Peripheral blood vessels"
            },
            {
              "entity_id": "T435",
              "entity": "神经病变",
              "entity_type": "Disease",
              "start_idx": 49,
              "end_idx": 53,
              "entity_en": "Neuropathy"
            },
            {
              "entity_id": "T436",
              "entity": "神经",
              "entity_type": "Anatomy",
              "start_idx": 49,
              "end_idx": 51,
              "entity_en": "nerve"
            },
            {
              "entity_id": "T437",
              "entity": "周围血管病变",
              "entity_type": "Disease",
              "start_idx": 54,
              "end_idx": 60,
              "entity_en": "Peripheral vascular disease"
            },
            {
              "entity_id": "T438",
              "entity": "周围血管",
              "entity_type": "Anatomy",
              "start_idx": 54,
              "end_idx": 58,
              "entity_en": "Peripheral blood vessels"
            },
            {
              "entity_id": "T439",
              "entity": "溃疡",
              "entity_type": "Disease",
              "start_idx": 75,
              "end_idx": 77,
              "entity_en": "ulcer"
            },
            {
              "entity_id": "T440",
              "entity": "心血管事件",
              "entity_type": "Disease",
              "start_idx": 88,
              "end_idx": 93,
              "entity_en": "Cardiovascular events"
            },
            {
              "entity_id": "T441",
              "entity": "心血管",
              "entity_type": "Anatomy",
              "start_idx": 88,
              "end_idx": 91,
              "entity_en": "Cardiovascular"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R177",
              "head_entity_id": "T430",
              "tail_entity_id": "T429"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R178",
              "head_entity_id": "T432",
              "tail_entity_id": "T431"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R179",
              "head_entity_id": "T434",
              "tail_entity_id": "T433"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R180",
              "head_entity_id": "T436",
              "tail_entity_id": "T435"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R181",
              "head_entity_id": "T438",
              "tail_entity_id": "T437"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R182",
              "head_entity_id": "T441",
              "tail_entity_id": "T440"
            }
          ],
          "sentence_en": "Treatment strategies for diabetic foot: Primary prevention - prevent or delay the occurrence of neuropathy and peripheral vascular disease; secondary prevention - relieve symptoms and delay the progression of neuropathy and peripheral vascular disease; tertiary prevention - revascularization, comprehensive treatment of ulcers, and reduce the amputation rate and the incidence of cardiovascular events."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 97,
          "end_idx": 98,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "Treatment strategies for diabetic foot: Primary prevention - prevent or delay the occurrence of neuropathy and peripheral vascular disease; secondary prevention - relieve symptoms and delay the progression of neuropathy and peripheral vascular disease; tertiary prevention - revascularization, comprehensive treatment of ulcers, and reduction of amputation rate and incidence of cardiovascular events."
    },
    {
      "paragraph_id": "59",
      "paragraph": "(二)糖尿病足的内科治疗 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(二)糖尿病足的内科治疗 ",
          "start_idx": 0,
          "end_idx": 13,
          "entities": [
            {
              "entity_id": "T442",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 3,
              "end_idx": 7,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T443",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 6,
              "end_idx": 7,
              "entity_en": "foot"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R183",
              "head_entity_id": "T443",
              "tail_entity_id": "T442"
            }
          ],
          "sentence_en": "2. Medical treatment of diabetic foot"
        }
      ],
      "paragraph_en": "2. Medical treatment of diabetic foot"
    },
    {
      "paragraph_id": "60",
      "paragraph": "在糖尿病足的药物治疗中，要重视综合治疗。糖尿病足常分为3种类型，即神经型、缺血型和神经缺血型(也叫混合型)。研究发现，我国糖尿病足以混合型为主，其次为缺血型，而单纯神经型比较少见。对于神经病变型，目前除治疗神经病变外，重要的是患肢减压，局部清创可促进溃疡愈合；而对于缺血型病变则可以通过药物治疗，运动锻炼和重建下肢血流的方法，取得一定疗效；即使混合型病变，如果血流得到改善，其神经病变也可得到部分缓解。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "在糖尿病足的药物治疗中，要重视综合治疗。糖尿病足常分为3种类型，即神经型、缺血型和神经缺血型(也叫混合型)。研究发现，我国糖尿病足以混合型为主，其次为缺血型，而单纯神经型比较少见。",
          "start_idx": 0,
          "end_idx": 90,
          "entities": [
            {
              "entity_id": "T444",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 1,
              "end_idx": 5,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T445",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 4,
              "end_idx": 5,
              "entity_en": "foot"
            },
            {
              "entity_id": "T446",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 20,
              "end_idx": 24,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T447",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 23,
              "end_idx": 24,
              "entity_en": "foot"
            },
            {
              "entity_id": "T448",
              "entity": "神经型",
              "entity_type": "Class",
              "start_idx": 33,
              "end_idx": 36,
              "entity_en": "Neurotic"
            },
            {
              "entity_id": "T449",
              "entity": "缺血型",
              "entity_type": "Class",
              "start_idx": 37,
              "end_idx": 40,
              "entity_en": "Ischemic"
            },
            {
              "entity_id": "T450",
              "entity": "神经缺血型(也叫混合型)",
              "entity_type": "Class",
              "start_idx": 41,
              "end_idx": 53,
              "entity_en": "Neuroischemic type (also called mixed type)"
            },
            {
              "entity_id": "T451",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 61,
              "end_idx": 65,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T452",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 64,
              "end_idx": 65,
              "entity_en": "foot"
            },
            {
              "entity_id": "T453",
              "entity": "混合型",
              "entity_type": "Class",
              "start_idx": 66,
              "end_idx": 69,
              "entity_en": "Hybrid"
            },
            {
              "entity_id": "T454",
              "entity": "缺血型",
              "entity_type": "Class",
              "start_idx": 75,
              "end_idx": 78,
              "entity_en": "Ischemic"
            },
            {
              "entity_id": "T455",
              "entity": "单纯神经型",
              "entity_type": "Class",
              "start_idx": 80,
              "end_idx": 85,
              "entity_en": "Simple neurological type"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R184",
              "head_entity_id": "T445",
              "tail_entity_id": "T444"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R185",
              "head_entity_id": "T447",
              "tail_entity_id": "T446"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R186",
              "head_entity_id": "T448",
              "tail_entity_id": "T446"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R187",
              "head_entity_id": "T449",
              "tail_entity_id": "T446"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R188",
              "head_entity_id": "T450",
              "tail_entity_id": "T446"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R189",
              "head_entity_id": "T452",
              "tail_entity_id": "T451"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R190",
              "head_entity_id": "T453",
              "tail_entity_id": "T451"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R191",
              "head_entity_id": "T454",
              "tail_entity_id": "T451"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R192",
              "head_entity_id": "T455",
              "tail_entity_id": "T451"
            }
          ],
          "sentence_en": "In the drug treatment of diabetic foot, it is important to pay attention to comprehensive treatment. Diabetic foot is often divided into three types, namely neuropathic, ischemic and neuroischemic (also called mixed). Studies have found that in my country, the main type of diabetic foot is mixed, followed by ischemic, while pure neuropathic is relatively rare."
        },
        {
          "sentence_id": "1",
          "sentence": "对于神经病变型，目前除治疗神经病变外，重要的是患肢减压，局部清创可促进溃疡愈合；而对于缺血型病变则可以通过药物治疗，运动锻炼和重建下肢血流的方法，取得一定疗效；即使混合型病变，如果血流得到改善，其神经病变也可得到部分缓解。",
          "start_idx": 90,
          "end_idx": 201,
          "entities": [
            {
              "entity_id": "T456",
              "entity": "神经病变型",
              "entity_type": "Class",
              "start_idx": 2,
              "end_idx": 7,
              "entity_en": "Neuropathic"
            },
            {
              "entity_id": "T457",
              "entity": "神经病变",
              "entity_type": "Disease",
              "start_idx": 13,
              "end_idx": 17,
              "entity_en": "Neuropathy"
            },
            {
              "entity_id": "T458",
              "entity": "神经",
              "entity_type": "Anatomy",
              "start_idx": 13,
              "end_idx": 15,
              "entity_en": "nerve"
            },
            {
              "entity_id": "T459",
              "entity": "局部清创",
              "entity_type": "Treatment",
              "start_idx": 28,
              "end_idx": 32,
              "entity_en": "Local debridement"
            },
            {
              "entity_id": "T460",
              "entity": "溃疡",
              "entity_type": "Symptom",
              "start_idx": 35,
              "end_idx": 37,
              "entity_en": "ulcer"
            },
            {
              "entity_id": "T461",
              "entity": "缺血型",
              "entity_type": "Class",
              "start_idx": 43,
              "end_idx": 46,
              "entity_en": "Ischemic"
            },
            {
              "entity_id": "T462",
              "entity": "运动锻炼",
              "entity_type": "Treatment",
              "start_idx": 58,
              "end_idx": 62,
              "entity_en": "Exercise"
            },
            {
              "entity_id": "T463",
              "entity": "重建下肢血流",
              "entity_type": "Operation",
              "start_idx": 63,
              "end_idx": 69,
              "entity_en": "Restoring blood flow to the lower extremities"
            },
            {
              "entity_id": "T464",
              "entity": "混合型",
              "entity_type": "Class",
              "start_idx": 82,
              "end_idx": 85,
              "entity_en": "Hybrid"
            },
            {
              "entity_id": "T465",
              "entity": "神经病变",
              "entity_type": "Disease",
              "start_idx": 98,
              "end_idx": 102,
              "entity_en": "Neuropathy"
            },
            {
              "entity_id": "T466",
              "entity": "神经",
              "entity_type": "Anatomy",
              "start_idx": 98,
              "end_idx": 100,
              "entity_en": "nerve"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R193",
              "head_entity_id": "T458",
              "tail_entity_id": "T457"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R194",
              "head_entity_id": "T466",
              "tail_entity_id": "T465"
            }
          ],
          "sentence_en": "For the neuropathy type, in addition to treating the neuropathy, it is important to decompress the affected limb, and local debridement can promote ulcer healing; for ischemic lesions, certain therapeutic effects can be achieved through drug treatment, exercise and reconstruction of lower limb blood flow; even for mixed lesions, if blood flow is improved, the neuropathy can be partially relieved."
        },
        {
          "sentence_id": "2",
          "sentence": " ",
          "start_idx": 201,
          "end_idx": 202,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "In the drug treatment of diabetic foot, it is important to pay attention to comprehensive treatment. Diabetic foot is often divided into three types, namely neuropathic, ischemic and neuroischemic (also called mixed). Studies have found that the diabetic foot in my country is mainly mixed, followed by ischemic, and pure neuropathic is relatively rare. For the neuropathy type, in addition to treating neuropathy, it is important to decompress the affected limb, and local debridement can promote ulcer healing; for ischemic lesions, certain therapeutic effects can be achieved through drug treatment, exercise and reconstruction of lower limb blood flow; even for mixed lesions, if blood flow is improved, the neuropathy can be partially relieved."
    },
    {
      "paragraph_id": "61",
      "paragraph": "1.良好的代谢管理：对于糖尿病足患者，应积极进行血糖控制，首选胰岛素控制血糖，同时对患者进行充分地血糖控制[糖化血红蛋白 (HbA1c)<7%] ，同时尽可能减少低血糖的发生以降低足溃疡和感染的发生率，继而降低患者的截肢风险。但由于糖尿病足患者常常年龄较大，合并症及并发症较多，因此不能一味地强调将患者的H bA1c控制在7%以下，此时应该参照中华医学会内分泌学分会制定的《中国成人2型糖尿病HbA1c控制目标的专家共识》推荐的个体化控制目标. ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "1.良好的代谢管理：对于糖尿病足患者，应积极进行血糖控制，首选胰岛素控制血糖，同时对患者进行充分地血糖控制[糖化血红蛋白 (HbA1c)<7%] ，同时尽可能减少低血糖的发生以降低足溃疡和感染的发生率，继而降低患者的截肢风险。但由于糖尿病足患者常常年龄较大，合并症及并发症较多，因此不能一味地强调将患者的H bA1c控制在7%以下，此时应该参照中华医学会内分泌学分会制定的《中国成人2型糖尿病HbA1c控制目标的专家共识》推荐的个体化控制目标. ",
          "start_idx": 0,
          "end_idx": 223,
          "entities": [
            {
              "entity_id": "T467",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 12,
              "end_idx": 16,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T468",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 15,
              "end_idx": 16,
              "entity_en": "foot"
            },
            {
              "entity_id": "T469",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 24,
              "end_idx": 26,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T470",
              "entity": "胰岛素",
              "entity_type": "Drug",
              "start_idx": 31,
              "end_idx": 34,
              "entity_en": "insulin"
            },
            {
              "entity_id": "T471",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 36,
              "end_idx": 38,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T472",
              "entity": "血糖",
              "entity_type": "Test_items",
              "start_idx": 49,
              "end_idx": 51,
              "entity_en": "blood sugar"
            },
            {
              "entity_id": "T473",
              "entity": "糖化血红蛋白 (HbA1c)",
              "entity_type": "Test_items",
              "start_idx": 54,
              "end_idx": 68,
              "entity_en": "Glycated hemoglobin (HbA1c)"
            },
            {
              "entity_id": "T474",
              "entity": "<7%",
              "entity_type": "Test_Value",
              "start_idx": 68,
              "end_idx": 71,
              "entity_en": "<7%"
            },
            {
              "entity_id": "T475",
              "entity": "低血糖",
              "entity_type": "Disease",
              "start_idx": 81,
              "end_idx": 84,
              "entity_en": "Hypoglycemia"
            },
            {
              "entity_id": "T476",
              "entity": "足溃疡",
              "entity_type": "Disease",
              "start_idx": 90,
              "end_idx": 93,
              "entity_en": "Foot ulcer"
            },
            {
              "entity_id": "T477",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 90,
              "end_idx": 91,
              "entity_en": "foot"
            },
            {
              "entity_id": "T478",
              "entity": "感染",
              "entity_type": "Disease",
              "start_idx": 94,
              "end_idx": 96,
              "entity_en": "Infect"
            },
            {
              "entity_id": "T479",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 116,
              "end_idx": 120,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T480",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 119,
              "end_idx": 120,
              "entity_en": "foot"
            },
            {
              "entity_id": "T481",
              "entity": "H bA1c",
              "entity_type": "Test_items",
              "start_idx": 152,
              "end_idx": 158,
              "entity_en": "HbA1c"
            },
            {
              "entity_id": "T482",
              "entity": "7%以下",
              "entity_type": "Test_Value",
              "start_idx": 161,
              "end_idx": 165,
              "entity_en": "Below 7%"
            },
            {
              "entity_id": "T483",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 191,
              "end_idx": 196,
              "entity_en": "Type 2 diabetes"
            },
            {
              "entity_id": "T484",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 191,
              "end_idx": 193,
              "entity_en": "Type 2"
            },
            {
              "entity_id": "T485",
              "entity": "HbA1c",
              "entity_type": "Test_items",
              "start_idx": 196,
              "end_idx": 201,
              "entity_en": "HbA1c"
            },
            {
              "entity_id": "T486",
              "entity": "截肢",
              "entity_type": "Operation",
              "start_idx": 108,
              "end_idx": 110,
              "entity_en": "Amputation"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R195",
              "head_entity_id": "T468",
              "tail_entity_id": "T467"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R196",
              "head_entity_id": "T471",
              "tail_entity_id": "T467"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R197",
              "head_entity_id": "T473",
              "tail_entity_id": "T467"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R198",
              "head_entity_id": "T477",
              "tail_entity_id": "T476"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R199",
              "head_entity_id": "T480",
              "tail_entity_id": "T479"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R200",
              "head_entity_id": "T481",
              "tail_entity_id": "T479"
            },
            {
              "relation_type": "Class_Disease",
              "relation_id": "R201",
              "head_entity_id": "T484",
              "tail_entity_id": "T483"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R202",
              "head_entity_id": "T485",
              "tail_entity_id": "T483"
            }
          ],
          "sentence_en": "1. Good metabolic management: For patients with diabetic foot, blood sugar control should be actively carried out, and insulin should be used first to control blood sugar. At the same time, patients should be fully controlled for blood sugar [glycosylated hemoglobin (HbA1c) <7%], and the occurrence of hypoglycemia should be reduced as much as possible to reduce the incidence of foot ulcers and infections, and then reduce the risk of amputation. However, since patients with diabetic foot are often older and have more comorbidities and complications, it is not advisable to blindly emphasize that the patient's HbA1c should be controlled below 7%. At this time, the individualized control target recommended by the \"Expert Consensus on HbA1c Control Targets for Chinese Adults with Type 2 Diabetes\" formulated by the Endocrinology Branch of the Chinese Medical Association should be referred to."
        }
      ],
      "paragraph_en": "1. Good metabolic management: For patients with diabetic foot, blood sugar control should be actively carried out, and insulin should be used first to control blood sugar. At the same time, patients should be fully controlled for blood sugar [glycosylated hemoglobin (HbA1c) <7%], and the occurrence of hypoglycemia should be reduced as much as possible to reduce the incidence of foot ulcers and infections, and then reduce the risk of amputation. However, since patients with diabetic foot are often older and have more comorbidities and complications, it is not advisable to blindly emphasize that the patient's HbA1c should be controlled below 7%. At this time, the individualized control target recommended by the \"Expert Consensus on HbA1c Control Targets for Chinese Adults with Type 2 Diabetes\" formulated by the Endocrinology Branch of the Chinese Medical Association should be referred to."
    },
    {
      "paragraph_id": "62",
      "paragraph": "对于糖尿病足合并高血压者，应将血压控制在140/85mmHg以下；糖尿病足合并脂代谢患者，应给予他汀类药物治疗，将低密度脂蛋白胆固醇水平控制在2.1mmol/L以下，若患者同时合并下肢动脉病变，则应将低密度脂蛋白胆固醇水平控制在1 .7mmol/L以下；若无临床禁忌，应该给予小剂量阿司匹林(75~150mg/d)。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "对于糖尿病足合并高血压者，应将血压控制在140/85mmHg以下；糖尿病足合并脂代谢患者，应给予他汀类药物治疗，将低密度脂蛋白胆固醇水平控制在2.1mmol/L以下，若患者同时合并下肢动脉病变，则应将低密度脂蛋白胆固醇水平控制在1 .7mmol/L以下；若无临床禁忌，应该给予小剂量阿司匹林(75~150mg/d)。",
          "start_idx": 0,
          "end_idx": 158,
          "entities": [
            {
              "entity_id": "T487",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 2,
              "end_idx": 6,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T488",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 5,
              "end_idx": 6,
              "entity_en": "foot"
            },
            {
              "entity_id": "T489",
              "entity": "高血压",
              "entity_type": "Disease",
              "start_idx": 8,
              "end_idx": 11,
              "entity_en": "hypertension"
            },
            {
              "entity_id": "T490",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 33,
              "end_idx": 37,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T491",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 36,
              "end_idx": 37,
              "entity_en": "foot"
            },
            {
              "entity_id": "T492",
              "entity": "他汀类药物",
              "entity_type": "Drug",
              "start_idx": 48,
              "end_idx": 53,
              "entity_en": "Statins"
            },
            {
              "entity_id": "T493",
              "entity": "下肢动脉病变",
              "entity_type": "Disease",
              "start_idx": 90,
              "end_idx": 96,
              "entity_en": "Lower extremity arterial disease"
            },
            {
              "entity_id": "T494",
              "entity": "下肢动脉",
              "entity_type": "Anatomy",
              "start_idx": 90,
              "end_idx": 94,
              "entity_en": "Lower limb arteries"
            },
            {
              "entity_id": "T495",
              "entity": "阿司匹林",
              "entity_type": "Drug",
              "start_idx": 141,
              "end_idx": 145,
              "entity_en": "aspirin"
            },
            {
              "entity_id": "T496",
              "entity": "75~150mg/d",
              "entity_type": "Frequency",
              "start_idx": 146,
              "end_idx": 156,
              "entity_en": "75–150 mg/day"
            },
            {
              "entity_id": "T497",
              "entity": "血压",
              "entity_type": "Test",
              "start_idx": 15,
              "end_idx": 17,
              "entity_en": "blood pressure"
            },
            {
              "entity_id": "T498",
              "entity": "140/85mmHg以下",
              "entity_type": "Test_Value",
              "start_idx": 20,
              "end_idx": 32,
              "entity_en": "140/85 mmHg or less"
            },
            {
              "entity_id": "T499",
              "entity": "低密度脂蛋白胆固醇",
              "entity_type": "Test_items",
              "start_idx": 57,
              "end_idx": 66,
              "entity_en": "LDL cholesterol"
            },
            {
              "entity_id": "T500",
              "entity": "2.1mmol/L以下",
              "entity_type": "Test_Value",
              "start_idx": 71,
              "end_idx": 82,
              "entity_en": "2.1mmol/L or less"
            },
            {
              "entity_id": "T501",
              "entity": "低密度脂蛋白胆固醇水平",
              "entity_type": "Test_items",
              "start_idx": 100,
              "end_idx": 111,
              "entity_en": "LDL cholesterol levels"
            },
            {
              "entity_id": "T502",
              "entity": "1 .7mmol/L以下",
              "entity_type": "Test_Value",
              "start_idx": 114,
              "end_idx": 126,
              "entity_en": "1.7mmol/L or less"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R203",
              "head_entity_id": "T488",
              "tail_entity_id": "T487"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R204",
              "head_entity_id": "T497",
              "tail_entity_id": "T489"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R205",
              "head_entity_id": "T491",
              "tail_entity_id": "T490"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R206",
              "head_entity_id": "T492",
              "tail_entity_id": "T490"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R207",
              "head_entity_id": "T494",
              "tail_entity_id": "T493"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R208",
              "head_entity_id": "T495",
              "tail_entity_id": "T493"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R209",
              "head_entity_id": "T501",
              "tail_entity_id": "T493"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R210",
              "head_entity_id": "T496",
              "tail_entity_id": "T495"
            }
          ],
          "sentence_en": "For patients with diabetic foot and hypertension, blood pressure should be controlled below 140/85 mmHg; patients with diabetic foot and lipid metabolism should be given statins to control low-density lipoprotein cholesterol levels below 2.1 mmol/L. If the patient also has lower limb arterial disease, the low-density lipoprotein cholesterol level should be controlled below 1.7 mmol/L; if there are no clinical contraindications, low-dose aspirin (75-150 mg/d) should be given."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 158,
          "end_idx": 159,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "For patients with diabetic foot and hypertension, blood pressure should be controlled below 140/85 mmHg; patients with diabetic foot and lipid metabolism should be given statins to control low-density lipoprotein cholesterol levels below 2.1 mmol/L. If the patient also has lower limb arterial disease, the low-density lipoprotein cholesterol level should be controlled below 1.7 mmol/L; if there are no clinical contraindications, low-dose aspirin (75-150 mg/d) should be given."
    },
    {
      "paragraph_id": "63",
      "paragraph": "2.下肢运动康复治疗：对于足部皮肤完整的缺血型或神经缺血型患者，运动锻炼能改善间歇性跛行患者的步行距离及行走时间。与安慰剂或常规护理相比较，监督下的运动康复锻炼可显著提高下肢动脉病变患者的最大步行距离[加权均数差 (WMD) =218.01m，95%CI：161.54~274.48m，P<0.00001] 、无痛行走距离(WMD=174.19m，95%CI：130.25~218.13m，P<0.00001) 、6min 步行距离(WMD=42.91m，95%CI：25.41~ 59.41m，P<0.00001)。同时还可以显著提高下肢动脉病变患者的运动功能指标，如行走受损问卷(WIQ) 距离评分、WIQ速度评分、WIQ爬梯评分。提示强化步行运动可以提高足部皮肤完整的缺血型或神经缺血型患者的运动耐受性，改善运动功能，且不增加不良事件的发生，是一种安全有效的治疗方式。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.下肢运动康复治疗：对于足部皮肤完整的缺血型或神经缺血型患者，运动锻炼能改善间歇性跛行患者的步行距离及行走时间。与安慰剂或常规护理相比较，监督下的运动康复锻炼可显著提高下肢动脉病变患者的最大步行距离[加权均数差 (WMD) =218.01m，95%CI：161.54~274.48m，P<0.00001] 、无痛行走距离(WMD=174.19m，95%CI：130.25~218.13m，P<0.00001) 、6min 步行距离(WMD=42.91m，95%CI：25.41~ 59.41m，P<0.00001)。",
          "start_idx": 0,
          "end_idx": 259,
          "entities": [
            {
              "entity_id": "T503",
              "entity": "运动锻炼",
              "entity_type": "Treatment",
              "start_idx": 32,
              "end_idx": 36,
              "entity_en": "Exercise"
            },
            {
              "entity_id": "T504",
              "entity": "间歇性跛行",
              "entity_type": "Disease",
              "start_idx": 39,
              "end_idx": 44,
              "entity_en": "Intermittent claudication"
            },
            {
              "entity_id": "T505",
              "entity": "运动康复锻炼",
              "entity_type": "Treatment",
              "start_idx": 74,
              "end_idx": 80,
              "entity_en": "Sports rehabilitation exercises"
            },
            {
              "entity_id": "T506",
              "entity": "下肢动脉病变",
              "entity_type": "Disease",
              "start_idx": 85,
              "end_idx": 91,
              "entity_en": "Lower extremity arterial disease"
            },
            {
              "entity_id": "T507",
              "entity": "下肢动脉",
              "entity_type": "Anatomy",
              "start_idx": 85,
              "end_idx": 89,
              "entity_en": "Lower limb arteries"
            },
            {
              "entity_id": "T510",
              "entity": "下肢运动康复治疗",
              "entity_type": "Treatment",
              "start_idx": 2,
              "end_idx": 10,
              "entity_en": "Lower limb exercise rehabilitation therapy"
            }
          ],
          "relations": [
            {
              "relation_type": "Treatment_Disease",
              "relation_id": "R211",
              "head_entity_id": "T503",
              "tail_entity_id": "T504"
            },
            {
              "relation_type": "Treatment_Disease",
              "relation_id": "R212",
              "head_entity_id": "T505",
              "tail_entity_id": "T506"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R213",
              "head_entity_id": "T507",
              "tail_entity_id": "T506"
            }
          ],
          "sentence_en": "2. Lower limb exercise rehabilitation therapy: For patients with ischemic or neuroischemic foot skin intact, exercise training can improve the walking distance and walking time of patients with intermittent claudication. Compared with placebo or routine care, supervised exercise rehabilitation training can significantly improve the maximum walking distance [weighted mean difference (WMD) = 218.01m, 95%CI: 161.54~274.48m, P<0.00001], pain-free walking distance (WMD=174.19m, 95%CI: 130.25~218.13m, P<0.00001), and 6-minute walking distance (WMD=42.91m, 95%CI: 25.41~ 59.41m, P<0.00001) in patients with lower limb arterial disease."
        },
        {
          "sentence_id": "1",
          "sentence": "同时还可以显著提高下肢动脉病变患者的运动功能指标，如行走受损问卷(WIQ) 距离评分、WIQ速度评分、WIQ爬梯评分。",
          "start_idx": 259,
          "end_idx": 318,
          "entities": [
            {
              "entity_id": "T508",
              "entity": "下肢动脉病变",
              "entity_type": "Disease",
              "start_idx": 9,
              "end_idx": 15,
              "entity_en": "Lower extremity arterial disease"
            },
            {
              "entity_id": "T509",
              "entity": "下肢动脉",
              "entity_type": "Anatomy",
              "start_idx": 9,
              "end_idx": 13,
              "entity_en": "Lower limb arteries"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R214",
              "head_entity_id": "T509",
              "tail_entity_id": "T508"
            }
          ],
          "sentence_en": "At the same time, it can also significantly improve the motor function indicators of patients with lower limb arterial lesions, such as the Walking Impairment Questionnaire (WIQ) distance score, WIQ speed score, and WIQ ladder climbing score."
        },
        {
          "sentence_id": "2",
          "sentence": "提示强化步行运动可以提高足部皮肤完整的缺血型或神经缺血型患者的运动耐受性，改善运动功能，且不增加不良事件的发生，是一种安全有效的治疗方式。",
          "start_idx": 318,
          "end_idx": 387,
          "entities": [
            {
              "entity_id": "T511",
              "entity": "强化步行运动",
              "entity_type": "Treatment",
              "start_idx": 2,
              "end_idx": 8,
              "entity_en": "Strengthen walking exercise"
            }
          ],
          "relations": [],
          "sentence_en": "These results suggest that enhanced walking exercise can improve exercise tolerance and motor function in patients with ischemic or neuroischemic foot skin intact without increasing the occurrence of adverse events, and is a safe and effective treatment method."
        },
        {
          "sentence_id": "3",
          "sentence": " ",
          "start_idx": 387,
          "end_idx": 388,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "2. Lower limb exercise rehabilitation therapy: For patients with intact foot skin ischemia or neuroischemia, exercise training can improve the walking distance and walking time of patients with intermittent claudication. Compared with placebo or routine care, supervised exercise rehabilitation training can significantly improve the maximum walking distance of patients with lower limb arterial disease [weighted mean difference (WMD) = 218.01m, 95%CI: 161.54~274.48m, P<0.00001], pain-free walking distance (WMD=174.19m, 95%CI: 130.25~218.13m, P<0.00001), and 6-minute walking distance (WMD=42.91m, 95%CI: 25.41~ 59.41m, P<0.00001). At the same time, it can also significantly improve the motor function indicators of patients with lower limb arterial disease, such as the walking impairment questionnaire (WIQ) distance score, WIQ speed score, and WIQ ladder score. These results suggest that enhanced walking exercise can improve exercise tolerance and motor function in patients with ischemic or neuroischemic foot skin intact without increasing the occurrence of adverse events, and is a safe and effective treatment method."
    },
    {
      "paragraph_id": "64",
      "paragraph": "3.  药物治疗 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "3.  药物治疗 ",
          "start_idx": 0,
          "end_idx": 9,
          "entities": [],
          "relations": [],
          "sentence_en": "3. Medication"
        }
      ],
      "paragraph_en": "3. Medication"
    },
    {
      "paragraph_id": "65",
      "paragraph": "(1)扩张血管药物治疗：目前临床所用的血管扩张药包括脂微球前列地尔注射液、贝前列素钠、西洛他唑、盐酸沙格雷酯、萘呋胺、丁咯地尔和己酮可可碱等。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(1)扩张血管药物治疗：目前临床所用的血管扩张药包括脂微球前列地尔注射液、贝前列素钠、西洛他唑、盐酸沙格雷酯、萘呋胺、丁咯地尔和己酮可可碱等。",
          "start_idx": 0,
          "end_idx": 71,
          "entities": [
            {
              "entity_id": "T512",
              "entity": "脂微球前列地尔注射液",
              "entity_type": "Drug",
              "start_idx": 26,
              "end_idx": 36,
              "entity_en": "Lipomicrosphere alprostadil injection"
            },
            {
              "entity_id": "T513",
              "entity": "贝前列素钠",
              "entity_type": "Drug",
              "start_idx": 37,
              "end_idx": 42,
              "entity_en": "Beraprost Sodium"
            },
            {
              "entity_id": "T514",
              "entity": "西洛他唑",
              "entity_type": "Drug",
              "start_idx": 43,
              "end_idx": 47,
              "entity_en": "Cilostazol"
            },
            {
              "entity_id": "T515",
              "entity": "盐酸沙格雷酯",
              "entity_type": "Drug",
              "start_idx": 48,
              "end_idx": 54,
              "entity_en": "Sarpogrelate hydrochloride"
            },
            {
              "entity_id": "T516",
              "entity": "萘呋胺",
              "entity_type": "Drug",
              "start_idx": 55,
              "end_idx": 58,
              "entity_en": "Naphthofuram"
            },
            {
              "entity_id": "T517",
              "entity": "丁咯地尔",
              "entity_type": "Drug",
              "start_idx": 59,
              "end_idx": 63,
              "entity_en": "Buflomedil"
            },
            {
              "entity_id": "T518",
              "entity": "己酮可可碱",
              "entity_type": "Drug",
              "start_idx": 64,
              "end_idx": 69,
              "entity_en": "Pentoxifylline"
            }
          ],
          "relations": [],
          "sentence_en": "(1) Vasodilator drug treatment: The vasodilators currently used in clinical practice include lipomicrosphere alprostadil injection, beraprost sodium, cilostazol, sarpogrelate hydrochloride, naphthofuram, buflomedil and pentoxifylline."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 71,
          "end_idx": 72,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "(1) Vasodilator drug treatment: The vasodilators currently used in clinical practice include lipomicrosphere alprostadil injection, beraprost sodium, cilostazol, sarpogrelate hydrochloride, naphthofuram, buflomedil and pentoxifylline."
    },
    {
      "paragraph_id": "67",
      "paragraph": "盐酸沙格雷酯是一种多靶点循环改善剂，对血小板以及血管平滑肌的5-羟色胺(5-HT)2受体具有特异性拮抗作用，从而抑制5-HT2导致的血小板凝聚，抑制血管收缩和平滑肌细胞增殖；改善红细胞的变形能力，改善侧支循环及微循环障碍。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "盐酸沙格雷酯是一种多靶点循环改善剂，对血小板以及血管平滑肌的5-羟色胺(5-HT)2受体具有特异性拮抗作用，从而抑制5-HT2导致的血小板凝聚，抑制血管收缩和平滑肌细胞增殖；改善红细胞的变形能力，改善侧支循环及微循环障碍。",
          "start_idx": 0,
          "end_idx": 111,
          "entities": [
            {
              "entity_id": "T519",
              "entity": "盐酸沙格雷酯",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 6,
              "entity_en": "Sarpogrelate hydrochloride"
            },
            {
              "entity_id": "T520",
              "entity": "多靶点循环改善剂",
              "entity_type": "Drug",
              "start_idx": 9,
              "end_idx": 17,
              "entity_en": "Multi-target circulation improver"
            }
          ],
          "relations": [],
          "sentence_en": "Sarpogrelate hydrochloride is a multi-target circulation improver that has a specific antagonistic effect on the 5-hydroxytryptamine (5-HT) 2 receptors of platelets and vascular smooth muscle, thereby inhibiting platelet aggregation caused by 5-HT2, inhibiting vasoconstriction and smooth muscle cell proliferation; improving the deformability of red blood cells, and improving collateral circulation and microcirculation disorders."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 111,
          "end_idx": 112,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "Sarpogrelate hydrochloride is a multi-target circulation improver that has a specific antagonistic effect on the 5-hydroxytryptamine (5-HT) 2 receptors of platelets and vascular smooth muscle, thereby inhibiting platelet aggregation caused by 5-HT2, inhibiting vasoconstriction and smooth muscle cell proliferation; improving the deformability of red blood cells, and improving collateral circulation and microcirculation disorders."
    },
    {
      "paragraph_id": "68",
      "paragraph": "一项系统评价纳入了9个RCT研究，荟萃分析结果显示，盐酸沙格雷酯治疗下肢血管病变，能减小患者溃疡面积，增加ABI、足背动脉血流量，无痛行走距离增加200.87m。一项RCT研究显示，盐酸沙格雷酯治疗糖尿病下肢血管病变，能有效增加患者最大行走距离和无痛行走距离，部分改善足背动脉和胫后动脉的流速、阻力指数和ABI指标。因此，盐酸沙格雷酯被推荐治疗慢性动脉闭塞症所引起的溃疡、疼痛以及冷感等缺血性诸症状，尤其对静息痛的疗效显著。盐酸沙格雷酯的推荐剂量为100mg/次，2次/d。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "一项系统评价纳入了9个RCT研究，荟萃分析结果显示，盐酸沙格雷酯治疗下肢血管病变，能减小患者溃疡面积，增加ABI、足背动脉血流量，无痛行走距离增加200.87m。一项RCT研究显示，盐酸沙格雷酯治疗糖尿病下肢血管病变，能有效增加患者最大行走距离和无痛行走距离，部分改善足背动脉和胫后动脉的流速、阻力指数和ABI指标。因此，盐酸沙格雷酯被推荐治疗慢性动脉闭塞症所引起的溃疡、疼痛以及冷感等缺血性诸症状，尤其对静息痛的疗效显著。盐酸沙格雷酯的推荐剂量为100mg/次，2次/d。",
          "start_idx": 0,
          "end_idx": 237,
          "entities": [
            {
              "entity_id": "T521",
              "entity": "盐酸沙格雷酯",
              "entity_type": "Drug",
              "start_idx": 26,
              "end_idx": 32,
              "entity_en": "Sarpogrelate hydrochloride"
            },
            {
              "entity_id": "T522",
              "entity": "下肢血管病变",
              "entity_type": "Disease",
              "start_idx": 34,
              "end_idx": 40,
              "entity_en": "Lower extremity vascular disease"
            },
            {
              "entity_id": "T523",
              "entity": "下肢血管",
              "entity_type": "Anatomy",
              "start_idx": 34,
              "end_idx": 38,
              "entity_en": "Lower limb blood vessels"
            },
            {
              "entity_id": "T524",
              "entity": "盐酸沙格雷酯",
              "entity_type": "Drug",
              "start_idx": 91,
              "end_idx": 97,
              "entity_en": "Sarpogrelate hydrochloride"
            },
            {
              "entity_id": "T525",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 99,
              "end_idx": 102,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T526",
              "entity": "下肢血管病变",
              "entity_type": "Disease",
              "start_idx": 102,
              "end_idx": 108,
              "entity_en": "Lower extremity vascular disease"
            },
            {
              "entity_id": "T527",
              "entity": "下肢血管",
              "entity_type": "Anatomy",
              "start_idx": 102,
              "end_idx": 106,
              "entity_en": "Lower limb blood vessels"
            },
            {
              "entity_id": "T528",
              "entity": "盐酸沙格雷酯",
              "entity_type": "Drug",
              "start_idx": 161,
              "end_idx": 167,
              "entity_en": "Sarpogrelate hydrochloride"
            },
            {
              "entity_id": "T529",
              "entity": "慢性动脉闭塞症",
              "entity_type": "Disease",
              "start_idx": 172,
              "end_idx": 179,
              "entity_en": "Chronic arterial occlusive disease"
            },
            {
              "entity_id": "T530",
              "entity": "溃疡",
              "entity_type": "Symptom",
              "start_idx": 183,
              "end_idx": 185,
              "entity_en": "ulcer"
            },
            {
              "entity_id": "T531",
              "entity": "疼痛",
              "entity_type": "Symptom",
              "start_idx": 186,
              "end_idx": 188,
              "entity_en": "pain"
            },
            {
              "entity_id": "T532",
              "entity": "动脉",
              "entity_type": "Anatomy",
              "start_idx": 174,
              "end_idx": 176,
              "entity_en": "artery"
            },
            {
              "entity_id": "T533",
              "entity": "冷感",
              "entity_type": "Symptom",
              "start_idx": 190,
              "end_idx": 192,
              "entity_en": "Cold"
            },
            {
              "entity_id": "T534",
              "entity": "静息痛",
              "entity_type": "Symptom",
              "start_idx": 203,
              "end_idx": 206,
              "entity_en": "Rest pain"
            },
            {
              "entity_id": "T535",
              "entity": "盐酸沙格雷酯",
              "entity_type": "Drug",
              "start_idx": 212,
              "end_idx": 218,
              "entity_en": "Sarpogrelate hydrochloride"
            },
            {
              "entity_id": "T536",
              "entity": "100mg/次",
              "entity_type": "Amount",
              "start_idx": 224,
              "end_idx": 231,
              "entity_en": "100 mg/time"
            },
            {
              "entity_id": "T537",
              "entity": "2次/d",
              "entity_type": "Frequency",
              "start_idx": 232,
              "end_idx": 236,
              "entity_en": "2 times/day"
            },
            {
              "entity_id": "T538",
              "entity": "溃疡",
              "entity_type": "Symptom",
              "start_idx": 46,
              "end_idx": 48,
              "entity_en": "ulcer"
            },
            {
              "entity_id": "T539",
              "entity": "足背动脉血流量",
              "entity_type": "Test_items",
              "start_idx": 57,
              "end_idx": 64,
              "entity_en": "Dorsal artery blood flow"
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R215",
              "head_entity_id": "T521",
              "tail_entity_id": "T522"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R216",
              "head_entity_id": "T523",
              "tail_entity_id": "T522"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R217",
              "head_entity_id": "T538",
              "tail_entity_id": "T522"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R218",
              "head_entity_id": "T539",
              "tail_entity_id": "T522"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R219",
              "head_entity_id": "T524",
              "tail_entity_id": "T525"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R220",
              "head_entity_id": "T524",
              "tail_entity_id": "T526"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R221",
              "head_entity_id": "T527",
              "tail_entity_id": "T526"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R222",
              "head_entity_id": "T528",
              "tail_entity_id": "T529"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R223",
              "head_entity_id": "T532",
              "tail_entity_id": "T529"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R224",
              "head_entity_id": "T530",
              "tail_entity_id": "T529"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R225",
              "head_entity_id": "T531",
              "tail_entity_id": "T529"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R226",
              "head_entity_id": "T533",
              "tail_entity_id": "T529"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R227",
              "head_entity_id": "T534",
              "tail_entity_id": "T529"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R228",
              "head_entity_id": "T536",
              "tail_entity_id": "T535"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R229",
              "head_entity_id": "T537",
              "tail_entity_id": "T535"
            }
          ],
          "sentence_en": "A systematic review included 9 RCT studies. The meta-analysis results showed that sarpogrelate hydrochloride can reduce the ulcer area, increase ABI and dorsalis pedis artery blood flow, and increase the pain-free walking distance by 200.87m in the treatment of lower limb vascular disease. An RCT study showed that sarpogrelate hydrochloride can effectively increase the maximum walking distance and pain-free walking distance of patients in the treatment of diabetic lower limb vascular disease, and partially improve the flow velocity, resistance index and ABI index of the dorsalis pedis artery and posterior tibial artery. Therefore, sarpogrelate hydrochloride is recommended for the treatment of ischemic symptoms such as ulcers, pain and cold sensation caused by chronic arterial occlusive disease, especially for rest pain. The recommended dose of sarpogrelate hydrochloride is 100 mg/time, 2 times/d."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 237,
          "end_idx": 238,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "A systematic review included 9 RCT studies. The meta-analysis results showed that sarpogrelate hydrochloride can reduce the ulcer area, increase ABI and dorsalis pedis artery blood flow, and increase the pain-free walking distance by 200.87m in the treatment of lower limb vascular disease. An RCT study showed that sarpogrelate hydrochloride can effectively increase the maximum walking distance and pain-free walking distance of patients in the treatment of diabetic lower limb vascular disease, and partially improve the flow velocity, resistance index and ABI index of the dorsalis pedis artery and posterior tibial artery. Therefore, sarpogrelate hydrochloride is recommended for the treatment of ischemic symptoms such as ulcers, pain and cold sensation caused by chronic arterial occlusive disease, especially for rest pain. The recommended dose of sarpogrelate hydrochloride is 100 mg/time, 2 times/d."
    },
    {
      "paragraph_id": "69",
      "paragraph": "在前列腺素类药物中，脂微球前列地尔注射液的疗效和耐受性最好。荟萃分析表明，与安慰剂相比，前列腺素El(PGE I) 能够显著增加步行距离，即使停止治疗后其步行能力仍然保持增加。脂微球前列地尔注射液的剂量根据患者病变程度推荐为10μg/次，1~2次/d，静脉推注或滴注，疗程14~ 21d。贝前列素钠治疗能改善糖尿病性周围血管病变患者下肢的主观症状，如烧灼样感觉、冷感觉、水肿、劳力性疼痛、针刺样疼痛及感觉异常。与安慰剂相比，每日口服贝前列素钠40μg，3次/d，治疗6个月，无痛性行走距离改善超过50%的LEAD患者在两组分别为43.5%与33.3%，两组间无痛性行走距离分别增加81.5%和52.5%，最大步行距离分别增加60.1%和35.0%，严重心血管事件的发生率分别为4.8%和8.9%。因此，贝前列素钠能有效地改善间歇性行患者的症状。贝前列腺素钠的剂量根据患者病变程度推荐为20~40μg/次，2~ 3次/d。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "在前列腺素类药物中，脂微球前列地尔注射液的疗效和耐受性最好。",
          "start_idx": 0,
          "end_idx": 30,
          "entities": [
            {
              "entity_id": "T540",
              "entity": "前列腺素类药物",
              "entity_type": "Drug",
              "start_idx": 1,
              "end_idx": 8,
              "entity_en": "Prostaglandins"
            },
            {
              "entity_id": "T541",
              "entity": "脂微球前列地尔注射液",
              "entity_type": "Drug",
              "start_idx": 10,
              "end_idx": 20,
              "entity_en": "Lipomicrosphere alprostadil injection"
            }
          ],
          "relations": [],
          "sentence_en": "Among prostaglandins, lipomicrosphere alprostadil injection has the best efficacy and tolerability."
        },
        {
          "sentence_id": "1",
          "sentence": "荟萃分析表明，与安慰剂相比，前列腺素El(PGE I) 能够显著增加步行距离，即使停止治疗后其步行能力仍然保持增加。脂微球前列地尔注射液的剂量根据患者病变程度推荐为10μg/次，1~2次/d，静脉推注或滴注，疗程14~ 21d。贝前列素钠治疗能改善糖尿病性周围血管病变患者下肢的主观症状，如烧灼样感觉、冷感觉、水肿、劳力性疼痛、针刺样疼痛及感觉异常。与安慰剂相比，每日口服贝前列素钠40μg，3次/d，治疗6个月，无痛性行走距离改善超过50%的LEAD患者在两组分别为43.5%与33.3%，两组间无痛性行走距离分别增加81.5%和52.5%，最大步行距离分别增加60.1%和35.0%，严重心血管事件的发生率分别为4.8%和8.9%。",
          "start_idx": 30,
          "end_idx": 348,
          "entities": [
            {
              "entity_id": "T542",
              "entity": "前列腺素El(PGE I)",
              "entity_type": "Drug",
              "start_idx": 14,
              "end_idx": 27,
              "entity_en": "Prostaglandin E1 (PGE I)"
            },
            {
              "entity_id": "T543",
              "entity": "脂微球前列地尔注射液",
              "entity_type": "Drug",
              "start_idx": 58,
              "end_idx": 68,
              "entity_en": "Lipomicrosphere alprostadil injection"
            },
            {
              "entity_id": "T544",
              "entity": "10μg/次",
              "entity_type": "Amount",
              "start_idx": 82,
              "end_idx": 88,
              "entity_en": "10 μg/time"
            },
            {
              "entity_id": "T545",
              "entity": "1~2次/d",
              "entity_type": "Frequency",
              "start_idx": 89,
              "end_idx": 95,
              "entity_en": "1~2 times/day"
            },
            {
              "entity_id": "T546",
              "entity": "静脉推注或滴注",
              "entity_type": "Method",
              "start_idx": 96,
              "end_idx": 103,
              "entity_en": "IV push or drip"
            },
            {
              "entity_id": "T547",
              "entity": "14~ 21d",
              "entity_type": "Duration",
              "start_idx": 106,
              "end_idx": 113,
              "entity_en": "14~ 21d"
            },
            {
              "entity_id": "T548",
              "entity": "贝前列素钠",
              "entity_type": "Drug",
              "start_idx": 114,
              "end_idx": 119,
              "entity_en": "Beraprost Sodium"
            },
            {
              "entity_id": "T549",
              "entity": "糖尿病性周围血管病变",
              "entity_type": "Disease",
              "start_idx": 124,
              "end_idx": 134,
              "entity_en": "Diabetic peripheral vascular disease"
            },
            {
              "entity_id": "T550",
              "entity": "周围血管",
              "entity_type": "Anatomy",
              "start_idx": 128,
              "end_idx": 132,
              "entity_en": "Peripheral blood vessels"
            },
            {
              "entity_id": "T551",
              "entity": "烧灼样感觉",
              "entity_type": "Symptom",
              "start_idx": 145,
              "end_idx": 150,
              "entity_en": "Burning sensation"
            },
            {
              "entity_id": "T552",
              "entity": "冷感觉",
              "entity_type": "Symptom",
              "start_idx": 151,
              "end_idx": 154,
              "entity_en": "Cold feeling"
            },
            {
              "entity_id": "T553",
              "entity": "水肿",
              "entity_type": "Symptom",
              "start_idx": 155,
              "end_idx": 157,
              "entity_en": "Edema"
            },
            {
              "entity_id": "T554",
              "entity": "劳力性疼痛",
              "entity_type": "Symptom",
              "start_idx": 158,
              "end_idx": 163,
              "entity_en": "Pain on exertion"
            },
            {
              "entity_id": "T555",
              "entity": "针刺样疼痛",
              "entity_type": "Symptom",
              "start_idx": 164,
              "end_idx": 169,
              "entity_en": "Needle-like pain"
            },
            {
              "entity_id": "T556",
              "entity": "感觉异常",
              "entity_type": "Symptom",
              "start_idx": 170,
              "end_idx": 174,
              "entity_en": "Paresthesias"
            },
            {
              "entity_id": "T557",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 184,
              "end_idx": 186,
              "entity_en": "oral"
            },
            {
              "entity_id": "T558",
              "entity": "贝前列素钠",
              "entity_type": "Drug",
              "start_idx": 186,
              "end_idx": 191,
              "entity_en": "Beraprost Sodium"
            },
            {
              "entity_id": "T559",
              "entity": "40μg",
              "entity_type": "Amount",
              "start_idx": 191,
              "end_idx": 195,
              "entity_en": "40 μg"
            },
            {
              "entity_id": "T560",
              "entity": "3次/d",
              "entity_type": "Frequency",
              "start_idx": 196,
              "end_idx": 200,
              "entity_en": "3 times/day"
            },
            {
              "entity_id": "T561",
              "entity": "6个月",
              "entity_type": "Duration",
              "start_idx": 203,
              "end_idx": 206,
              "entity_en": "6 months"
            },
            {
              "entity_id": "T562",
              "entity": "LEAD",
              "entity_type": "Disease",
              "start_idx": 222,
              "end_idx": 226,
              "entity_en": "LEAD"
            },
            {
              "entity_id": "T563",
              "entity": "43.5%",
              "entity_type": "Test_Value",
              "start_idx": 234,
              "end_idx": 239,
              "entity_en": "43.5%"
            },
            {
              "entity_id": "T564",
              "entity": "33.3%",
              "entity_type": "Test_Value",
              "start_idx": 240,
              "end_idx": 245,
              "entity_en": "33.3%"
            },
            {
              "entity_id": "T565",
              "entity": "增加81.5%和52.5%",
              "entity_type": "Test_Value",
              "start_idx": 258,
              "end_idx": 271,
              "entity_en": "Increased by 81.5% and 52.5%"
            },
            {
              "entity_id": "T566",
              "entity": "增加60.1%和35.0%",
              "entity_type": "Test_Value",
              "start_idx": 280,
              "end_idx": 293,
              "entity_en": "Increased by 60.1% and 35.0%"
            },
            {
              "entity_id": "T567",
              "entity": "严重",
              "entity_type": "Level",
              "start_idx": 294,
              "end_idx": 296,
              "entity_en": "serious"
            },
            {
              "entity_id": "T568",
              "entity": "心血管事件",
              "entity_type": "ADE",
              "start_idx": 296,
              "end_idx": 301,
              "entity_en": "Cardiovascular events"
            }
          ],
          "relations": [
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R230",
              "head_entity_id": "T545",
              "tail_entity_id": "T543"
            },
            {
              "relation_type": "Duration_Drug",
              "relation_id": "R231",
              "head_entity_id": "T547",
              "tail_entity_id": "T543"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R232",
              "head_entity_id": "T544",
              "tail_entity_id": "T543"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R233",
              "head_entity_id": "T546",
              "tail_entity_id": "T543"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R234",
              "head_entity_id": "T550",
              "tail_entity_id": "T549"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R235",
              "head_entity_id": "T551",
              "tail_entity_id": "T549"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R236",
              "head_entity_id": "T552",
              "tail_entity_id": "T549"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R237",
              "head_entity_id": "T553",
              "tail_entity_id": "T549"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R238",
              "head_entity_id": "T554",
              "tail_entity_id": "T549"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R239",
              "head_entity_id": "T555",
              "tail_entity_id": "T549"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R240",
              "head_entity_id": "T556",
              "tail_entity_id": "T549"
            },
            {
              "relation_type": "Method_Drug",
              "relation_id": "R241",
              "head_entity_id": "T557",
              "tail_entity_id": "T558"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R242",
              "head_entity_id": "T558",
              "tail_entity_id": "T562"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R243",
              "head_entity_id": "T568",
              "tail_entity_id": "T558"
            },
            {
              "relation_type": "Duration_Drug",
              "relation_id": "R244",
              "head_entity_id": "T561",
              "tail_entity_id": "T558"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R245",
              "head_entity_id": "T560",
              "tail_entity_id": "T558"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R246",
              "head_entity_id": "T559",
              "tail_entity_id": "T558"
            }
          ],
          "sentence_en": "Meta-analysis showed that compared with placebo, prostaglandin El (PGE I) can significantly increase walking distance, and even after stopping treatment, the walking ability remains increased. The dose of lipomicrosphere alprostadil injection is recommended to be 10 μg/time, 1~2 times/d, intravenous push or drip, and the course of treatment is 14~21d according to the degree of the patient's lesion. Beraprost sodium treatment can improve the subjective symptoms of lower limbs in patients with diabetic peripheral vascular disease, such as burning sensation, cold sensation, edema, exertional pain, needle-like pain and paresthesia. Compared with placebo, daily oral beraprost sodium 40 μg, 3 times/d, for 6 months, the pain-free walking distance of LEAD patients improved by more than 50% in 43.5% and 33.3% of the two groups, the pain-free walking distance increased by 81.5% and 52.5% respectively, the maximum walking distance increased by 60.1% and 35.0% respectively, and the incidence of serious cardiovascular events was 4.8% and 8.9% respectively."
        },
        {
          "sentence_id": "2",
          "sentence": "因此，贝前列素钠能有效地改善间歇性行患者的症状。",
          "start_idx": 348,
          "end_idx": 372,
          "entities": [
            {
              "entity_id": "T569",
              "entity": "贝前列素钠",
              "entity_type": "Drug",
              "start_idx": 3,
              "end_idx": 8,
              "entity_en": "Beraprost Sodium"
            },
            {
              "entity_id": "T570",
              "entity": "间歇性行",
              "entity_type": "Disease",
              "start_idx": 14,
              "end_idx": 18,
              "entity_en": "Intermittent"
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R247",
              "head_entity_id": "T569",
              "tail_entity_id": "T570"
            }
          ],
          "sentence_en": "Therefore, beraprost sodium can effectively improve the symptoms of patients with intermittent walking."
        },
        {
          "sentence_id": "3",
          "sentence": "贝前列腺素钠的剂量根据患者病变程度推荐为20~40μg/次，2~ 3次/d。",
          "start_idx": 372,
          "end_idx": 410,
          "entities": [
            {
              "entity_id": "T571",
              "entity": "贝前列腺素钠",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 6,
              "entity_en": "Beprostaglandin Sodium"
            },
            {
              "entity_id": "T572",
              "entity": "20~40μg/次",
              "entity_type": "Amount",
              "start_idx": 20,
              "end_idx": 29,
              "entity_en": "20~40μg/time"
            },
            {
              "entity_id": "T573",
              "entity": "2~ 3次/d",
              "entity_type": "Frequency",
              "start_idx": 30,
              "end_idx": 37,
              "entity_en": "2~3 times/day"
            }
          ],
          "relations": [
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R248",
              "head_entity_id": "T573",
              "tail_entity_id": "T571"
            }
          ],
          "sentence_en": "The recommended dose of beta-prostaglandin sodium is 20~40μg/time, 2~3 times/day, depending on the severity of the patient's lesions."
        },
        {
          "sentence_id": "4",
          "sentence": " ",
          "start_idx": 410,
          "end_idx": 411,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "Among prostaglandins, lipomicrosphere alprostadil injection has the best efficacy and tolerability. Meta-analysis shows that compared with placebo, prostaglandin El (PGE I) can significantly increase walking distance, and its walking ability remains increased even after treatment is stopped. The dose of lipomicrosphere alprostadil injection is recommended to be 10μg/time, 1~2 times/d, intravenous push or drip, and the course of treatment is 14~21d according to the degree of patient lesions. Beraprost sodium treatment can improve the subjective symptoms of lower limbs in patients with diabetic peripheral vascular disease, such as burning sensation, cold sensation, edema, exertional pain, pin-like pain and paresthesia. Compared with placebo, daily oral administration of beraprost sodium 40 μg, 3 times/d, for 6 months, the pain-free walking distance of LEAD patients improved by more than 50% in 43.5% and 33.3% of the two groups, respectively. The pain-free walking distance increased by 81.5% and 52.5% between the two groups, respectively. The maximum walking distance increased by 60.1% and 35.0%, respectively. The incidence of serious cardiovascular events was 4.8% and 8.9%, respectively. Therefore, beraprost sodium can effectively improve the symptoms of patients with intermittent walking. The recommended dose of beraprost sodium is 20~40μg/time, 2~3 times/d according to the degree of the patient's lesion."
    },
    {
      "paragraph_id": "70",
      "paragraph": "目前临床应用较多还有其他一些扩张血管药物，比如己酮可可碱，中药通塞脉片等。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "目前临床应用较多还有其他一些扩张血管药物，比如己酮可可碱，中药通塞脉片等。",
          "start_idx": 0,
          "end_idx": 37,
          "entities": [
            {
              "entity_id": "T574",
              "entity": "己酮可可碱",
              "entity_type": "Drug",
              "start_idx": 23,
              "end_idx": 28,
              "entity_en": "Pentoxifylline"
            },
            {
              "entity_id": "T575",
              "entity": "通塞脉片",
              "entity_type": "Drug",
              "start_idx": 31,
              "end_idx": 35,
              "entity_en": "Tongsaimai Tablets"
            }
          ],
          "relations": [],
          "sentence_en": "There are also some other vasodilator drugs that are widely used in clinical practice, such as pentoxifylline and the traditional Chinese medicine Tongsaimai tablets."
        }
      ],
      "paragraph_en": "There are also some other vasodilator drugs that are widely used in clinical practice, such as pentoxifylline and the traditional Chinese medicine Tongsaimai tablets."
    },
    {
      "paragraph_id": "71",
      "paragraph": "(2)抗血小板药物治疗：在糖尿病足患者，氯吡格雷是有适应证的抗血小板药物，与阿司匹林相比，氯吡格雷联合阿司匹林的抗血小板治疗能显著降低其全因死亡率(RR=0.73，95%CI：0.58~0.93)和心血管事件(RR=0.81，95%CI：0.67~0.98)发生，但严重出血的风险轻度增加。此外，氯吡格雷联合阿司匹林的双联抗血小板治疗能显著降低下肢血管重建术后的大截肢事件[与单纯的阿司匹林治疗相比，RR=0.68，95%CI：0.46~0.99，需治疗人数(NNT)=94]。因此，目前推荐氯吡格雷为对阿司匹林不耐受或对阿司匹林过敏的患者的另一种治疗选择。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(2)抗血小板药物治疗：在糖尿病足患者，氯吡格雷是有适应证的抗血小板药物，与阿司匹林相比，氯吡格雷联合阿司匹林的抗血小板治疗能显著降低其全因死亡率(RR=0.73，95%CI：0.58~0.93)和心血管事件(RR=0.81，95%CI：0.67~0.98)发生，但严重出血的风险轻度增加。",
          "start_idx": 0,
          "end_idx": 145,
          "entities": [
            {
              "entity_id": "T576",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 13,
              "end_idx": 17,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T577",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 16,
              "end_idx": 17,
              "entity_en": "foot"
            },
            {
              "entity_id": "T578",
              "entity": "氯吡格雷",
              "entity_type": "Drug",
              "start_idx": 20,
              "end_idx": 24,
              "entity_en": "Clopidogrel"
            },
            {
              "entity_id": "T579",
              "entity": "阿司匹林",
              "entity_type": "Drug",
              "start_idx": 38,
              "end_idx": 42,
              "entity_en": "aspirin"
            },
            {
              "entity_id": "T580",
              "entity": "氯吡格雷",
              "entity_type": "Drug",
              "start_idx": 45,
              "end_idx": 49,
              "entity_en": "Clopidogrel"
            },
            {
              "entity_id": "T581",
              "entity": "阿司匹林",
              "entity_type": "Drug",
              "start_idx": 51,
              "end_idx": 55,
              "entity_en": "aspirin"
            },
            {
              "entity_id": "T582",
              "entity": "心血管事件",
              "entity_type": "ADE",
              "start_idx": 99,
              "end_idx": 104,
              "entity_en": "Cardiovascular events"
            },
            {
              "entity_id": "T583",
              "entity": "出血",
              "entity_type": "ADE",
              "start_idx": 135,
              "end_idx": 137,
              "entity_en": "Bleeding"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R249",
              "head_entity_id": "T577",
              "tail_entity_id": "T576"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R250",
              "head_entity_id": "T578",
              "tail_entity_id": "T576"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R251",
              "head_entity_id": "T579",
              "tail_entity_id": "T576"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R252",
              "head_entity_id": "T582",
              "tail_entity_id": "T578"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R253",
              "head_entity_id": "T583",
              "tail_entity_id": "T578"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R254",
              "head_entity_id": "T582",
              "tail_entity_id": "T579"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R255",
              "head_entity_id": "T583",
              "tail_entity_id": "T579"
            }
          ],
          "sentence_en": "(2) Antiplatelet drug therapy: Clopidogrel is an indicated antiplatelet drug for patients with diabetic foot. Compared with aspirin, antiplatelet therapy with clopidogrel combined with aspirin can significantly reduce all-cause mortality (RR=0.73, 95%CI: 0.58~0.93) and cardiovascular events (RR=0.81, 95%CI: 0.67~0.98), but the risk of severe bleeding is slightly increased."
        },
        {
          "sentence_id": "1",
          "sentence": "此外，氯吡格雷联合阿司匹林的双联抗血小板治疗能显著降低下肢血管重建术后的大截肢事件[与单纯的阿司匹林治疗相比，RR=0.68，95%CI：0.46~0.99，需治疗人数(NNT)=94]。",
          "start_idx": 145,
          "end_idx": 239,
          "entities": [
            {
              "entity_id": "T584",
              "entity": "氯吡格雷",
              "entity_type": "Drug",
              "start_idx": 3,
              "end_idx": 7,
              "entity_en": "Clopidogrel"
            },
            {
              "entity_id": "T585",
              "entity": "阿司匹林",
              "entity_type": "Drug",
              "start_idx": 9,
              "end_idx": 13,
              "entity_en": "aspirin"
            },
            {
              "entity_id": "T586",
              "entity": "下肢血管重建",
              "entity_type": "Operation",
              "start_idx": 27,
              "end_idx": 33,
              "entity_en": "Lower limb vascular reconstruction"
            },
            {
              "entity_id": "T587",
              "entity": "大截肢",
              "entity_type": "Operation",
              "start_idx": 36,
              "end_idx": 39,
              "entity_en": "Major amputation"
            },
            {
              "entity_id": "T588",
              "entity": "阿司匹林",
              "entity_type": "Drug",
              "start_idx": 46,
              "end_idx": 50,
              "entity_en": "aspirin"
            }
          ],
          "relations": [],
          "sentence_en": "In addition, dual antiplatelet therapy with clopidogrel combined with aspirin can significantly reduce major amputation events after lower limb revascularization [compared with aspirin treatment alone, RR=0.68, 95%CI: 0.46~0.99, number needed to treat (NNT)=94]."
        },
        {
          "sentence_id": "2",
          "sentence": "因此，目前推荐氯吡格雷为对阿司匹林不耐受或对阿司匹林过敏的患者的另一种治疗选择。",
          "start_idx": 239,
          "end_idx": 279,
          "entities": [
            {
              "entity_id": "T589",
              "entity": "氯吡格雷",
              "entity_type": "Drug",
              "start_idx": 7,
              "end_idx": 11,
              "entity_en": "Clopidogrel"
            },
            {
              "entity_id": "T590",
              "entity": "阿司匹林",
              "entity_type": "Drug",
              "start_idx": 13,
              "end_idx": 17,
              "entity_en": "aspirin"
            },
            {
              "entity_id": "T591",
              "entity": "阿司匹林",
              "entity_type": "Drug",
              "start_idx": 22,
              "end_idx": 26,
              "entity_en": "aspirin"
            }
          ],
          "relations": [],
          "sentence_en": "Therefore, clopidogrel is currently recommended as an alternative treatment option for patients who are intolerant to or allergic to aspirin."
        }
      ],
      "paragraph_en": "(2) Antiplatelet therapy: Clopidogrel is an indicated antiplatelet drug for patients with diabetic foot. Compared with aspirin, antiplatelet therapy with clopidogrel combined with aspirin can significantly reduce all-cause mortality (RR=0.73, 95%CI: 0.58~0.93) and cardiovascular events (RR=0.81, 95%CI: 0.67~0.98), but the risk of severe bleeding is slightly increased. In addition, dual antiplatelet therapy with clopidogrel combined with aspirin can significantly reduce major amputation events after lower limb revascularization [compared with aspirin alone, RR=0.68, 95%CI: 0.46~0.99, number needed to treat (NNT)=94]. Therefore, clopidogrel is currently recommended as another treatment option for patients who are intolerant to or allergic to aspirin."
    },
    {
      "paragraph_id": "72",
      "paragraph": "此外，在行血管旁路手术的糖尿病足患者，阿司匹林或阿司匹林联合双密达莫(ASA/DIP)治疗能显著改善移植人工血管的血管通畅率(OR=0.42，95%C：0.22~0.83，P=0.01)。但在自体静脉移植血管中任何时间点均未发现这种效果，而在人造血管移植中的各个时间点都能发现这种益处，包括在移植12个月后(OR=0.19，95%CI：0.10~0.36，P<0.00001)。阿司匹林联合氯毗格雷与阿司匹林比较，所有血管移植物的通畅率在24个月时均无明显差异，组间的截肢或死亡发生率差异无统计学意义，而阿司匹林联合氯吡格雷虽然不增加大出血或致死性出血风险，但增加总的出血风险(OR=2.65，95%CI：1.69~4.15)，包括轻度出血(OR=2.34，95%CI：1.37~4.00)和中度出血(OR=4.13，95%CI：1.37~12.45)。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "此外，在行血管旁路手术的糖尿病足患者，阿司匹林或阿司匹林联合双密达莫(ASA/DIP)治疗能显著改善移植人工血管的血管通畅率(OR=0.42，95%C：0.22~0.83，P=0.01)。但在自体静脉移植血管中任何时间点均未发现这种效果，而在人造血管移植中的各个时间点都能发现这种益处，包括在移植12个月后(OR=0.19，95%CI：0.10~0.36，P<0.00001)。阿司匹林联合氯毗格雷与阿司匹林比较，所有血管移植物的通畅率在24个月时均无明显差异，组间的截肢或死亡发生率差异无统计学意义，而阿司匹林联合氯吡格雷虽然不增加大出血或致死性出血风险，但增加总的出血风险(OR=2.65，95%CI：1.69~4.15)，包括轻度出血(OR=2.34，95%CI：1.37~4.00)和中度出血(OR=4.13，95%CI：1.37~12.45)。",
          "start_idx": 0,
          "end_idx": 377,
          "entities": [
            {
              "entity_id": "T592",
              "entity": "行血管旁路手术",
              "entity_type": "Operation",
              "start_idx": 4,
              "end_idx": 11,
              "entity_en": "Vascular bypass surgery"
            },
            {
              "entity_id": "T593",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 12,
              "end_idx": 16,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T594",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 15,
              "end_idx": 16,
              "entity_en": "foot"
            },
            {
              "entity_id": "T595",
              "entity": "阿司匹林",
              "entity_type": "Drug",
              "start_idx": 19,
              "end_idx": 23,
              "entity_en": "aspirin"
            },
            {
              "entity_id": "T596",
              "entity": "阿司匹林",
              "entity_type": "Drug",
              "start_idx": 24,
              "end_idx": 28,
              "entity_en": "aspirin"
            },
            {
              "entity_id": "T597",
              "entity": "双密达莫",
              "entity_type": "Drug",
              "start_idx": 30,
              "end_idx": 34,
              "entity_en": "Double mitraz"
            },
            {
              "entity_id": "T598",
              "entity": "血管通畅率",
              "entity_type": "Test_items",
              "start_idx": 57,
              "end_idx": 62,
              "entity_en": "Vascular patency"
            },
            {
              "entity_id": "T599",
              "entity": "自体静脉移植",
              "entity_type": "Operation",
              "start_idx": 96,
              "end_idx": 102,
              "entity_en": "Autologous vein graft"
            },
            {
              "entity_id": "T600",
              "entity": "人造血管移植",
              "entity_type": "Operation",
              "start_idx": 121,
              "end_idx": 127,
              "entity_en": "Artificial blood vessel transplantation"
            },
            {
              "entity_id": "T601",
              "entity": "阿司匹林",
              "entity_type": "Drug",
              "start_idx": 189,
              "end_idx": 193,
              "entity_en": "aspirin"
            },
            {
              "entity_id": "T602",
              "entity": "氯毗格雷",
              "entity_type": "Drug",
              "start_idx": 195,
              "end_idx": 199,
              "entity_en": "Clopidogrel"
            },
            {
              "entity_id": "T603",
              "entity": "阿司匹林",
              "entity_type": "Drug",
              "start_idx": 200,
              "end_idx": 204,
              "entity_en": "aspirin"
            },
            {
              "entity_id": "T604",
              "entity": "截肢",
              "entity_type": "Operation",
              "start_idx": 234,
              "end_idx": 236,
              "entity_en": "Amputation"
            },
            {
              "entity_id": "T605",
              "entity": "阿司匹林",
              "entity_type": "Drug",
              "start_idx": 252,
              "end_idx": 256,
              "entity_en": "aspirin"
            },
            {
              "entity_id": "T606",
              "entity": "氯吡格雷",
              "entity_type": "Drug",
              "start_idx": 258,
              "end_idx": 262,
              "entity_en": "Clopidogrel"
            },
            {
              "entity_id": "T607",
              "entity": "大出血",
              "entity_type": "ADE",
              "start_idx": 267,
              "end_idx": 270,
              "entity_en": "Heavy bleeding"
            },
            {
              "entity_id": "T608",
              "entity": "致死性出血",
              "entity_type": "ADE",
              "start_idx": 271,
              "end_idx": 276,
              "entity_en": "Fatal hemorrhage"
            },
            {
              "entity_id": "T609",
              "entity": "出血",
              "entity_type": "ADE",
              "start_idx": 284,
              "end_idx": 286,
              "entity_en": "Bleeding"
            },
            {
              "entity_id": "T610",
              "entity": "出血",
              "entity_type": "ADE",
              "start_idx": 318,
              "end_idx": 320,
              "entity_en": "Bleeding"
            },
            {
              "entity_id": "T611",
              "entity": "轻度",
              "entity_type": "Level",
              "start_idx": 316,
              "end_idx": 318,
              "entity_en": "Mild"
            },
            {
              "entity_id": "T612",
              "entity": "中度",
              "entity_type": "Level",
              "start_idx": 346,
              "end_idx": 348,
              "entity_en": "Moderate"
            },
            {
              "entity_id": "T613",
              "entity": "出血",
              "entity_type": "ADE",
              "start_idx": 348,
              "end_idx": 350,
              "entity_en": "Bleeding"
            }
          ],
          "relations": [
            {
              "relation_type": "Operation_Disease",
              "relation_id": "R256",
              "head_entity_id": "T592",
              "tail_entity_id": "T593"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R257",
              "head_entity_id": "T594",
              "tail_entity_id": "T593"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R258",
              "head_entity_id": "T598",
              "tail_entity_id": "T593"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R259",
              "head_entity_id": "T595",
              "tail_entity_id": "T593"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R260",
              "head_entity_id": "T597",
              "tail_entity_id": "T593"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R261",
              "head_entity_id": "T609",
              "tail_entity_id": "T605"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R262",
              "head_entity_id": "T609",
              "tail_entity_id": "T606"
            }
          ],
          "sentence_en": "In addition, in patients with diabetic foot undergoing vascular bypass surgery, aspirin or aspirin combined with dipyridamole (ASA/DIP) treatment can significantly improve the vascular patency of grafted artificial blood vessels (OR=0.42, 95%C: 0.22-0.83, P=0.01). However, this effect was not found at any time point in autologous vein grafts, while this benefit was found at all time points in artificial blood vessel grafts, including 12 months after transplantation (OR=0.19, 95%CI: 0.10-0.36, P<0.00001). Compared with aspirin alone, there was no significant difference in the patency rate of all vascular grafts at 24 months in the combination of aspirin combined with clopidogrel, and there was no statistically significant difference in the incidence of amputation or death between the two groups. Although aspirin combined with clopidogrel did not increase the risk of major or fatal bleeding, it increased the overall bleeding risk (OR=2.65, 95%CI: 1.69~4.15), including mild bleeding (OR=2.34, 95%CI: 1.37~4.00) and moderate bleeding (OR=4.13, 95%CI: 1.37~12.45)."
        }
      ],
      "paragraph_en": "In addition, in patients with diabetic foot undergoing vascular bypass surgery, aspirin or aspirin combined with dipyridamole (ASA/DIP) treatment can significantly improve the vascular patency of grafted artificial blood vessels (OR=0.42, 95%C: 0.22-0.83, P=0.01). However, this effect was not found at any time point in autologous vein grafts, while this benefit was found at all time points in artificial blood vessel grafts, including 12 months after transplantation (OR=0.19, 95%CI: 0.10-0.36, P<0.00001). Compared with aspirin alone, there was no significant difference in the patency rate of all vascular grafts at 24 months in the combination of aspirin combined with clopidogrel, and there was no statistically significant difference in the incidence of amputation or death between the two groups. Although aspirin combined with clopidogrel did not increase the risk of major or fatal bleeding, it increased the overall bleeding risk (OR=2.65, 95%CI: 1.69~4.15), including mild bleeding (OR=2.34, 95%CI: 1.37~4.00) and moderate bleeding (OR=4.13, 95%CI: 1.37~12.45)."
    },
    {
      "paragraph_id": "73",
      "paragraph": "(3)抗凝血药物(肝素、低分子肝素及口服抗凝血药物)：月前没有明确的证据支持在糖尿病足前期的间歇性跛行阶段应用抗凝血治疗。与单用阿司匹林相比，在严重肢体缺血患者，低分子肝素联合阿司匹林能显著降低血管腔内微创治疗(球囊扩张及支架植入)的糖尿病足患者的血管闭塞/再狭窄(高达85%)(OR=0.15，95%CI：0.06~0.42，P=0.0003)；而巴曲酶联合阿司匹林显著降低糖尿病患者的再狭窄(OR=0.28，95%Cl：0.13~0.60)，不伴出血和其他消化道不良事件的显著增加。在急性肢体缺血的初期治疗中，起始手术或者溶栓治疗对于30d、6个月或1年的保肢或死亡发生，两者差异无统计学意义；但起始溶栓治疗组(1.3%)30d的卒中发生率较起始手术治疗组(0%)显著增加(OR=6.41，95%CI：1.57~26.22)；30d的大出血发生率分别为8.8%与3.3%(OR=2.80，95%CI：1.70~4.60)，病灶远端的栓塞发生率分别为12.4%与0%(OR=8.35，95%CI：4.47~15.58)；因此，在急性肢体缺血患者，起始手术治疗或者溶栓治疗对于保肢或死亡均无明显差异，但起始溶栓治疗会使肢体缺血与出血并发症风险增加。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(3)抗凝血药物(肝素、低分子肝素及口服抗凝血药物)：月前没有明确的证据支持在糖尿病足前期的间歇性跛行阶段应用抗凝血治疗。与单用阿司匹林相比，在严重肢体缺血患者，低分子肝素联合阿司匹林能显著降低血管腔内微创治疗(球囊扩张及支架植入)的糖尿病足患者的血管闭塞/再狭窄(高达85%)(OR=0.15，95%CI：0.06~0.42，P=0.0003)；而巴曲酶联合阿司匹林显著降低糖尿病患者的再狭窄(OR=0.28，95%Cl：0.13~0.60)，不伴出血和其他消化道不良事件的显著增加。",
          "start_idx": 0,
          "end_idx": 243,
          "entities": [
            {
              "entity_id": "T614",
              "entity": "肝素",
              "entity_type": "Drug",
              "start_idx": 9,
              "end_idx": 11,
              "entity_en": "heparin"
            },
            {
              "entity_id": "T615",
              "entity": "低分子肝素",
              "entity_type": "Drug",
              "start_idx": 12,
              "end_idx": 17,
              "entity_en": "Low molecular weight heparin"
            },
            {
              "entity_id": "T616",
              "entity": "口服",
              "entity_type": "Method",
              "start_idx": 18,
              "end_idx": 20,
              "entity_en": "oral"
            },
            {
              "entity_id": "T617",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 39,
              "end_idx": 43,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T618",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 42,
              "end_idx": 43,
              "entity_en": "foot"
            },
            {
              "entity_id": "T619",
              "entity": "间歇性跛行",
              "entity_type": "Symptom",
              "start_idx": 46,
              "end_idx": 51,
              "entity_en": "Intermittent claudication"
            },
            {
              "entity_id": "T620",
              "entity": "阿司匹林",
              "entity_type": "Drug",
              "start_idx": 64,
              "end_idx": 68,
              "entity_en": "aspirin"
            },
            {
              "entity_id": "T621",
              "entity": "严重",
              "entity_type": "Level",
              "start_idx": 72,
              "end_idx": 74,
              "entity_en": "serious"
            },
            {
              "entity_id": "T622",
              "entity": "肢体缺血",
              "entity_type": "Disease",
              "start_idx": 74,
              "end_idx": 78,
              "entity_en": "Limb ischemia"
            },
            {
              "entity_id": "T623",
              "entity": "肢体",
              "entity_type": "Anatomy",
              "start_idx": 74,
              "end_idx": 76,
              "entity_en": "Limbs"
            },
            {
              "entity_id": "T624",
              "entity": "低分子肝素",
              "entity_type": "Drug",
              "start_idx": 81,
              "end_idx": 86,
              "entity_en": "Low molecular weight heparin"
            },
            {
              "entity_id": "T625",
              "entity": "阿司匹林",
              "entity_type": "Drug",
              "start_idx": 88,
              "end_idx": 92,
              "entity_en": "aspirin"
            },
            {
              "entity_id": "T626",
              "entity": "血管腔内微创治疗(球囊扩张及支架植入)",
              "entity_type": "Operation",
              "start_idx": 97,
              "end_idx": 116,
              "entity_en": "Minimally invasive endovascular treatment (balloon dilatation and stent implantation)"
            },
            {
              "entity_id": "T627",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 117,
              "end_idx": 121,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T628",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 120,
              "end_idx": 121,
              "entity_en": "foot"
            },
            {
              "entity_id": "T629",
              "entity": "血管闭塞/再狭窄",
              "entity_type": "Symptom",
              "start_idx": 124,
              "end_idx": 132,
              "entity_en": "Vascular occlusion/restenosis"
            },
            {
              "entity_id": "T630",
              "entity": "巴曲酶",
              "entity_type": "Drug",
              "start_idx": 175,
              "end_idx": 178,
              "entity_en": "Batroxobin"
            },
            {
              "entity_id": "T631",
              "entity": "阿司匹林",
              "entity_type": "Drug",
              "start_idx": 180,
              "end_idx": 184,
              "entity_en": "aspirin"
            },
            {
              "entity_id": "T632",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 188,
              "end_idx": 191,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T633",
              "entity": "再狭窄",
              "entity_type": "Symptom",
              "start_idx": 194,
              "end_idx": 197,
              "entity_en": "Restenosis"
            },
            {
              "entity_id": "T634",
              "entity": "出血",
              "entity_type": "ADE",
              "start_idx": 225,
              "end_idx": 227,
              "entity_en": "Bleeding"
            },
            {
              "entity_id": "T635",
              "entity": "消化道不良事件",
              "entity_type": "ADE",
              "start_idx": 230,
              "end_idx": 237,
              "entity_en": "Gastrointestinal adverse events"
            },
            {
              "entity_id": "T636",
              "entity": "消化道",
              "entity_type": "Anatomy",
              "start_idx": 230,
              "end_idx": 233,
              "entity_en": "Digestive tract"
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R263",
              "head_entity_id": "T614",
              "tail_entity_id": "T617"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R264",
              "head_entity_id": "T615",
              "tail_entity_id": "T617"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R265",
              "head_entity_id": "T618",
              "tail_entity_id": "T617"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R266",
              "head_entity_id": "T619",
              "tail_entity_id": "T617"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R267",
              "head_entity_id": "T620",
              "tail_entity_id": "T622"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R268",
              "head_entity_id": "T623",
              "tail_entity_id": "T622"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R269",
              "head_entity_id": "T624",
              "tail_entity_id": "T622"
            },
            {
              "relation_type": "Operation_Disease",
              "relation_id": "R270",
              "head_entity_id": "T626",
              "tail_entity_id": "T627"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R271",
              "head_entity_id": "T629",
              "tail_entity_id": "T627"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R272",
              "head_entity_id": "T630",
              "tail_entity_id": "T632"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R273",
              "head_entity_id": "T634",
              "tail_entity_id": "T630"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R274",
              "head_entity_id": "T635",
              "tail_entity_id": "T630"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R275",
              "head_entity_id": "T631",
              "tail_entity_id": "T632"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R276",
              "head_entity_id": "T634",
              "tail_entity_id": "T631"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R277",
              "head_entity_id": "T635",
              "tail_entity_id": "T631"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R278",
              "head_entity_id": "T633",
              "tail_entity_id": "T632"
            }
          ],
          "sentence_en": "(3) Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants): There is no clear evidence to support the use of anticoagulant therapy in the intermittent claudication stage of diabetic foot. Compared with aspirin alone, low molecular weight heparin combined with aspirin can significantly reduce vascular occlusion/restenosis (up to 85%) in patients with severe limb ischemia who have undergone minimally invasive endovascular treatment (balloon dilatation and stent implantation) (OR=0.15, 95%CI: 0.06-0.42, P=0.0003); while batroxobin combined with aspirin significantly reduced restenosis in diabetic patients (OR=0.28, 95%CI: 0.13-0.60), without a significant increase in bleeding and other gastrointestinal adverse events."
        },
        {
          "sentence_id": "1",
          "sentence": "在急性肢体缺血的初期治疗中，起始手术或者溶栓治疗对于30d、6个月或1年的保肢或死亡发生，两者差异无统计学意义；但起始溶栓治疗组(1.3%)30d的卒中发生率较起始手术治疗组(0%)显著增加(OR=6.41，95%CI：1.57~26.22)；30d的大出血发生率分别为8.8%与3.3%(OR=2.80，95%CI：1.70~4.60)，病灶远端的栓塞发生率分别为12.4%与0%(OR=8.35，95%CI：4.47~15.58)；因此，在急性肢体缺血患者，起始手术治疗或者溶栓治疗对于保肢或死亡均无明显差异，但起始溶栓治疗会使肢体缺血与出血并发症风险增加。",
          "start_idx": 243,
          "end_idx": 524,
          "entities": [
            {
              "entity_id": "T637",
              "entity": "急性肢体缺血",
              "entity_type": "Disease",
              "start_idx": 1,
              "end_idx": 7,
              "entity_en": "Acute limb ischemia"
            },
            {
              "entity_id": "T638",
              "entity": "肢体",
              "entity_type": "Anatomy",
              "start_idx": 3,
              "end_idx": 5,
              "entity_en": "Limbs"
            },
            {
              "entity_id": "T639",
              "entity": "卒中",
              "entity_type": "ADE",
              "start_idx": 74,
              "end_idx": 76,
              "entity_en": "Stroke"
            },
            {
              "entity_id": "T640",
              "entity": "大出血",
              "entity_type": "ADE",
              "start_idx": 126,
              "end_idx": 129,
              "entity_en": "Heavy bleeding"
            },
            {
              "entity_id": "T641",
              "entity": "病灶远端的栓塞",
              "entity_type": "ADE",
              "start_idx": 170,
              "end_idx": 177,
              "entity_en": "Embolization distal to the lesion"
            },
            {
              "entity_id": "T642",
              "entity": "急性肢体缺血",
              "entity_type": "Disease",
              "start_idx": 222,
              "end_idx": 228,
              "entity_en": "Acute limb ischemia"
            },
            {
              "entity_id": "T643",
              "entity": "肢体",
              "entity_type": "Anatomy",
              "start_idx": 224,
              "end_idx": 226,
              "entity_en": "Limbs"
            },
            {
              "entity_id": "T644",
              "entity": "肢体缺血",
              "entity_type": "ADE",
              "start_idx": 266,
              "end_idx": 270,
              "entity_en": "Limb ischemia"
            },
            {
              "entity_id": "T645",
              "entity": "出血",
              "entity_type": "ADE",
              "start_idx": 271,
              "end_idx": 273,
              "entity_en": "Bleeding"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R279",
              "head_entity_id": "T638",
              "tail_entity_id": "T637"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R280",
              "head_entity_id": "T643",
              "tail_entity_id": "T642"
            }
          ],
          "sentence_en": "In the initial treatment of acute limb ischemia, there was no statistically significant difference between initial surgery or thrombolytic therapy in terms of limb salvage or death at 30 days, 6 months or 1 year; however, the 30-day stroke rate in the initial thrombolytic therapy group (1.3%) was significantly higher than that in the initial surgical treatment group (0%) (OR=6.41, 95%CI: 1.57-26.22); the 30-day major bleeding rates were 8.8% and 3.3%, respectively (OR=2.80, 95%CI: 1.70-4.60), and the distal embolism rates were 12.4% and 0%, respectively (OR=8.35, 95%CI: 4.47-15.58); therefore, in patients with acute limb ischemia, there was no significant difference between initial surgery or thrombolytic therapy in terms of limb salvage or death, but initial thrombolytic therapy would increase the risk of limb ischemia and bleeding complications."
        }
      ],
      "paragraph_en": "(3) Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants): There is no clear evidence to support the use of anticoagulant therapy in the intermittent claudication stage of diabetic foot. Compared with aspirin alone, low molecular weight heparin combined with aspirin can significantly reduce vascular occlusion/restenosis (up to 85%) in patients with severe limb ischemia who have undergone minimally invasive endovascular treatment (balloon dilatation and stent implantation) (OR=0.15, 95%CI: 0.06-0.42, P=0.0003); while batroxobin combined with aspirin significantly reduced restenosis in diabetic patients (OR=0.28, 95%CI: 0.13-0.60), without a significant increase in bleeding and other gastrointestinal adverse events. In the initial treatment of acute limb ischemia, there was no statistically significant difference between initial surgery or thrombolytic therapy in terms of limb salvage or death at 30 days, 6 months or 1 year; however, the 30-day stroke rate in the initial thrombolytic therapy group (1.3%) was significantly higher than that in the initial surgical treatment group (0%) (OR=6.41, 95%CI: 1.57-26.22); the 30-day major bleeding rates were 8.8% and 3.3%, respectively (OR=2.80, 95%CI: 1.70-4.60), and the distal embolism rates were 12.4% and 0%, respectively (OR=8.35, 95%CI: 4.47-15.58); therefore, in patients with acute limb ischemia, there was no significant difference between initial surgery or thrombolytic therapy in terms of limb salvage or death, but initial thrombolytic therapy would increase the risk of limb ischemia and bleeding complications."
    },
    {
      "paragraph_id": "74",
      "paragraph": "从某种程度上讲，上述药物治疗方法仅仅是对于轻至中度的下肢动脉缺血性病变的患者延缓其病变的发展，是糖尿病足治疗的基础；但对于严重下肢缺血(CLI)患者多数并不能达到改善症状、保肢的目的。因此，对于缺血严重而内科常规治疗无效者，需行经皮介入治疗或外科手术治疗。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "从某种程度上讲，上述药物治疗方法仅仅是对于轻至中度的下肢动脉缺血性病变的患者延缓其病变的发展，是糖尿病足治疗的基础；但对于严重下肢缺血(CLI)患者多数并不能达到改善症状、保肢的目的。",
          "start_idx": 0,
          "end_idx": 92,
          "entities": [
            {
              "entity_id": "T646",
              "entity": "轻至中度",
              "entity_type": "Level",
              "start_idx": 21,
              "end_idx": 25,
              "entity_en": "Mild to moderate"
            },
            {
              "entity_id": "T647",
              "entity": "下肢动脉缺血性病变",
              "entity_type": "Disease",
              "start_idx": 26,
              "end_idx": 35,
              "entity_en": "Ischemic lower extremity arterial disease"
            },
            {
              "entity_id": "T648",
              "entity": "下肢动脉",
              "entity_type": "Anatomy",
              "start_idx": 26,
              "end_idx": 30,
              "entity_en": "Lower limb arteries"
            },
            {
              "entity_id": "T649",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 48,
              "end_idx": 52,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T650",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 51,
              "end_idx": 52,
              "entity_en": "foot"
            },
            {
              "entity_id": "T651",
              "entity": "严重",
              "entity_type": "Level",
              "start_idx": 61,
              "end_idx": 63,
              "entity_en": "serious"
            },
            {
              "entity_id": "T652",
              "entity": "下肢缺血(CLI)",
              "entity_type": "Disease",
              "start_idx": 63,
              "end_idx": 72,
              "entity_en": "Lower limb ischemia (CLI)"
            },
            {
              "entity_id": "T653",
              "entity": "下肢",
              "entity_type": "Anatomy",
              "start_idx": 63,
              "end_idx": 65,
              "entity_en": "Lower limbs"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R281",
              "head_entity_id": "T648",
              "tail_entity_id": "T647"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R282",
              "head_entity_id": "T650",
              "tail_entity_id": "T649"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R283",
              "head_entity_id": "T653",
              "tail_entity_id": "T652"
            }
          ],
          "sentence_en": "To some extent, the above-mentioned drug treatment methods can only delay the progression of lesions in patients with mild to moderate lower limb arterial ischemic lesions, and are the basis for the treatment of diabetic foot; however, they cannot achieve the goal of improving symptoms and preserving limbs in most patients with severe lower limb ischemia (CLI)."
        },
        {
          "sentence_id": "1",
          "sentence": "因此，对于缺血严重而内科常规治疗无效者，需行经皮介入治疗或外科手术治疗。",
          "start_idx": 92,
          "end_idx": 128,
          "entities": [
            {
              "entity_id": "T654",
              "entity": "缺血",
              "entity_type": "Symptom",
              "start_idx": 5,
              "end_idx": 7,
              "entity_en": "Ischemia"
            },
            {
              "entity_id": "T655",
              "entity": "严重",
              "entity_type": "Level",
              "start_idx": 7,
              "end_idx": 9,
              "entity_en": "serious"
            },
            {
              "entity_id": "T656",
              "entity": "经皮介入治疗",
              "entity_type": "Operation",
              "start_idx": 22,
              "end_idx": 28,
              "entity_en": "Percutaneous interventional therapy"
            }
          ],
          "relations": [],
          "sentence_en": "Therefore, for patients with severe ischemia who are not responsive to conventional medical treatment, percutaneous intervention or surgical treatment is required."
        }
      ],
      "paragraph_en": "To some extent, the above-mentioned drug treatment methods can only delay the progression of patients with mild to moderate lower limb arterial ischemic lesions, and are the basis for the treatment of diabetic foot; however, they cannot achieve the goal of improving symptoms and saving limbs in most patients with severe lower limb ischemia (CLI). Therefore, for patients with severe ischemia who are ineffective with conventional medical treatment, percutaneous interventional treatment or surgical treatment is required."
    },
    {
      "paragraph_id": "75",
      "paragraph": "(二)? 手术干预治疗 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(二)? 手术干预治疗 ",
          "start_idx": 0,
          "end_idx": 12,
          "entities": [],
          "relations": [],
          "sentence_en": "(ii) Surgical intervention"
        }
      ],
      "paragraph_en": "(ii) Surgical intervention"
    },
    {
      "paragraph_id": "76",
      "paragraph": "对于缺血严重，系统药物治疗效果不理想的患者，手术血流重建则是必要的措施。手术血流重建的方法，有以下几种：",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "对于缺血严重，系统药物治疗效果不理想的患者，手术血流重建则是必要的措施。",
          "start_idx": 0,
          "end_idx": 36,
          "entities": [
            {
              "entity_id": "T657",
              "entity": "缺血",
              "entity_type": "Symptom",
              "start_idx": 2,
              "end_idx": 4,
              "entity_en": "Ischemia"
            },
            {
              "entity_id": "T658",
              "entity": "严重",
              "entity_type": "Level",
              "start_idx": 4,
              "end_idx": 6,
              "entity_en": "serious"
            },
            {
              "entity_id": "T659",
              "entity": "血流重建",
              "entity_type": "Operation",
              "start_idx": 24,
              "end_idx": 28,
              "entity_en": "Blood flow restoration"
            }
          ],
          "relations": [],
          "sentence_en": "For patients with severe ischemia and unsatisfactory responses to systemic drug treatment, surgical blood flow restoration is a necessary measure."
        },
        {
          "sentence_id": "1",
          "sentence": "手术血流重建的方法，有以下几种：",
          "start_idx": 36,
          "end_idx": 52,
          "entities": [
            {
              "entity_id": "T660",
              "entity": "血流重建",
              "entity_type": "Operation",
              "start_idx": 2,
              "end_idx": 6,
              "entity_en": "Blood flow restoration"
            }
          ],
          "relations": [],
          "sentence_en": "There are several methods of surgical blood flow restoration:"
        }
      ],
      "paragraph_en": "For patients with severe ischemia and unsatisfactory responses to systemic drug treatment, surgical blood flow reconstruction is a necessary measure. There are several methods for surgical blood flow reconstruction:"
    },
    {
      "paragraph_id": "77",
      "paragraph": "1.下肢动脉腔内介人治疗：主要具体方法包括经皮穿刺动脉内成形(主要指普通/药物涂层球囊扩张术)和在球囊扩张的基础上支架成形术或直接的动脉腔内支架成形术以及目前常用的各种减容手术。作为一种微创手段，可以作为首选，尤其是当患者年老体弱或伴有其他疾病无法耐受动脉旁路手术时。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "1.下肢动脉腔内介人治疗：主要具体方法包括经皮穿刺动脉内成形(主要指普通/药物涂层球囊扩张术)和在球囊扩张的基础上支架成形术或直接的动脉腔内支架成形术以及目前常用的各种减容手术。",
          "start_idx": 0,
          "end_idx": 89,
          "entities": [
            {
              "entity_id": "T661",
              "entity": "下肢动脉腔内介人治疗",
              "entity_type": "Operation",
              "start_idx": 2,
              "end_idx": 12,
              "entity_en": "Endovascular treatment of lower extremity arteries"
            },
            {
              "entity_id": "T662",
              "entity": "经皮穿刺动脉内成形(主要指普通/药物涂层球囊扩张术)",
              "entity_type": "Operation",
              "start_idx": 21,
              "end_idx": 47,
              "entity_en": "Percutaneous transluminal angioplasty (mainly ordinary/drug-coated balloon angioplasty)"
            },
            {
              "entity_id": "T663",
              "entity": "球囊扩张",
              "entity_type": "Operation",
              "start_idx": 49,
              "end_idx": 53,
              "entity_en": "Balloon dilatation"
            },
            {
              "entity_id": "T664",
              "entity": "支架成形术",
              "entity_type": "Operation",
              "start_idx": 57,
              "end_idx": 62,
              "entity_en": "Stent angioplasty"
            },
            {
              "entity_id": "T665",
              "entity": "动脉腔内支架成形术",
              "entity_type": "Operation",
              "start_idx": 66,
              "end_idx": 75,
              "entity_en": "Endovascular stenting"
            }
          ],
          "relations": [],
          "sentence_en": "1. Intraluminal interventional treatment of lower limb arteries: The main specific methods include percutaneous puncture angioplasty (mainly ordinary/drug-coated balloon angioplasty) and stent angioplasty based on balloon angioplasty or direct intraluminal stent angioplasty and various commonly used volume reduction surgeries."
        },
        {
          "sentence_id": "1",
          "sentence": "作为一种微创手段，可以作为首选，尤其是当患者年老体弱或伴有其他疾病无法耐受动脉旁路手术时。",
          "start_idx": 89,
          "end_idx": 134,
          "entities": [
            {
              "entity_id": "T666",
              "entity": "动脉旁路手术",
              "entity_type": "Operation",
              "start_idx": 37,
              "end_idx": 43,
              "entity_en": "Arterial bypass surgery"
            }
          ],
          "relations": [],
          "sentence_en": "As a minimally invasive method, it can be the first choice, especially when the patient is elderly and frail or has other diseases and cannot tolerate arterial bypass surgery."
        }
      ],
      "paragraph_en": "1. Endovascular interventional therapy of lower extremity arteries: The main specific methods include percutaneous puncture angioplasty (mainly ordinary/drug-coated balloon angioplasty) and stent angioplasty based on balloon angioplasty or direct intravascular stent angioplasty and various commonly used volume reduction surgeries. As a minimally invasive method, it can be the first choice, especially when the patient is old and weak or has other diseases and cannot tolerate arterial bypass surgery."
    },
    {
      "paragraph_id": "78",
      "paragraph": "(1)下肢动脉腔内介人治疗适应证：Rutherford分级3级以上，Fontaine分级Ⅱb以上。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(1)下肢动脉腔内介人治疗适应证：Rutherford分级3级以上，Fontaine分级Ⅱb以上。",
          "start_idx": 0,
          "end_idx": 49,
          "entities": [
            {
              "entity_id": "T667",
              "entity": "下肢动脉腔内介人治疗",
              "entity_type": "Operation",
              "start_idx": 3,
              "end_idx": 13,
              "entity_en": "Endovascular treatment of lower extremity arteries"
            }
          ],
          "relations": [],
          "sentence_en": "(1) Indications for endovascular treatment of lower extremity arteries: Rutherford grade 3 or above, Fontaine grade IIb or above."
        }
      ],
      "paragraph_en": "(1) Indications for endovascular treatment of lower extremity arteries: Rutherford grade 3 or above, Fontaine grade IIb or above."
    },
    {
      "paragraph_id": "79",
      "paragraph": "(2)疗效评价：目前的评估指标包括主观指标和客观指标。前者包括主观症状的改善，如疼痛缓解或减轻程度，肢体发冷感觉改善情况等；后者包括ABI，溃疡面愈合情况，截肢平面的降低等。对于糖尿病下肢缺血患者，只要有一项指标得到改善就视为临床成功。腔内介人治疗术后，靶血管血流恢复即视为技术成功。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(2)疗效评价：目前的评估指标包括主观指标和客观指标。",
          "start_idx": 0,
          "end_idx": 27,
          "entities": [],
          "relations": [],
          "sentence_en": "(2) Efficacy evaluation: Current evaluation indicators include subjective indicators and objective indicators."
        },
        {
          "sentence_id": "1",
          "sentence": "前者包括主观症状的改善，如疼痛缓解或减轻程度，肢体发冷感觉改善情况等；后者包括ABI，溃疡面愈合情况，截肢平面的降低等。对于糖尿病下肢缺血患者，只要有一项指标得到改善就视为临床成功。",
          "start_idx": 27,
          "end_idx": 118,
          "entities": [
            {
              "entity_id": "T668",
              "entity": "肢体发冷感觉",
              "entity_type": "Symptom",
              "start_idx": 23,
              "end_idx": 29,
              "entity_en": "Cold feeling in limbs"
            },
            {
              "entity_id": "T669",
              "entity": "疼痛",
              "entity_type": "Symptom",
              "start_idx": 13,
              "end_idx": 15,
              "entity_en": "pain"
            },
            {
              "entity_id": "T670",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 62,
              "end_idx": 65,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T671",
              "entity": "下肢缺血",
              "entity_type": "Disease",
              "start_idx": 65,
              "end_idx": 69,
              "entity_en": "Lower limb ischemia"
            },
            {
              "entity_id": "T672",
              "entity": "下肢",
              "entity_type": "Anatomy",
              "start_idx": 65,
              "end_idx": 67,
              "entity_en": "Lower limbs"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R284",
              "head_entity_id": "T672",
              "tail_entity_id": "T671"
            }
          ],
          "sentence_en": "The former includes the improvement of subjective symptoms, such as pain relief or reduction, improvement of limb coldness, etc.; the latter includes ABI, ulcer healing, lowering of amputation plane, etc. For patients with diabetic lower limb ischemia, as long as one indicator is improved, it is considered clinical success."
        },
        {
          "sentence_id": "2",
          "sentence": "腔内介人治疗术后，靶血管血流恢复即视为技术成功。",
          "start_idx": 118,
          "end_idx": 142,
          "entities": [
            {
              "entity_id": "T673",
              "entity": "腔内介人治疗术后",
              "entity_type": "Disease",
              "start_idx": 0,
              "end_idx": 8,
              "entity_en": "After endovascular interventional therapy"
            }
          ],
          "relations": [],
          "sentence_en": "After endovascular interventional therapy, restoration of target blood flow is considered a technical success."
        }
      ],
      "paragraph_en": "(2) Evaluation of efficacy: Current evaluation indicators include subjective indicators and objective indicators. The former include improvement of subjective symptoms, such as pain relief or reduction, improvement of limb coldness, etc.; the latter include ABI, ulcer healing, lowering of amputation plane, etc. For patients with diabetic lower limb ischemia, as long as one indicator is improved, it is considered clinical success. After endovascular interventional treatment, restoration of target blood flow is considered technical success."
    },
    {
      "paragraph_id": "80",
      "paragraph": "2.下肢动脉旁路移植：常用方法有膝上旁路和膝下旁路等，具体手术方式根据术者经验及患者血管条件而定。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.下肢动脉旁路移植：常用方法有膝上旁路和膝下旁路等，具体手术方式根据术者经验及患者血管条件而定。",
          "start_idx": 0,
          "end_idx": 49,
          "entities": [
            {
              "entity_id": "T674",
              "entity": "下肢动脉旁路移植",
              "entity_type": "Operation",
              "start_idx": 2,
              "end_idx": 10,
              "entity_en": "Lower Limb Artery Bypass Graft"
            }
          ],
          "relations": [],
          "sentence_en": "2. Lower limb artery bypass transplantation: Commonly used methods include above-knee bypass and below-knee bypass. The specific surgical method depends on the surgeon's experience and the patient's vascular conditions."
        }
      ],
      "paragraph_en": "2. Lower limb artery bypass transplantation: Commonly used methods include above-knee bypass and below-knee bypass. The specific surgical method depends on the surgeon's experience and the patient's vascular conditions."
    },
    {
      "paragraph_id": "81",
      "paragraph": "(1)动脉旁路移植的适应证：①下肢远端有比较好的动脉流出道；②患者体质较好，能够耐受手术。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(1)动脉旁路移植的适应证：①下肢远端有比较好的动脉流出道；②患者体质较好，能够耐受手术。",
          "start_idx": 0,
          "end_idx": 45,
          "entities": [
            {
              "entity_id": "T675",
              "entity": "动脉旁路移植",
              "entity_type": "Operation",
              "start_idx": 3,
              "end_idx": 9,
              "entity_en": "Arterial bypass graft"
            }
          ],
          "relations": [],
          "sentence_en": "(1) Indications for arterial bypass grafting: ① There is a relatively good arterial outflow tract in the distal lower limb; ② The patient is in good physical condition and can tolerate the surgery."
        }
      ],
      "paragraph_en": "(1) Indications for arterial bypass grafting: ① There is a relatively good arterial outflow tract in the distal lower limb; ② The patient is in good physical condition and can tolerate the surgery."
    },
    {
      "paragraph_id": "82",
      "paragraph": "(2)疗效评价：评价指标基本同下肢动脉腔内介入治疗的评价；吻合口远端血运得到改善视为技术成功。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(2)疗效评价：评价指标基本同下肢动脉腔内介入治疗的评价；吻合口远端血运得到改善视为技术成功。",
          "start_idx": 0,
          "end_idx": 47,
          "entities": [
            {
              "entity_id": "T676",
              "entity": "下肢动脉腔内介入治疗",
              "entity_type": "Operation",
              "start_idx": 15,
              "end_idx": 25,
              "entity_en": "Endovascular interventional therapy of lower extremity arteries"
            }
          ],
          "relations": [],
          "sentence_en": "(2) Evaluation of efficacy: The evaluation indicators are basically the same as those of lower limb arterial endovascular interventional treatment; improvement in blood flow distal to the anastomosis is considered a technical success."
        }
      ],
      "paragraph_en": "(2) Evaluation of efficacy: The evaluation indicators are basically the same as those of lower limb arterial endovascular interventional treatment; improvement in blood flow distal to the anastomosis is considered a technical success."
    },
    {
      "paragraph_id": "83",
      "paragraph": "3.干细胞移植：干细胞目前尚不能作为治疗糖尿病下肢血管病变的常规手段，国内外研究报道干细胞移植治疗下肢血管病变有一定疗效。目前干细胞移植包括自体和异体移植，是最近十多年发展起来的新技术。自体干细胞移植在国内得到一定程度的普及，取得了良好的效果。目前干细胞的来源有骨髓、外周血和改良的骨髓3种方法。自体干细胞至少有2个优点：(1)不存在免疫排斥；(2)没有胚胎干细胞的伦理问题。异体干细胞主要包括脐血、间充质和胚胎干细胞，前两者在临床上已经有比较好的结果。但是限于国家政策，异体干细胞移植需要有一定的资质，目前处于临床研究阶段，有条件的单位可根据情况决定是否选择。此外，干细胞联合凝胶可以修复糖尿病足的创面，临床上技术尚不完全成熟，建议有条件单位要谨慎开展。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "3.干细胞移植：干细胞目前尚不能作为治疗糖尿病下肢血管病变的常规手段，国内外研究报道干细胞移植治疗下肢血管病变有一定疗效。目前干细胞移植包括自体和异体移植，是最近十多年发展起来的新技术。自体干细胞移植在国内得到一定程度的普及，取得了良好的效果。目前干细胞的来源有骨髓、外周血和改良的骨髓3种方法。自体干细胞至少有2个优点：(1)不存在免疫排斥；(2)没有胚胎干细胞的伦理问题。异体干细胞主要包括脐血、间充质和胚胎干细胞，前两者在临床上已经有比较好的结果。但是限于国家政策，异体干细胞移植需要有一定的资质，目前处于临床研究阶段，有条件的单位可根据情况决定是否选择。此外，干细胞联合凝胶可以修复糖尿病足的创面，临床上技术尚不完全成熟，建议有条件单位要谨慎开展。",
          "start_idx": 0,
          "end_idx": 328,
          "entities": [
            {
              "entity_id": "T677",
              "entity": "干细胞移植",
              "entity_type": "Operation",
              "start_idx": 2,
              "end_idx": 7,
              "entity_en": "Stem cell transplantation"
            },
            {
              "entity_id": "T678",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 20,
              "end_idx": 23,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T679",
              "entity": "下肢血管病变",
              "entity_type": "Disease",
              "start_idx": 23,
              "end_idx": 29,
              "entity_en": "Lower extremity vascular disease"
            },
            {
              "entity_id": "T680",
              "entity": "下肢血管",
              "entity_type": "Anatomy",
              "start_idx": 23,
              "end_idx": 27,
              "entity_en": "Lower limb blood vessels"
            },
            {
              "entity_id": "T681",
              "entity": "干细胞移植",
              "entity_type": "Operation",
              "start_idx": 42,
              "end_idx": 47,
              "entity_en": "Stem cell transplantation"
            },
            {
              "entity_id": "T682",
              "entity": "下肢血管病变",
              "entity_type": "Disease",
              "start_idx": 49,
              "end_idx": 55,
              "entity_en": "Lower extremity vascular disease"
            },
            {
              "entity_id": "T683",
              "entity": "下肢血管",
              "entity_type": "Anatomy",
              "start_idx": 49,
              "end_idx": 53,
              "entity_en": "Lower limb blood vessels"
            },
            {
              "entity_id": "T684",
              "entity": "干细胞移植",
              "entity_type": "Operation",
              "start_idx": 63,
              "end_idx": 68,
              "entity_en": "Stem cell transplantation"
            },
            {
              "entity_id": "T685",
              "entity": "自体和异体移植",
              "entity_type": "Operation",
              "start_idx": 70,
              "end_idx": 77,
              "entity_en": "Autologous and allogeneic transplantation"
            },
            {
              "entity_id": "T686",
              "entity": "自体干细胞移植",
              "entity_type": "Operation",
              "start_idx": 93,
              "end_idx": 100,
              "entity_en": "Autologous stem cell transplantation"
            },
            {
              "entity_id": "T687",
              "entity": "异体干细胞移植",
              "entity_type": "Operation",
              "start_idx": 236,
              "end_idx": 243,
              "entity_en": "Allogeneic stem cell transplantation"
            },
            {
              "entity_id": "T688",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 295,
              "end_idx": 299,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T689",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 298,
              "end_idx": 299,
              "entity_en": "foot"
            },
            {
              "entity_id": "T690",
              "entity": "创面",
              "entity_type": "Symptom",
              "start_idx": 300,
              "end_idx": 302,
              "entity_en": "Wound"
            },
            {
              "entity_id": "T691",
              "entity": "免疫排斥",
              "entity_type": "ADE",
              "start_idx": 167,
              "end_idx": 171,
              "entity_en": "Immune rejection"
            }
          ],
          "relations": [
            {
              "relation_type": "Operation_Disease",
              "relation_id": "R285",
              "head_entity_id": "T677",
              "tail_entity_id": "T678"
            },
            {
              "relation_type": "Operation_Disease",
              "relation_id": "R286",
              "head_entity_id": "T677",
              "tail_entity_id": "T679"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R287",
              "head_entity_id": "T680",
              "tail_entity_id": "T679"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R288",
              "head_entity_id": "T683",
              "tail_entity_id": "T682"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R289",
              "head_entity_id": "T689",
              "tail_entity_id": "T688"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R290",
              "head_entity_id": "T690",
              "tail_entity_id": "T688"
            }
          ],
          "sentence_en": "3. Stem cell transplantation: Stem cells are not currently a routine treatment for diabetic lower limb vascular disease. Domestic and foreign studies have reported that stem cell transplantation has a certain effect in treating lower limb vascular disease. Currently, stem cell transplantation includes autologous and allogeneic transplantation, which is a new technology developed in the past decade. Autologous stem cell transplantation has been popularized to a certain extent in China and has achieved good results. Currently, there are three sources of stem cells: bone marrow, peripheral blood, and modified bone marrow. Autologous stem cells have at least two advantages: (1) there is no immune rejection; (2) there are no ethical issues of embryonic stem cells. Allogeneic stem cells mainly include umbilical cord blood, mesenchymal and embryonic stem cells. The first two have shown relatively good results in clinical practice. However, due to national policies, allogeneic stem cell transplantation requires certain qualifications. It is currently in the clinical research stage. Units with conditions can decide whether to choose it according to the situation. In addition, stem cells combined with gel can repair the wound surface of diabetic foot. The technology is not yet fully mature in clinical practice. It is recommended that units with conditions should be cautious in carrying out the transplantation."
        }
      ],
      "paragraph_en": "3. Stem cell transplantation: Stem cells are not currently a routine treatment for diabetic lower limb vascular disease. Domestic and foreign studies have reported that stem cell transplantation has a certain effect in treating lower limb vascular disease. Currently, stem cell transplantation includes autologous and allogeneic transplantation, which is a new technology developed in the past decade. Autologous stem cell transplantation has been popularized to a certain extent in China and has achieved good results. Currently, there are three sources of stem cells: bone marrow, peripheral blood, and modified bone marrow. Autologous stem cells have at least two advantages: (1) there is no immune rejection; (2) there are no ethical issues of embryonic stem cells. Allogeneic stem cells mainly include umbilical cord blood, mesenchymal and embryonic stem cells. The first two have shown relatively good results in clinical practice. However, due to national policies, allogeneic stem cell transplantation requires certain qualifications. It is currently in the clinical research stage. Units with conditions can decide whether to choose it according to the situation. In addition, stem cells combined with gel can repair the wound surface of diabetic foot. The technology is not yet fully mature in clinical practice. It is recommended that units with conditions should be cautious in carrying out the transplantation."
    },
    {
      "paragraph_id": "84",
      "paragraph": "4.围手术期的处理：无论采用哪种治疗方法，均要重视围手术期的处理。除内科药物治疗外，主要有以下几种措施：",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "4.围手术期的处理：无论采用哪种治疗方法，均要重视围手术期的处理。",
          "start_idx": 0,
          "end_idx": 33,
          "entities": [],
          "relations": [],
          "sentence_en": "4. Perioperative management: Regardless of the treatment method used, perioperative management should be taken seriously."
        },
        {
          "sentence_id": "1",
          "sentence": "除内科药物治疗外，主要有以下几种措施：",
          "start_idx": 33,
          "end_idx": 52,
          "entities": [],
          "relations": [],
          "sentence_en": "In addition to medical treatment, there are mainly the following measures:"
        }
      ],
      "paragraph_en": "4. Perioperative management: Regardless of the treatment method used, perioperative management should be taken seriously. In addition to medical drug treatment, there are mainly the following measures:"
    },
    {
      "paragraph_id": "85",
      "paragraph": "(1)抗凝治疗：糖尿病下肢缺血患者，多为血液高凝状态，可以采用抗凝措施防止血栓形成，尤其是在膝下动脉血运重建后。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(1)抗凝治疗：糖尿病下肢缺血患者，多为血液高凝状态，可以采用抗凝措施防止血栓形成，尤其是在膝下动脉血运重建后。",
          "start_idx": 0,
          "end_idx": 56,
          "entities": [
            {
              "entity_id": "T692",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 8,
              "end_idx": 11,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T693",
              "entity": "下肢缺血",
              "entity_type": "Symptom",
              "start_idx": 11,
              "end_idx": 15,
              "entity_en": "Lower limb ischemia"
            },
            {
              "entity_id": "T694",
              "entity": "液高凝状态",
              "entity_type": "Symptom",
              "start_idx": 21,
              "end_idx": 26,
              "entity_en": "Hypercoagulable state"
            },
            {
              "entity_id": "T695",
              "entity": "采用抗凝措施",
              "entity_type": "Treatment",
              "start_idx": 29,
              "end_idx": 35,
              "entity_en": "Anticoagulation measures"
            },
            {
              "entity_id": "T696",
              "entity": "血栓",
              "entity_type": "Disease",
              "start_idx": 37,
              "end_idx": 39,
              "entity_en": "thrombus"
            }
          ],
          "relations": [
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R291",
              "head_entity_id": "T693",
              "tail_entity_id": "T692"
            }
          ],
          "sentence_en": "(1) Anticoagulant therapy: Most diabetic patients with lower limb ischemia are in a state of hypercoagulable blood. Anticoagulant measures can be used to prevent thrombosis, especially after the revascularization of the infrapopliteal artery."
        }
      ],
      "paragraph_en": "(1) Anticoagulant therapy: Most diabetic patients with lower limb ischemia are in a state of hypercoagulable blood. Anticoagulant measures can be used to prevent thrombosis, especially after the revascularization of the infrapopliteal artery."
    },
    {
      "paragraph_id": "86",
      "paragraph": "(2)抗血小板治疗：常规应用。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(2)抗血小板治疗：常规应用。",
          "start_idx": 0,
          "end_idx": 15,
          "entities": [],
          "relations": [],
          "sentence_en": "(2) Antiplatelet therapy: routine application."
        }
      ],
      "paragraph_en": "(2) Antiplatelet therapy: routine application."
    },
    {
      "paragraph_id": "87",
      "paragraph": "(3)扩血管药物：常规应用",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(3)扩血管药物：常规应用",
          "start_idx": 0,
          "end_idx": 13,
          "entities": [],
          "relations": [],
          "sentence_en": "(3) Vasodilator drugs: routine use"
        }
      ],
      "paragraph_en": "(3) Vasodilator drugs: routine use"
    },
    {
      "paragraph_id": "88",
      "paragraph": "(4)降纤治疗：糖尿病足患者的纤维蛋白原高于正常者，可给予降纤治疗。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(4)降纤治疗：糖尿病足患者的纤维蛋白原高于正常者，可给予降纤治疗。",
          "start_idx": 0,
          "end_idx": 34,
          "entities": [
            {
              "entity_id": "T697",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 8,
              "end_idx": 12,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T698",
              "entity": "纤维蛋白原",
              "entity_type": "Test_items",
              "start_idx": 15,
              "end_idx": 20,
              "entity_en": "Fibrinogen"
            },
            {
              "entity_id": "T699",
              "entity": "高",
              "entity_type": "Test_Value",
              "start_idx": 20,
              "end_idx": 21,
              "entity_en": "high"
            },
            {
              "entity_id": "T700",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 11,
              "end_idx": 12,
              "entity_en": "foot"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R292",
              "head_entity_id": "T700",
              "tail_entity_id": "T697"
            },
            {
              "relation_type": "Test_items_Disease",
              "relation_id": "R293",
              "head_entity_id": "T698",
              "tail_entity_id": "T697"
            }
          ],
          "sentence_en": "(4) Fibrinogen reduction therapy: Patients with diabetic foot who have higher fibrinogen levels than normal can be given fibroblast reduction therapy."
        }
      ],
      "paragraph_en": "(4) Fibrinogen reduction therapy: Patients with diabetic foot who have higher fibrinogen levels than normal can be given fibroblast reduction therapy."
    },
    {
      "paragraph_id": "89",
      "paragraph": "(四)糖尿病足创面处理",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(四)糖尿病足创面处理",
          "start_idx": 0,
          "end_idx": 11,
          "entities": [
            {
              "entity_id": "T701",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 3,
              "end_idx": 7,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T702",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 6,
              "end_idx": 7,
              "entity_en": "foot"
            },
            {
              "entity_id": "T703",
              "entity": "创面",
              "entity_type": "Symptom",
              "start_idx": 7,
              "end_idx": 9,
              "entity_en": "Wound"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R294",
              "head_entity_id": "T702",
              "tail_entity_id": "T701"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R295",
              "head_entity_id": "T703",
              "tail_entity_id": "T701"
            }
          ],
          "sentence_en": "4. Treatment of diabetic foot wounds"
        }
      ],
      "paragraph_en": "4. Treatment of diabetic foot wounds"
    },
    {
      "paragraph_id": "90",
      "paragraph": "1.促进创面愈合的前提条件：在创面处理的同时，需积极进行全身情况的治疗，包括控制血糖、抗感染、代谢调节、下肢血运重建等。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "1.促进创面愈合的前提条件：在创面处理的同时，需积极进行全身情况的治疗，包括控制血糖、抗感染、代谢调节、下肢血运重建等。",
          "start_idx": 0,
          "end_idx": 60,
          "entities": [
            {
              "entity_id": "T704",
              "entity": "创面",
              "entity_type": "Symptom",
              "start_idx": 4,
              "end_idx": 6,
              "entity_en": "Wound"
            },
            {
              "entity_id": "T705",
              "entity": "创面",
              "entity_type": "Symptom",
              "start_idx": 15,
              "end_idx": 17,
              "entity_en": "Wound"
            },
            {
              "entity_id": "T706",
              "entity": "下肢血运重建",
              "entity_type": "Operation",
              "start_idx": 52,
              "end_idx": 58,
              "entity_en": "Lower extremity revascularization"
            }
          ],
          "relations": [],
          "sentence_en": "1. Prerequisites for promoting wound healing: While treating the wound, systemic treatment must be actively carried out, including blood sugar control, anti-infection, metabolic regulation, and lower limb blood supply reconstruction."
        }
      ],
      "paragraph_en": "1. Prerequisites for promoting wound healing: While treating the wound, systemic treatment must be actively carried out, including blood sugar control, anti-infection, metabolic regulation, and lower limb blood supply reconstruction."
    },
    {
      "paragraph_id": "91",
      "paragraph": "2.非手术治疗",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "2.非手术治疗",
          "start_idx": 0,
          "end_idx": 7,
          "entities": [],
          "relations": [],
          "sentence_en": "2. Non-surgical treatment"
        }
      ],
      "paragraph_en": "2. Non-surgical treatment"
    },
    {
      "paragraph_id": "92",
      "paragraph": "(1)姑息性清创：换药时，在避免活动性出血和过度损失健康组织的前提下，可用组织剪去除明确坏死组织，以缩短自溶性清创时间，减少感染机会，改善深部组织引流，但须注意保留间生态组织。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(1)姑息性清创：换药时，在避免活动性出血和过度损失健康组织的前提下，可用组织剪去除明确坏死组织，以缩短自溶性清创时间，减少感染机会，改善深部组织引流，但须注意保留间生态组织。",
          "start_idx": 0,
          "end_idx": 88,
          "entities": [
            {
              "entity_id": "T707",
              "entity": "活动性出血",
              "entity_type": "Symptom",
              "start_idx": 16,
              "end_idx": 21,
              "entity_en": "Active bleeding"
            },
            {
              "entity_id": "T708",
              "entity": "过度损失健康组织",
              "entity_type": "Symptom",
              "start_idx": 22,
              "end_idx": 30,
              "entity_en": "Excessive loss of healthy tissue"
            },
            {
              "entity_id": "T709",
              "entity": "坏死组织",
              "entity_type": "Symptom",
              "start_idx": 44,
              "end_idx": 48,
              "entity_en": "Necrotic tissue"
            },
            {
              "entity_id": "T710",
              "entity": "感染",
              "entity_type": "Symptom",
              "start_idx": 62,
              "end_idx": 64,
              "entity_en": "Infect"
            }
          ],
          "relations": [],
          "sentence_en": "(1) Palliative debridement: When changing the dressing, tissue scissors can be used to remove clear necrotic tissue while avoiding active bleeding and excessive loss of healthy tissue to shorten the autolytic debridement time, reduce the chance of infection, and improve deep tissue drainage, but attention must be paid to preserving the interstitial ecological tissue."
        }
      ],
      "paragraph_en": "(1) Palliative debridement: When changing the dressing, tissue scissors can be used to remove clear necrotic tissue while avoiding active bleeding and excessive loss of healthy tissue to shorten the autolytic debridement time, reduce the chance of infection, and improve deep tissue drainage, but attention must be paid to preserving the interstitial ecological tissue."
    },
    {
      "paragraph_id": "93",
      "paragraph": "(2)创面换药：创面换药可门诊进行，根据创面感染程度和渗出量决定换药频次。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(2)创面换药：创面换药可门诊进行，根据创面感染程度和渗出量决定换药频次。",
          "start_idx": 0,
          "end_idx": 37,
          "entities": [
            {
              "entity_id": "T711",
              "entity": "创面",
              "entity_type": "Symptom",
              "start_idx": 20,
              "end_idx": 22,
              "entity_en": "Wound"
            },
            {
              "entity_id": "T712",
              "entity": "感染",
              "entity_type": "Symptom",
              "start_idx": 22,
              "end_idx": 24,
              "entity_en": "Infect"
            },
            {
              "entity_id": "T713",
              "entity": "渗出",
              "entity_type": "Symptom",
              "start_idx": 27,
              "end_idx": 29,
              "entity_en": "Exudation"
            },
            {
              "entity_id": "T714",
              "entity": "创面",
              "entity_type": "Symptom",
              "start_idx": 3,
              "end_idx": 5,
              "entity_en": "Wound"
            },
            {
              "entity_id": "T715",
              "entity": "创面",
              "entity_type": "Symptom",
              "start_idx": 8,
              "end_idx": 10,
              "entity_en": "Wound"
            }
          ],
          "relations": [],
          "sentence_en": "(2) Wound dressing change: Wound dressing change can be performed on an outpatient basis, and the frequency of dressing change is determined based on the degree of wound infection and the amount of exudate."
        }
      ],
      "paragraph_en": "(2) Wound dressing change: Wound dressing change can be performed on an outpatient basis, and the frequency of dressing change is determined based on the degree of wound infection and the amount of exudate."
    },
    {
      "paragraph_id": "94",
      "paragraph": "(3)创面用药：根据创面不同阶段选择创面用药，如创面以感染表现为主，可单独应用碘伏等消毒剂，加强换药频次；如创面坏死组织已溶脱，基底肉芽组织开始增生，可选择消毒杀菌类药物和促进生长类药物复合使用。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(3)创面用药：根据创面不同阶段选择创面用药，如创面以感染表现为主，可单独应用碘伏等消毒剂，加强换药频次；如创面坏死组织已溶脱，基底肉芽组织开始增生，可选择消毒杀菌类药物和促进生长类药物复合使用。",
          "start_idx": 0,
          "end_idx": 98,
          "entities": [
            {
              "entity_id": "T716",
              "entity": "创面",
              "entity_type": "Symptom",
              "start_idx": 18,
              "end_idx": 20,
              "entity_en": "Wound"
            },
            {
              "entity_id": "T717",
              "entity": "创面",
              "entity_type": "Symptom",
              "start_idx": 24,
              "end_idx": 26,
              "entity_en": "Wound"
            },
            {
              "entity_id": "T718",
              "entity": "感染",
              "entity_type": "Symptom",
              "start_idx": 27,
              "end_idx": 29,
              "entity_en": "Infect"
            },
            {
              "entity_id": "T719",
              "entity": "碘伏",
              "entity_type": "Drug",
              "start_idx": 39,
              "end_idx": 41,
              "entity_en": "Iodine"
            },
            {
              "entity_id": "T720",
              "entity": "创面坏死组织已溶脱",
              "entity_type": "Symptom",
              "start_idx": 54,
              "end_idx": 63,
              "entity_en": "Necrotic tissue on wound surface has dissolved"
            },
            {
              "entity_id": "T721",
              "entity": "基底肉芽组织开始增生",
              "entity_type": "Symptom",
              "start_idx": 64,
              "end_idx": 74,
              "entity_en": "Basal granulation tissue begins to proliferate"
            }
          ],
          "relations": [],
          "sentence_en": "(3) Wound medication: Wound medication should be selected according to the different stages of the wound. If the wound is mainly infected, disinfectants such as iodine can be used alone to increase the frequency of dressing changes. If the necrotic tissue of the wound has been dissolved and the basal granulation tissue has begun to proliferate, disinfectants and bactericidal drugs and growth-promoting drugs can be used in combination."
        }
      ],
      "paragraph_en": "(3) Wound medication: Wound medication should be selected according to the different stages of the wound. If the wound is mainly infected, disinfectants such as iodine can be used alone to increase the frequency of dressing changes. If the necrotic tissue of the wound has been dissolved and the basal granulation tissue has begun to proliferate, disinfectants and bactericidal drugs and growth-promoting drugs can be used in combination."
    },
    {
      "paragraph_id": "95",
      "paragraph": "(4)敷料选择：优先选择具有杀菌、吸附渗液保持创面适度湿性、防粘连等具有复合功能且高性价比的伤口敷料，也可根据创面情况选择多种单一功能敷料逐层覆盖使用。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(4)敷料选择：优先选择具有杀菌、吸附渗液保持创面适度湿性、防粘连等具有复合功能且高性价比的伤口敷料，也可根据创面情况选择多种单一功能敷料逐层覆盖使用。",
          "start_idx": 0,
          "end_idx": 76,
          "entities": [
            {
              "entity_id": "T722",
              "entity": "创面",
              "entity_type": "Symptom",
              "start_idx": 23,
              "end_idx": 25,
              "entity_en": "Wound"
            },
            {
              "entity_id": "T723",
              "entity": "创面",
              "entity_type": "Symptom",
              "start_idx": 55,
              "end_idx": 57,
              "entity_en": "Wound"
            }
          ],
          "relations": [],
          "sentence_en": "(4) Dressing selection: Priority should be given to wound dressings that have multiple functions and are cost-effective, such as sterilization, adsorption of exudate to maintain moderate moisture on the wound surface, and anti-adhesion. Alternatively, a variety of single-function dressings can be selected and used layer by layer according to the condition of the wound surface."
        }
      ],
      "paragraph_en": "(4) Dressing selection: Priority should be given to wound dressings that have multiple functions and are cost-effective, such as sterilization, adsorption of exudate to maintain moderate moisture on the wound surface, and anti-adhesion. Alternatively, a variety of single-function dressings can be selected and used layer by layer according to the condition of the wound surface."
    },
    {
      "paragraph_id": "96",
      "paragraph": "(5)持续封闭式负压吸引：可有效改善创面引流，加速坏死组织溶脱和肉芽组织增生，但需住院接受治疗。对糖尿病足创面应注意避免压力设置过高、避免因覆盖不当导致相邻足趾压迫缺血。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(5)持续封闭式负压吸引：可有效改善创面引流，加速坏死组织溶脱和肉芽组织增生，但需住院接受治疗。对糖尿病足创面应注意避免压力设置过高、避免因覆盖不当导致相邻足趾压迫缺血。",
          "start_idx": 0,
          "end_idx": 85,
          "entities": [
            {
              "entity_id": "T724",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 49,
              "end_idx": 53,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T725",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 52,
              "end_idx": 53,
              "entity_en": "foot"
            },
            {
              "entity_id": "T726",
              "entity": "创面",
              "entity_type": "Symptom",
              "start_idx": 53,
              "end_idx": 55,
              "entity_en": "Wound"
            },
            {
              "entity_id": "T727",
              "entity": "足趾压迫缺血",
              "entity_type": "Symptom",
              "start_idx": 78,
              "end_idx": 84,
              "entity_en": "Toe compression ischemia"
            },
            {
              "entity_id": "T728",
              "entity": "足趾",
              "entity_type": "Anatomy",
              "start_idx": 78,
              "end_idx": 80,
              "entity_en": "Toes"
            },
            {
              "entity_id": "T729",
              "entity": "持续封闭式负压吸引",
              "entity_type": "Treatment",
              "start_idx": 3,
              "end_idx": 12,
              "entity_en": "Continuous closed negative pressure suction"
            }
          ],
          "relations": [
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R296",
              "head_entity_id": "T726",
              "tail_entity_id": "T724"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R297",
              "head_entity_id": "T727",
              "tail_entity_id": "T724"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R298",
              "head_entity_id": "T725",
              "tail_entity_id": "T724"
            }
          ],
          "sentence_en": "(5) Continuous closed negative pressure suction: It can effectively improve wound drainage, accelerate the dissolution of necrotic tissue and the proliferation of granulation tissue, but requires hospitalization for treatment. For diabetic foot wounds, care should be taken to avoid setting too high a pressure and avoid compression ischemia of adjacent toes due to improper coverage."
        }
      ],
      "paragraph_en": "(5) Continuous closed negative pressure suction: It can effectively improve wound drainage, accelerate the dissolution of necrotic tissue and the proliferation of granulation tissue, but requires hospitalization for treatment. For diabetic foot wounds, care should be taken to avoid setting too high a pressure and avoid compression ischemia of adjacent toes due to improper coverage."
    },
    {
      "paragraph_id": "97",
      "paragraph": "(6)生物治疗：①干细胞疗法：可选择自体骨髓干细胞或外周血干细胞，小腿肌肉多点注射后有助于促进缺血肢体的侧支循环建立，改善远端缺血状况。②自体富血小板血浆凝腔外用疗法：可有效改善缺血性创面的局部肉芽组织增生能力，但需应用于清创后相对无菌创面。③蛆虫疗法：可用于加速去除创面坏死组织，缩短疗程，但需采用医用级蛆虫。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(6)生物治疗：①干细胞疗法：可选择自体骨髓干细胞或外周血干细胞，小腿肌肉多点注射后有助于促进缺血肢体的侧支循环建立，改善远端缺血状况。",
          "start_idx": 0,
          "end_idx": 68,
          "entities": [
            {
              "entity_id": "T730",
              "entity": "干细胞疗法",
              "entity_type": "Treatment",
              "start_idx": 9,
              "end_idx": 14,
              "entity_en": "Stem Cell Therapy"
            },
            {
              "entity_id": "T734",
              "entity": "生物治疗",
              "entity_type": "Treatment",
              "start_idx": 3,
              "end_idx": 7,
              "entity_en": "Biological treatment"
            }
          ],
          "relations": [],
          "sentence_en": "(6) Biological treatment: ① Stem cell therapy: Autologous bone marrow stem cells or peripheral blood stem cells can be selected. Multiple injections into the calf muscle can help promote the establishment of collateral circulation in the ischemic limb and improve distal ischemia."
        },
        {
          "sentence_id": "1",
          "sentence": "②自体富血小板血浆凝腔外用疗法：可有效改善缺血性创面的局部肉芽组织增生能力，但需应用于清创后相对无菌创面。",
          "start_idx": 68,
          "end_idx": 121,
          "entities": [
            {
              "entity_id": "T731",
              "entity": "自体富血小板血浆凝腔外用疗法",
              "entity_type": "Treatment",
              "start_idx": 1,
              "end_idx": 15,
              "entity_en": "Autologous platelet-rich plasma coagulation therapy"
            }
          ],
          "relations": [],
          "sentence_en": "② Autologous platelet-rich plasma coagulation external therapy: It can effectively improve the local granulation tissue proliferation ability of ischemic wounds, but it needs to be applied to relatively sterile wounds after debridement."
        },
        {
          "sentence_id": "2",
          "sentence": "③蛆虫疗法：可用于加速去除创面坏死组织，缩短疗程，但需采用医用级蛆虫。",
          "start_idx": 121,
          "end_idx": 156,
          "entities": [
            {
              "entity_id": "T732",
              "entity": "蛆虫疗法",
              "entity_type": "Treatment",
              "start_idx": 1,
              "end_idx": 5,
              "entity_en": "Maggot therapy"
            },
            {
              "entity_id": "T733",
              "entity": "创面坏死组织",
              "entity_type": "Symptom",
              "start_idx": 13,
              "end_idx": 19,
              "entity_en": "Necrotic tissue on wound surface"
            }
          ],
          "relations": [],
          "sentence_en": "③ Maggot therapy: It can be used to accelerate the removal of necrotic tissue from the wound and shorten the course of treatment, but medical-grade maggots must be used."
        }
      ],
      "paragraph_en": "(6) Biological treatment: ① Stem cell therapy: Autologous bone marrow stem cells or peripheral blood stem cells can be selected. Multiple injections into the calf muscle can help promote the establishment of collateral circulation in the ischemic limb and improve distal ischemia. ② Autologous platelet-rich plasma coagulation cavity external application therapy: It can effectively improve the local granulation tissue proliferation ability of ischemic wounds, but it must be applied to relatively sterile wounds after debridement. ③ Maggot therapy: It can be used to accelerate the removal of necrotic tissue in the wound and shorten the course of treatment, but medical-grade maggots must be used."
    },
    {
      "paragraph_id": "98",
      "paragraph": "(7)减压支具应用：在治疗和愈后预防复发过程中，应根据创面部位，适时选择减压鞋垫，糖尿病足鞋等专业支县，有助于避免创面加深和复发。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(7)减压支具应用：在治疗和愈后预防复发过程中，应根据创面部位，适时选择减压鞋垫，糖尿病足鞋等专业支县，有助于避免创面加深和复发。",
          "start_idx": 0,
          "end_idx": 65,
          "entities": [
            {
              "entity_id": "T735",
              "entity": "创面加深和复发",
              "entity_type": "Symptom",
              "start_idx": 57,
              "end_idx": 64,
              "entity_en": "Wound deepening and recurrence"
            }
          ],
          "relations": [],
          "sentence_en": "(7) Application of decompression braces: During treatment and prevention of recurrence after recovery, decompression insoles, diabetic foot shoes and other professional braces should be selected in a timely manner according to the location of the wound, which will help prevent wound deepening and recurrence."
        }
      ],
      "paragraph_en": "(7) Application of decompression braces: During treatment and prevention of recurrence after recovery, decompression insoles, diabetic foot shoes and other professional braces should be selected in a timely manner according to the location of the wound, which will help prevent wound deepening and recurrence."
    },
    {
      "paragraph_id": "99",
      "paragraph": "(8)物理治疗：理疗和创面高压氧治疗，有助于改善创面的炎症和微循环状况，促进创面愈合。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(8)物理治疗：理疗和创面高压氧治疗，有助于改善创面的炎症和微循环状况，促进创面愈合。",
          "start_idx": 0,
          "end_idx": 43,
          "entities": [
            {
              "entity_id": "T736",
              "entity": "理疗",
              "entity_type": "Treatment",
              "start_idx": 8,
              "end_idx": 10,
              "entity_en": "physiotherapy"
            },
            {
              "entity_id": "T737",
              "entity": "创面高压氧治疗",
              "entity_type": "Treatment",
              "start_idx": 11,
              "end_idx": 18,
              "entity_en": "Hyperbaric oxygen therapy for wounds"
            },
            {
              "entity_id": "T738",
              "entity": "物理治疗",
              "entity_type": "Treatment",
              "start_idx": 3,
              "end_idx": 7,
              "entity_en": "Physical therapy"
            }
          ],
          "relations": [],
          "sentence_en": "(8) Physical therapy: Physical therapy and hyperbaric oxygen therapy for wounds can help improve inflammation and microcirculation of wounds and promote wound healing."
        }
      ],
      "paragraph_en": "(8) Physical therapy: Physical therapy and hyperbaric oxygen therapy for wounds can help improve inflammation and microcirculation of wounds and promote wound healing."
    },
    {
      "paragraph_id": "100",
      "paragraph": "3.手术治疗：应根据创面情况、患者全身状况，适时进行清创术或植皮术等手术治疗，可有效去除坏死组织，尽早封闭创面，显著缩短疗程，避免因长期换药导致下肢废用性肌萎缩、骨质疏松、深静脉血栓及心肺功能下降等并发症。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "3.手术治疗：应根据创面情况、患者全身状况，适时进行清创术或植皮术等手术治疗，可有效去除坏死组织，尽早封闭创面，显著缩短疗程，避免因长期换药导致下肢废用性肌萎缩、骨质疏松、深静脉血栓及心肺功能下降等并发症。",
          "start_idx": 0,
          "end_idx": 103,
          "entities": [
            {
              "entity_id": "T739",
              "entity": "清创术",
              "entity_type": "Operation",
              "start_idx": 26,
              "end_idx": 29,
              "entity_en": "Debridement"
            },
            {
              "entity_id": "T740",
              "entity": "植皮术",
              "entity_type": "Operation",
              "start_idx": 30,
              "end_idx": 33,
              "entity_en": "Skin grafting"
            },
            {
              "entity_id": "T741",
              "entity": "坏死组织",
              "entity_type": "Symptom",
              "start_idx": 44,
              "end_idx": 48,
              "entity_en": "Necrotic tissue"
            },
            {
              "entity_id": "T742",
              "entity": "长期换药",
              "entity_type": "Reason",
              "start_idx": 66,
              "end_idx": 70,
              "entity_en": "Long-term dressing"
            },
            {
              "entity_id": "T743",
              "entity": "下肢废用性肌萎缩",
              "entity_type": "Disease",
              "start_idx": 72,
              "end_idx": 80,
              "entity_en": "Disuse muscular atrophy of lower limbs"
            },
            {
              "entity_id": "T744",
              "entity": "下肢",
              "entity_type": "Anatomy",
              "start_idx": 72,
              "end_idx": 74,
              "entity_en": "Lower limbs"
            },
            {
              "entity_id": "T745",
              "entity": "骨质疏松",
              "entity_type": "Disease",
              "start_idx": 81,
              "end_idx": 85,
              "entity_en": "Osteoporosis"
            },
            {
              "entity_id": "T746",
              "entity": "深静脉血栓",
              "entity_type": "Disease",
              "start_idx": 86,
              "end_idx": 91,
              "entity_en": "Deep vein thrombosis"
            },
            {
              "entity_id": "T747",
              "entity": "深静脉",
              "entity_type": "Anatomy",
              "start_idx": 86,
              "end_idx": 89,
              "entity_en": "Deep veins"
            },
            {
              "entity_id": "T748",
              "entity": "心肺功能下降",
              "entity_type": "Disease",
              "start_idx": 92,
              "end_idx": 98,
              "entity_en": "Decreased cardiopulmonary function"
            },
            {
              "entity_id": "T749",
              "entity": "心",
              "entity_type": "Anatomy",
              "start_idx": 92,
              "end_idx": 93,
              "entity_en": "Heart"
            },
            {
              "entity_id": "T750",
              "entity": "肺",
              "entity_type": "Anatomy",
              "start_idx": 93,
              "end_idx": 94,
              "entity_en": "lung"
            },
            {
              "entity_id": "T751",
              "entity": "创面",
              "entity_type": "Symptom",
              "start_idx": 10,
              "end_idx": 12,
              "entity_en": "Wound"
            },
            {
              "entity_id": "T752",
              "entity": "创面",
              "entity_type": "Symptom",
              "start_idx": 53,
              "end_idx": 55,
              "entity_en": "Wound"
            }
          ],
          "relations": [
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R299",
              "head_entity_id": "T742",
              "tail_entity_id": "T743"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R300",
              "head_entity_id": "T742",
              "tail_entity_id": "T745"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R301",
              "head_entity_id": "T742",
              "tail_entity_id": "T746"
            },
            {
              "relation_type": "Reason_Disease",
              "relation_id": "R302",
              "head_entity_id": "T742",
              "tail_entity_id": "T748"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R303",
              "head_entity_id": "T744",
              "tail_entity_id": "T743"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R304",
              "head_entity_id": "T747",
              "tail_entity_id": "T746"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R305",
              "head_entity_id": "T749",
              "tail_entity_id": "T748"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R306",
              "head_entity_id": "T750",
              "tail_entity_id": "T748"
            }
          ],
          "sentence_en": "3. Surgical treatment: Debridement or skin grafting and other surgical treatments should be performed in a timely manner according to the wound condition and the patient's general condition. This can effectively remove necrotic tissue, close the wound as soon as possible, significantly shorten the course of treatment, and avoid complications such as disuse muscle atrophy of the lower limbs, osteoporosis, deep vein thrombosis, and decreased cardiopulmonary function due to long-term dressing changes."
        }
      ],
      "paragraph_en": "3. Surgical treatment: Debridement or skin grafting and other surgical treatments should be performed in a timely manner according to the wound condition and the patient's general condition. This can effectively remove necrotic tissue, close the wound as soon as possible, significantly shorten the course of treatment, and avoid complications such as disuse muscle atrophy of the lower limbs, osteoporosis, deep vein thrombosis, and decreased cardiopulmonary function due to long-term dressing changes."
    },
    {
      "paragraph_id": "101",
      "paragraph": "(1)手术时机：在全身状况许可的前提下，应尽早进行清创术去除创面坏死组织；在创面肉芽组织增生已覆盖骨骼、肌腱等深部组织，具备条件时应及时进行植皮术以避免创面肉芽组织水肿老化、疗程过长等问题。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(1)手术时机：在全身状况许可的前提下，应尽早进行清创术去除创面坏死组织；在创面肉芽组织增生已覆盖骨骼、肌腱等深部组织，具备条件时应及时进行植皮术以避免创面肉芽组织水肿老化、疗程过长等问题。",
          "start_idx": 0,
          "end_idx": 95,
          "entities": [
            {
              "entity_id": "T753",
              "entity": "清创术",
              "entity_type": "Operation",
              "start_idx": 25,
              "end_idx": 28,
              "entity_en": "Debridement"
            },
            {
              "entity_id": "T754",
              "entity": "创面坏死组织",
              "entity_type": "Symptom",
              "start_idx": 30,
              "end_idx": 36,
              "entity_en": "Necrotic tissue on wound surface"
            },
            {
              "entity_id": "T755",
              "entity": "植皮术",
              "entity_type": "Operation",
              "start_idx": 70,
              "end_idx": 73,
              "entity_en": "Skin grafting"
            },
            {
              "entity_id": "T756",
              "entity": "创面肉芽组织增生已覆盖骨骼、肌腱等深部组织",
              "entity_type": "Symptom",
              "start_idx": 38,
              "end_idx": 59,
              "entity_en": "Granulation tissue proliferation on the wound surface has covered deep tissues such as bones and tendons"
            },
            {
              "entity_id": "T757",
              "entity": "创面肉芽组织水肿老化",
              "entity_type": "Symptom",
              "start_idx": 76,
              "end_idx": 86,
              "entity_en": "Granulation tissue edema and aging on wound surface"
            }
          ],
          "relations": [],
          "sentence_en": "(1) Timing of surgery: If the general condition permits, debridement should be performed as soon as possible to remove necrotic tissue from the wound. When the granulation tissue on the wound has proliferated and covered deep tissues such as bones and tendons, skin grafting should be performed in a timely manner if conditions permit to avoid problems such as edema and aging of the granulation tissue on the wound and excessive treatment."
        }
      ],
      "paragraph_en": "(1) Timing of surgery: If the general condition permits, debridement should be performed as soon as possible to remove necrotic tissue from the wound. When the granulation tissue on the wound has proliferated and covered deep tissues such as bones and tendons, skin grafting should be performed in a timely manner if conditions permit to avoid problems such as edema and aging of the granulation tissue on the wound and excessive treatment."
    },
    {
      "paragraph_id": "102",
      "paragraph": "(2)创面清创手术的适应证：①已发生明确的足趾、足掌、肢体坏疽创面；②坏死性筋膜炎急性炎症期的创面；③形成足底筋膜、肌膜间隙脓肿的创面：④形成感染性窦道的创面；⑤肌腱、骨骼等深部组织外露失活，换药难以去除的创面；⑥残存大量坏死组织的创面；⑦创面基底肉芽组织增生，无深部组织外露，达到植皮条件而通过换药1个月内难以愈合的创面。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(2)创面清创手术的适应证：①已发生明确的足趾、足掌、肢体坏疽创面；②坏死性筋膜炎急性炎症期的创面；③形成足底筋膜、肌膜间隙脓肿的创面：④形成感染性窦道的创面；⑤肌腱、骨骼等深部组织外露失活，换药难以去除的创面；⑥残存大量坏死组织的创面；⑦创面基底肉芽组织增生，无深部组织外露，达到植皮条件而通过换药1个月内难以愈合的创面。",
          "start_idx": 0,
          "end_idx": 162,
          "entities": [
            {
              "entity_id": "T758",
              "entity": "创面清创手术",
              "entity_type": "Operation",
              "start_idx": 3,
              "end_idx": 9,
              "entity_en": "Wound debridement surgery"
            },
            {
              "entity_id": "T759",
              "entity": "足趾、足掌、肢体坏疽创面",
              "entity_type": "Symptom",
              "start_idx": 21,
              "end_idx": 33,
              "entity_en": "Gangrenous wounds on toes, soles, and limbs"
            },
            {
              "entity_id": "T760",
              "entity": "足趾",
              "entity_type": "Anatomy",
              "start_idx": 21,
              "end_idx": 23,
              "entity_en": "Toes"
            },
            {
              "entity_id": "T761",
              "entity": "足掌",
              "entity_type": "Anatomy",
              "start_idx": 24,
              "end_idx": 26,
              "entity_en": "Sole"
            },
            {
              "entity_id": "T762",
              "entity": "肢体",
              "entity_type": "Anatomy",
              "start_idx": 27,
              "end_idx": 29,
              "entity_en": "Limbs"
            },
            {
              "entity_id": "T763",
              "entity": "坏死性筋膜炎",
              "entity_type": "Disease",
              "start_idx": 35,
              "end_idx": 41,
              "entity_en": "Necrotizing fasciitis"
            },
            {
              "entity_id": "T764",
              "entity": "筋膜",
              "entity_type": "Anatomy",
              "start_idx": 38,
              "end_idx": 40,
              "entity_en": "Fascia"
            },
            {
              "entity_id": "T765",
              "entity": "足底筋膜、肌膜间隙脓肿的创面",
              "entity_type": "Symptom",
              "start_idx": 53,
              "end_idx": 67,
              "entity_en": "Plantar fascia and myometrial space abscess wound"
            },
            {
              "entity_id": "T766",
              "entity": "足底筋膜",
              "entity_type": "Anatomy",
              "start_idx": 53,
              "end_idx": 57,
              "entity_en": "Plantar Fascia"
            },
            {
              "entity_id": "T767",
              "entity": "肌膜间隙",
              "entity_type": "Anatomy",
              "start_idx": 58,
              "end_idx": 62,
              "entity_en": "Myometrial space"
            },
            {
              "entity_id": "T768",
              "entity": "感染性窦道的创面",
              "entity_type": "Symptom",
              "start_idx": 71,
              "end_idx": 79,
              "entity_en": "Infected sinus wound"
            },
            {
              "entity_id": "T769",
              "entity": "肌腱、骨骼等深部组织外露失活",
              "entity_type": "Symptom",
              "start_idx": 81,
              "end_idx": 95,
              "entity_en": "Exposure and devitalization of deep tissues such as tendons and bones"
            },
            {
              "entity_id": "T770",
              "entity": "换药难以去除的创面",
              "entity_type": "Symptom",
              "start_idx": 96,
              "end_idx": 105,
              "entity_en": "Wounds that are difficult to remove during dressing changes"
            },
            {
              "entity_id": "T771",
              "entity": "肌腱",
              "entity_type": "Anatomy",
              "start_idx": 81,
              "end_idx": 83,
              "entity_en": "tendon"
            },
            {
              "entity_id": "T772",
              "entity": "骨骼",
              "entity_type": "Anatomy",
              "start_idx": 84,
              "end_idx": 86,
              "entity_en": "skeleton"
            },
            {
              "entity_id": "T773",
              "entity": "残存大量坏死组织的创面",
              "entity_type": "Symptom",
              "start_idx": 107,
              "end_idx": 118,
              "entity_en": "Wounds with a large amount of necrotic tissue"
            },
            {
              "entity_id": "T774",
              "entity": "创面基底肉芽组织增生",
              "entity_type": "Symptom",
              "start_idx": 120,
              "end_idx": 130,
              "entity_en": "Granulation tissue hyperplasia at the base of the wound"
            },
            {
              "entity_id": "T775",
              "entity": "植皮",
              "entity_type": "Operation",
              "start_idx": 141,
              "end_idx": 143,
              "entity_en": "Skin grafting"
            },
            {
              "entity_id": "T776",
              "entity": "难以愈合的创面",
              "entity_type": "Symptom",
              "start_idx": 154,
              "end_idx": 161,
              "entity_en": "Difficult to heal wounds"
            },
            {
              "entity_id": "T777",
              "entity": "创面",
              "entity_type": "Symptom",
              "start_idx": 47,
              "end_idx": 49,
              "entity_en": "Wound"
            }
          ],
          "relations": [
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R307",
              "head_entity_id": "T764",
              "tail_entity_id": "T763"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R308",
              "head_entity_id": "T777",
              "tail_entity_id": "T763"
            }
          ],
          "sentence_en": "(2) Indications for wound debridement surgery: ① Wounds with clear gangrene of the toes, soles, and limbs; ② Wounds in the acute inflammatory stage of necrotizing fasciitis; ③ Wounds with abscesses in the plantar fascia and interfascial space; ④ Wounds with infected sinuses; ⑤ Wounds with exposed and inactive deep tissues such as tendons and bones that are difficult to remove with dressing changes; ⑥ Wounds with a large amount of residual necrotic tissue; ⑦ Wounds with hyperplasia of granulation tissue at the base of the wound, no exposure of deep tissues, and conditions for skin grafting but difficult to heal within 1 month with dressing changes."
        }
      ],
      "paragraph_en": "(2) Indications for wound debridement surgery: ① Wounds with clear gangrene of the toes, soles, and limbs; ② Wounds in the acute inflammatory stage of necrotizing fasciitis; ③ Wounds with abscesses in the plantar fascia and interfascial space; ④ Wounds with infected sinuses; ⑤ Wounds with exposed and inactive deep tissues such as tendons and bones that are difficult to remove with dressing changes; ⑥ Wounds with a large amount of residual necrotic tissue; ⑦ Wounds with hyperplasia of granulation tissue at the base of the wound, no exposure of deep tissues, and conditions for skin grafting but difficult to heal within 1 month with dressing changes."
    },
    {
      "paragraph_id": "103",
      "paragraph": "(3)手术方式的选择：尽可能优先选择简单、维发损伤小的手术方案，争取以简单方法解决复杂问题。①止血带：疑似血运障碍者，建议慎用止血带。②清创术：注意探查深层组织损伤情况，避免肌肉组织夹心样坏死和骨筋膜间室综合征，术后能够通畅引流；建议通过多次清创的手术方式，避免损伤过多健康组织，对无明确坏死表现的骨质应尽可能保全。③缝合术：不推荐清创后一期缝合。④植皮术：创面基底达到植皮条件，应尽早手术封闭创面。建议优先选择刃厚皮植皮，能够选择游离皮片移植的不需选择皮瓣移植。⑤皮瓣移植术：因糖尿病足患者多双下肢同步发生血管缺血性病变，故不推荐皮瓣转移移植手术，以避免出现皮瓣修复失败甚至供瓣区愈合不良。需在术前对术区血管详细检查评估的前提下，制定手术方案，选择皮瓣的优先顺序为邻位、远位、带蒂、游离。⑥截肢/趾术：对坏死肢体感染危及生命、血供无法重建、创面难以愈合、因疼痛难以忍受，患者家庭经济状况难以坚持长期非手术治疗而强烈要求者，可进行截肢治疗。⑦截肢平面选择：一般可根据患者全身状况、局部供血和损伤情况决定截胶平面，争取达到残端一期愈合的情况下保留患肢功能。目前临床上使用比较广泛的是采用经皮氧分压测定(也可结合血管影像学检查)，一般来讲，组织的经皮氧分压<20mmHg时，预示着截肢残端无法愈合；经皮氧分压>40mmHg时，预示着戴肢残端可以愈合；介于二者之间有愈合的可能，可能需要采用增加血流的方法。",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "(3)手术方式的选择：尽可能优先选择简单、维发损伤小的手术方案，争取以简单方法解决复杂问题。①止血带：疑似血运障碍者，建议慎用止血带。②清创术：注意探查深层组织损伤情况，避免肌肉组织夹心样坏死和骨筋膜间室综合征，术后能够通畅引流；建议通过多次清创的手术方式，避免损伤过多健康组织，对无明确坏死表现的骨质应尽可能保全。③缝合术：不推荐清创后一期缝合。④植皮术：创面基底达到植皮条件，应尽早手术封闭创面。建议优先选择刃厚皮植皮，能够选择游离皮片移植的不需选择皮瓣移植。⑤皮瓣移植术：因糖尿病足患者多双下肢同步发生血管缺血性病变，故不推荐皮瓣转移移植手术，以避免出现皮瓣修复失败甚至供瓣区愈合不良。需在术前对术区血管详细检查评估的前提下，制定手术方案，选择皮瓣的优先顺序为邻位、远位、带蒂、游离。⑥截肢/趾术：对坏死肢体感染危及生命、血供无法重建、创面难以愈合、因疼痛难以忍受，患者家庭经济状况难以坚持长期非手术治疗而强烈要求者，可进行截肢治疗。",
          "start_idx": 0,
          "end_idx": 420,
          "entities": [
            {
              "entity_id": "T778",
              "entity": "血运障碍",
              "entity_type": "Disease",
              "start_idx": 53,
              "end_idx": 57,
              "entity_en": "Blood flow disorder"
            },
            {
              "entity_id": "T779",
              "entity": "清创术",
              "entity_type": "Operation",
              "start_idx": 68,
              "end_idx": 71,
              "entity_en": "Debridement"
            },
            {
              "entity_id": "T780",
              "entity": "深层组织损伤",
              "entity_type": "Symptom",
              "start_idx": 76,
              "end_idx": 82,
              "entity_en": "Deep tissue damage"
            },
            {
              "entity_id": "T781",
              "entity": "肌肉组织夹心样坏死",
              "entity_type": "Disease",
              "start_idx": 87,
              "end_idx": 96,
              "entity_en": "Muscle tissue sandwich necrosis"
            },
            {
              "entity_id": "T782",
              "entity": "肌肉组织",
              "entity_type": "Anatomy",
              "start_idx": 87,
              "end_idx": 91,
              "entity_en": "Muscle tissue"
            },
            {
              "entity_id": "T783",
              "entity": "骨筋膜间室综合征",
              "entity_type": "Disease",
              "start_idx": 97,
              "end_idx": 105,
              "entity_en": "Compartment syndrome"
            },
            {
              "entity_id": "T784",
              "entity": "骨筋膜间室",
              "entity_type": "Anatomy",
              "start_idx": 97,
              "end_idx": 102,
              "entity_en": "Osteofascial compartment"
            },
            {
              "entity_id": "T785",
              "entity": "清创",
              "entity_type": "Operation",
              "start_idx": 121,
              "end_idx": 123,
              "entity_en": "Debridement"
            },
            {
              "entity_id": "T786",
              "entity": "缝合术",
              "entity_type": "Operation",
              "start_idx": 159,
              "end_idx": 162,
              "entity_en": "Suturing"
            },
            {
              "entity_id": "T787",
              "entity": "清创",
              "entity_type": "Operation",
              "start_idx": 166,
              "end_idx": 168,
              "entity_en": "Debridement"
            },
            {
              "entity_id": "T788",
              "entity": "植皮术",
              "entity_type": "Operation",
              "start_idx": 175,
              "end_idx": 178,
              "entity_en": "Skin grafting"
            },
            {
              "entity_id": "T789",
              "entity": "植皮",
              "entity_type": "Operation",
              "start_idx": 185,
              "end_idx": 187,
              "entity_en": "Skin grafting"
            },
            {
              "entity_id": "T790",
              "entity": "创面",
              "entity_type": "Symptom",
              "start_idx": 179,
              "end_idx": 181,
              "entity_en": "Wound"
            },
            {
              "entity_id": "T791",
              "entity": "创面",
              "entity_type": "Symptom",
              "start_idx": 197,
              "end_idx": 199,
              "entity_en": "Wound"
            },
            {
              "entity_id": "T792",
              "entity": "刃厚皮植皮",
              "entity_type": "Operation",
              "start_idx": 206,
              "end_idx": 211,
              "entity_en": "Split-thickness skin graft"
            },
            {
              "entity_id": "T793",
              "entity": "游离皮片移植",
              "entity_type": "Operation",
              "start_idx": 216,
              "end_idx": 222,
              "entity_en": "Free skin graft"
            },
            {
              "entity_id": "T794",
              "entity": "皮瓣移植",
              "entity_type": "Operation",
              "start_idx": 227,
              "end_idx": 231,
              "entity_en": "Skin flap transplantation"
            },
            {
              "entity_id": "T795",
              "entity": "皮瓣移植术",
              "entity_type": "Operation",
              "start_idx": 233,
              "end_idx": 238,
              "entity_en": "Skin flap transplantation"
            },
            {
              "entity_id": "T796",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 240,
              "end_idx": 244,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T797",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 243,
              "end_idx": 244,
              "entity_en": "foot"
            },
            {
              "entity_id": "T798",
              "entity": "双下肢同步发生血管缺血性病变",
              "entity_type": "Disease",
              "start_idx": 247,
              "end_idx": 261,
              "entity_en": "Synchronous ischemic vascular lesions in both lower limbs"
            },
            {
              "entity_id": "T799",
              "entity": "双下肢",
              "entity_type": "Anatomy",
              "start_idx": 247,
              "end_idx": 250,
              "entity_en": "Both lower limbs"
            },
            {
              "entity_id": "T800",
              "entity": "皮瓣转移移植手术",
              "entity_type": "Operation",
              "start_idx": 266,
              "end_idx": 274,
              "entity_en": "Skin flap transfer surgery"
            },
            {
              "entity_id": "T801",
              "entity": "皮瓣修复失败",
              "entity_type": "ADE",
              "start_idx": 280,
              "end_idx": 286,
              "entity_en": "Failed flap repair"
            },
            {
              "entity_id": "T802",
              "entity": "供瓣区愈合不良",
              "entity_type": "ADE",
              "start_idx": 288,
              "end_idx": 295,
              "entity_en": "Poor healing of the donor site"
            },
            {
              "entity_id": "T803",
              "entity": "截肢/趾术",
              "entity_type": "Operation",
              "start_idx": 346,
              "end_idx": 351,
              "entity_en": "Amputation/toe surgery"
            },
            {
              "entity_id": "T804",
              "entity": "坏死肢体感染",
              "entity_type": "Disease",
              "start_idx": 353,
              "end_idx": 359,
              "entity_en": "Necrotic limb infection"
            },
            {
              "entity_id": "T805",
              "entity": "肢体",
              "entity_type": "Anatomy",
              "start_idx": 355,
              "end_idx": 357,
              "entity_en": "Limbs"
            },
            {
              "entity_id": "T806",
              "entity": "危及生命",
              "entity_type": "Symptom",
              "start_idx": 359,
              "end_idx": 363,
              "entity_en": "Life-threatening"
            },
            {
              "entity_id": "T807",
              "entity": "血供无法重建",
              "entity_type": "Symptom",
              "start_idx": 364,
              "end_idx": 370,
              "entity_en": "Blood supply cannot be restored"
            },
            {
              "entity_id": "T808",
              "entity": "创面难以愈合",
              "entity_type": "Symptom",
              "start_idx": 371,
              "end_idx": 377,
              "entity_en": "Difficulty in wound healing"
            },
            {
              "entity_id": "T809",
              "entity": "疼痛难以忍受",
              "entity_type": "Symptom",
              "start_idx": 379,
              "end_idx": 385,
              "entity_en": "The pain is unbearable"
            },
            {
              "entity_id": "T810",
              "entity": "截肢",
              "entity_type": "Operation",
              "start_idx": 415,
              "end_idx": 417,
              "entity_en": "Amputation"
            }
          ],
          "relations": [
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R309",
              "head_entity_id": "T780",
              "tail_entity_id": "T781"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R310",
              "head_entity_id": "T780",
              "tail_entity_id": "T783"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R311",
              "head_entity_id": "T782",
              "tail_entity_id": "T781"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R312",
              "head_entity_id": "T784",
              "tail_entity_id": "T783"
            },
            {
              "relation_type": "Operation_Disease",
              "relation_id": "R313",
              "head_entity_id": "T795",
              "tail_entity_id": "T796"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R314",
              "head_entity_id": "T797",
              "tail_entity_id": "T796"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R315",
              "head_entity_id": "T799",
              "tail_entity_id": "T798"
            },
            {
              "relation_type": "Operation_Disease",
              "relation_id": "R316",
              "head_entity_id": "T803",
              "tail_entity_id": "T804"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R317",
              "head_entity_id": "T805",
              "tail_entity_id": "T804"
            },
            {
              "relation_type": "Operation_Disease",
              "relation_id": "R318",
              "head_entity_id": "T810",
              "tail_entity_id": "T804"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R319",
              "head_entity_id": "T806",
              "tail_entity_id": "T804"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R320",
              "head_entity_id": "T807",
              "tail_entity_id": "T804"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R321",
              "head_entity_id": "T808",
              "tail_entity_id": "T804"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R322",
              "head_entity_id": "T809",
              "tail_entity_id": "T804"
            }
          ],
          "sentence_en": "(3) Choice of surgical method: Give priority to simple surgical methods with minimal damage to the uterus, and try to solve complex problems with simple methods. ① Tourniquet: It is recommended to use tourniquets with caution in patients with suspected blood flow disorders. ② Debridement: Pay attention to the exploration of deep tissue damage, avoid sandwich necrosis of muscle tissue and compartment syndrome, and ensure smooth drainage after surgery; it is recommended to use multiple debridements to avoid excessive damage to healthy tissue, and preserve bones without clear necrosis as much as possible. ③ Suturing: Primary suture after debridement is not recommended. ④ Skin grafting: When the wound base meets the conditions for skin grafting, the wound should be closed surgically as soon as possible. It is recommended to give priority to blade-thickness skin grafting, and flap transplantation is not necessary if free skin grafting can be selected. ⑤ Flap transplantation: Because diabetic foot patients often have synchronous vascular ischemic lesions in both lower limbs, flap transfer and transplantation surgery is not recommended to avoid flap repair failure or even poor healing of the donor area. The surgical plan should be formulated based on the detailed examination and evaluation of the blood vessels in the surgical area before the operation. The priority order of flap selection is adjacent, distal, pedicled, and free. ⑥ Amputation/toe surgery: Amputation can be performed for patients with life-threatening infection of necrotic limbs, inability to reconstruct blood supply, difficulty in wound healing, unbearable pain, and strong requests from patients whose family economic conditions make it difficult to adhere to long-term non-surgical treatment."
        },
        {
          "sentence_id": "1",
          "sentence": "⑦截肢平面选择：一般可根据患者全身状况、局部供血和损伤情况决定截胶平面，争取达到残端一期愈合的情况下保留患肢功能。",
          "start_idx": 420,
          "end_idx": 477,
          "entities": [
            {
              "entity_id": "T811",
              "entity": "截肢",
              "entity_type": "Operation",
              "start_idx": 1,
              "end_idx": 3,
              "entity_en": "Amputation"
            }
          ],
          "relations": [],
          "sentence_en": "⑦ Selection of amputation plane: Generally, the amputation plane can be determined based on the patient's general condition, local blood supply and injury conditions, and the function of the affected limb should be retained while achieving primary healing of the stump."
        },
        {
          "sentence_id": "2",
          "sentence": "目前临床上使用比较广泛的是采用经皮氧分压测定(也可结合血管影像学检查)，一般来讲，组织的经皮氧分压<20mmHg时，预示着截肢残端无法愈合；经皮氧分压>40mmHg时，预示着戴肢残端可以愈合；介于二者之间有愈合的可能，可能需要采用增加血流的方法。",
          "start_idx": 477,
          "end_idx": 600,
          "entities": [
            {
              "entity_id": "T812",
              "entity": "经皮氧分压测定",
              "entity_type": "Test",
              "start_idx": 15,
              "end_idx": 22,
              "entity_en": "Transcutaneous oxygen pressure measurement"
            },
            {
              "entity_id": "T813",
              "entity": "血管影像学检查",
              "entity_type": "Test",
              "start_idx": 27,
              "end_idx": 34,
              "entity_en": "Vascular imaging"
            },
            {
              "entity_id": "T814",
              "entity": "组织的经皮氧分压",
              "entity_type": "Test",
              "start_idx": 41,
              "end_idx": 49,
              "entity_en": "Transcutaneous oxygen tension"
            },
            {
              "entity_id": "T815",
              "entity": "截肢残端无法愈合",
              "entity_type": "Symptom",
              "start_idx": 61,
              "end_idx": 69,
              "entity_en": "Amputation stumps fail to heal"
            },
            {
              "entity_id": "T816",
              "entity": "经皮氧分压",
              "entity_type": "Test",
              "start_idx": 70,
              "end_idx": 75,
              "entity_en": "Transcutaneous oxygen tension"
            },
            {
              "entity_id": "T817",
              "entity": ">40mmHg",
              "entity_type": "Test_Value",
              "start_idx": 75,
              "end_idx": 82,
              "entity_en": ">40 mmHg"
            },
            {
              "entity_id": "T818",
              "entity": "<20mmHg",
              "entity_type": "Test_Value",
              "start_idx": 49,
              "end_idx": 56,
              "entity_en": "<20 mmHg"
            }
          ],
          "relations": [],
          "sentence_en": "Currently, the most widely used method in clinical practice is transcutaneous oxygen partial pressure measurement (which can also be combined with vascular imaging examination). Generally speaking, when the transcutaneous oxygen partial pressure of the tissue is <20 mmHg, it indicates that the amputation stump cannot heal; when the transcutaneous oxygen partial pressure is >40 mmHg, it indicates that the amputation stump can heal; if it is between the two, there is a possibility of healing, and methods to increase blood flow may be needed."
        }
      ],
      "paragraph_en": "(3) Choice of surgical method: Give priority to simple surgical methods with minimal damage to the uterus, and try to solve complex problems with simple methods. ① Tourniquet: It is recommended to use tourniquets with caution in patients with suspected blood flow disorders. ② Debridement: Pay attention to the exploration of deep tissue damage, avoid sandwich necrosis of muscle tissue and osteofascial compartment syndrome, and ensure smooth drainage after surgery; it is recommended to use multiple debridements to avoid damaging too much healthy tissue, and preserve as much bone as possible without clear necrosis. ③ Suturing: Primary suture after debridement is not recommended. ④ Skin grafting: When the wound base meets the conditions for skin grafting, the wound should be closed surgically as soon as possible. It is recommended to give priority to blade-thickness skin grafting, and flap transplantation is not necessary if free skin grafting can be selected. ⑤ Flap transplantation: Because diabetic foot patients often have synchronous vascular ischemic lesions in both lower limbs, flap transfer and transplantation surgery is not recommended to avoid flap repair failure or even poor healing of the donor area. The surgical plan should be formulated on the premise of a detailed examination and evaluation of the blood vessels in the surgical area before the operation. The priority order of flap selection is adjacent, distal, pedicled, and free. ⑥ Amputation/toe surgery: Amputation can be performed for patients with life-threatening infection of necrotic limbs, inability to reconstruct blood supply, difficulty in wound healing, unbearable pain, and strong demands for long-term non-surgical treatment due to the economic conditions of the patient's family. ⑦ Selection of amputation plane: Generally, the amputation plane can be determined based on the patient's general condition, local blood supply, and injury, and the function of the affected limb can be retained while achieving primary healing of the stump. At present, the most widely used method in clinical practice is the measurement of transcutaneous oxygen partial pressure (which can also be combined with vascular imaging examination). Generally speaking, when the transcutaneous oxygen partial pressure of the tissue is <20mmHg, it indicates that the amputated stump cannot heal; when the transcutaneous oxygen partial pressure is >40mmHg, it indicates that the stump can heal; between the two, there is a possibility of healing, and methods to increase blood flow may be needed."
    },
    {
      "paragraph_id": "66",
      "paragraph": "西洛他唑是一种强效磷酸二酯Ⅲ抑制剂，2007年被泛大西洋协作组织(TASC) Ⅱ指南推荐作为治疗间歇性跛行的一线药物。在糖尿病足的治疗中，西洛他唑既可以抑制血小板的聚集，防止血栓形成；另一方面，也能够通过扩张血管的作用，增加狭窄动脉的血流量，改善患肢取血状态。西洛他唑的应用可以大幅延迟糖尿病患者截肢的发生，并且改善糖尿病足患者下肢动脉缺血的情况。一般来讲，24周的西洛他唑(100mg，2次/d)治疗可以有效预防糖尿病足者发生溃疡；经8周的西洛他唑(100mg，2次/d)治疗，2型糖尿病下肢缺血患者的经皮氧分压、间歇性跛行、肢体冷感以及疼痛感等显著改善且优于阿司匹林，给予西洛他唑100mg与50mg，2次/d，其无痛性跛行距离均有较好的改善(WMD=31.4lm，95%CI：22.38~40.45m，P<0.00001； WMD=19.89m，95%CI：9.44~30.34m，P=0.0002)，最大跛行距离也有明显改善(WMD=43.12m，95% CI：18.28~67.96m，P=0.0007；WMD=32.00m，95%CI：14.17~49.83m，P=0.0004)，提示西洛他唑能够改善下肢动脉粥样硬化性病变(LEAD) 患者的步行距离，但目前没有足够的证据证明服用西洛他唑能够降低全因病死率和心血管事件或者改善患者的生活质量。此外，经血管腔内微创治疗(球囊扩张及支架植入) 的LEAD患者，西洛他唑治疗较噻氯匹啶有更少的再闭塞发生(OR=0.32，95%CI：0.13~0.76，P=0.01)，且西洛他唑治疗是预防血管再狭窄的独立预测因子。西洛他唑的不良反应主要有头痛、腹泻、大便异常、头晕以及心悸，但症状轻微可以忍受，严重不良事件包括心血管事件及死亡率与安慰剂相比并没有增加，但长期有效性尚不明确。西洛他唑的推荐剂量为50~100mg/次，2次/d。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "西洛他唑是一种强效磷酸二酯Ⅲ抑制剂，2007年被泛大西洋协作组织(TASC) Ⅱ指南推荐作为治疗间歇性跛行的一线药物。在糖尿病足的治疗中，西洛他唑既可以抑制血小板的聚集，防止血栓形成；另一方面，也能够通过扩张血管的作用，增加狭窄动脉的血流量，改善患肢取血状态。西洛他唑的应用可以大幅延迟糖尿病患者截肢的发生，并且改善糖尿病足患者下肢动脉缺血的情况。一般来讲，24周的西洛他唑(100mg，2次/d)治疗可以有效预防糖尿病足者发生溃疡；经8周的西洛他唑(100mg，2次/d)治疗，2型糖尿病下肢缺血患者的经皮氧分压、间歇性跛行、肢体冷感以及疼痛感等显著改善且优于阿司匹林，给予西洛他唑100mg与50mg，2次/d，其无痛性跛行距离均有较好的改善(WMD=31.4lm，95%CI：22.38~40.45m，P<0.00001； WMD=19.89m，95%CI：9.44~30.34m，P=0.0002)，最大跛行距离也有明显改善(WMD=43.12m，95% CI：18.28~67.96m，P=0.0007；WMD=32.00m，95%CI：14.17~49.83m，P=0.0004)，提示西洛他唑能够改善下肢动脉粥样硬化性病变(LEAD) 患者的步行距离，但目前没有足够的证据证明服用西洛他唑能够降低全因病死率和心血管事件或者改善患者的生活质量。此外，经血管腔内微创治疗(球囊扩张及支架植入) 的LEAD患者，西洛他唑治疗较噻氯匹啶有更少的再闭塞发生(OR=0.32，95%CI：0.13~0.76，P=0.01)，且西洛他唑治疗是预防血管再狭窄的独立预测因子。西洛他唑的不良反应主要有头痛、腹泻、大便异常、头晕以及心悸，但症状轻微可以忍受，严重不良事件包括心血管事件及死亡率与安慰剂相比并没有增加，但长期有效性尚不明确。",
          "start_idx": 0,
          "end_idx": 766,
          "entities": [
            {
              "entity_id": "T819",
              "entity": "西洛他唑",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 4,
              "entity_en": "Cilostazol"
            },
            {
              "entity_id": "T820",
              "entity": "强效磷酸二酯Ⅲ抑制剂",
              "entity_type": "Drug",
              "start_idx": 7,
              "end_idx": 17,
              "entity_en": "Potent phosphodiesterol III inhibitor"
            },
            {
              "entity_id": "T821",
              "entity": "间歇性跛行",
              "entity_type": "Disease",
              "start_idx": 48,
              "end_idx": 53,
              "entity_en": "Intermittent claudication"
            },
            {
              "entity_id": "T822",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 60,
              "end_idx": 64,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T823",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 63,
              "end_idx": 64,
              "entity_en": "foot"
            },
            {
              "entity_id": "T824",
              "entity": "西洛他唑",
              "entity_type": "Drug",
              "start_idx": 69,
              "end_idx": 73,
              "entity_en": "Cilostazol"
            },
            {
              "entity_id": "T825",
              "entity": "血小板的聚集",
              "entity_type": "Pathogenesis",
              "start_idx": 78,
              "end_idx": 84,
              "entity_en": "Platelet aggregation"
            },
            {
              "entity_id": "T826",
              "entity": "血栓",
              "entity_type": "Symptom",
              "start_idx": 87,
              "end_idx": 89,
              "entity_en": "thrombus"
            },
            {
              "entity_id": "T827",
              "entity": "西洛他唑",
              "entity_type": "Drug",
              "start_idx": 130,
              "end_idx": 134,
              "entity_en": "Cilostazol"
            },
            {
              "entity_id": "T828",
              "entity": "糖尿病",
              "entity_type": "Disease",
              "start_idx": 143,
              "end_idx": 146,
              "entity_en": "diabetes"
            },
            {
              "entity_id": "T829",
              "entity": "截肢",
              "entity_type": "Operation",
              "start_idx": 148,
              "end_idx": 150,
              "entity_en": "Amputation"
            },
            {
              "entity_id": "T830",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 158,
              "end_idx": 162,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T831",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 161,
              "end_idx": 162,
              "entity_en": "foot"
            },
            {
              "entity_id": "T832",
              "entity": "下肢动脉缺血",
              "entity_type": "Disease",
              "start_idx": 164,
              "end_idx": 170,
              "entity_en": "Lower limb arterial ischemia"
            },
            {
              "entity_id": "T833",
              "entity": "下肢动脉",
              "entity_type": "Anatomy",
              "start_idx": 164,
              "end_idx": 168,
              "entity_en": "Lower limb arteries"
            },
            {
              "entity_id": "T834",
              "entity": "24周",
              "entity_type": "Duration",
              "start_idx": 179,
              "end_idx": 182,
              "entity_en": "24 weeks"
            },
            {
              "entity_id": "T835",
              "entity": "西洛他唑",
              "entity_type": "Drug",
              "start_idx": 183,
              "end_idx": 187,
              "entity_en": "Cilostazol"
            },
            {
              "entity_id": "T836",
              "entity": "100mg",
              "entity_type": "Amount",
              "start_idx": 188,
              "end_idx": 193,
              "entity_en": "100mg"
            },
            {
              "entity_id": "T837",
              "entity": "2次/d",
              "entity_type": "Frequency",
              "start_idx": 194,
              "end_idx": 198,
              "entity_en": "2 times/day"
            },
            {
              "entity_id": "T838",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 207,
              "end_idx": 211,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T839",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 210,
              "end_idx": 211,
              "entity_en": "foot"
            },
            {
              "entity_id": "T840",
              "entity": "溃疡",
              "entity_type": "Symptom",
              "start_idx": 214,
              "end_idx": 216,
              "entity_en": "ulcer"
            },
            {
              "entity_id": "T841",
              "entity": "8周",
              "entity_type": "Duration",
              "start_idx": 218,
              "end_idx": 220,
              "entity_en": "8 weeks"
            },
            {
              "entity_id": "T842",
              "entity": "西洛他唑",
              "entity_type": "Drug",
              "start_idx": 221,
              "end_idx": 225,
              "entity_en": "Cilostazol"
            },
            {
              "entity_id": "T843",
              "entity": "100mg",
              "entity_type": "Amount",
              "start_idx": 226,
              "end_idx": 231,
              "entity_en": "100mg"
            },
            {
              "entity_id": "T844",
              "entity": "2次/d",
              "entity_type": "Frequency",
              "start_idx": 232,
              "end_idx": 236,
              "entity_en": "2 times/day"
            },
            {
              "entity_id": "T845",
              "entity": "2型糖尿病",
              "entity_type": "Disease",
              "start_idx": 240,
              "end_idx": 245,
              "entity_en": "Type 2 diabetes"
            },
            {
              "entity_id": "T846",
              "entity": "2型",
              "entity_type": "Class",
              "start_idx": 240,
              "end_idx": 242,
              "entity_en": "Type 2"
            },
            {
              "entity_id": "T847",
              "entity": "下肢缺血",
              "entity_type": "Disease",
              "start_idx": 245,
              "end_idx": 249,
              "entity_en": "Lower limb ischemia"
            },
            {
              "entity_id": "T848",
              "entity": "下肢",
              "entity_type": "Anatomy",
              "start_idx": 245,
              "end_idx": 247,
              "entity_en": "Lower limbs"
            },
            {
              "entity_id": "T849",
              "entity": "经皮氧分压",
              "entity_type": "Test",
              "start_idx": 252,
              "end_idx": 257,
              "entity_en": "Transcutaneous oxygen tension"
            },
            {
              "entity_id": "T850",
              "entity": "间歇性跛行",
              "entity_type": "Symptom",
              "start_idx": 258,
              "end_idx": 263,
              "entity_en": "Intermittent claudication"
            },
            {
              "entity_id": "T851",
              "entity": "肢体冷感",
              "entity_type": "Symptom",
              "start_idx": 264,
              "end_idx": 268,
              "entity_en": "Body coldness"
            },
            {
              "entity_id": "T852",
              "entity": "肢体",
              "entity_type": "Anatomy",
              "start_idx": 264,
              "end_idx": 266,
              "entity_en": "Limbs"
            },
            {
              "entity_id": "T853",
              "entity": "疼痛感",
              "entity_type": "Symptom",
              "start_idx": 270,
              "end_idx": 273,
              "entity_en": "Pain"
            },
            {
              "entity_id": "T854",
              "entity": "阿司匹林",
              "entity_type": "Drug",
              "start_idx": 281,
              "end_idx": 285,
              "entity_en": "aspirin"
            },
            {
              "entity_id": "T855",
              "entity": "西洛他唑",
              "entity_type": "Drug",
              "start_idx": 288,
              "end_idx": 292,
              "entity_en": "Cilostazol"
            },
            {
              "entity_id": "T856",
              "entity": "100mg",
              "entity_type": "Amount",
              "start_idx": 292,
              "end_idx": 297,
              "entity_en": "100mg"
            },
            {
              "entity_id": "T857",
              "entity": "50mg",
              "entity_type": "Amount",
              "start_idx": 298,
              "end_idx": 302,
              "entity_en": "50mg"
            },
            {
              "entity_id": "T858",
              "entity": "2次/d",
              "entity_type": "Frequency",
              "start_idx": 303,
              "end_idx": 307,
              "entity_en": "2 times/day"
            },
            {
              "entity_id": "T859",
              "entity": "西洛他唑",
              "entity_type": "Drug",
              "start_idx": 499,
              "end_idx": 503,
              "entity_en": "Cilostazol"
            },
            {
              "entity_id": "T860",
              "entity": "下肢动脉粥样硬化性病变(LEAD)",
              "entity_type": "Disease",
              "start_idx": 507,
              "end_idx": 524,
              "entity_en": "Lower extremity atherosclerotic disease (LEAD)"
            },
            {
              "entity_id": "T861",
              "entity": "下肢动脉",
              "entity_type": "Anatomy",
              "start_idx": 507,
              "end_idx": 511,
              "entity_en": "Lower limb arteries"
            },
            {
              "entity_id": "T862",
              "entity": "西洛他唑",
              "entity_type": "Drug",
              "start_idx": 547,
              "end_idx": 551,
              "entity_en": "Cilostazol"
            },
            {
              "entity_id": "T863",
              "entity": "心血管事件",
              "entity_type": "Disease",
              "start_idx": 561,
              "end_idx": 566,
              "entity_en": "Cardiovascular events"
            },
            {
              "entity_id": "T864",
              "entity": "心血管",
              "entity_type": "Anatomy",
              "start_idx": 561,
              "end_idx": 564,
              "entity_en": "Cardiovascular"
            },
            {
              "entity_id": "T865",
              "entity": "经血管腔内微创治疗(球囊扩张及支架植入)",
              "entity_type": "Operation",
              "start_idx": 581,
              "end_idx": 601,
              "entity_en": "Minimally invasive endovascular treatment (balloon dilatation and stent implantation)"
            },
            {
              "entity_id": "T866",
              "entity": "LEAD",
              "entity_type": "Disease",
              "start_idx": 603,
              "end_idx": 607,
              "entity_en": "LEAD"
            },
            {
              "entity_id": "T867",
              "entity": "西洛他唑",
              "entity_type": "Drug",
              "start_idx": 610,
              "end_idx": 614,
              "entity_en": "Cilostazol"
            },
            {
              "entity_id": "T868",
              "entity": "噻氯匹啶",
              "entity_type": "Drug",
              "start_idx": 617,
              "end_idx": 621,
              "entity_en": "Ticlopidine"
            },
            {
              "entity_id": "T869",
              "entity": "再闭塞",
              "entity_type": "ADE",
              "start_idx": 625,
              "end_idx": 628,
              "entity_en": "Reocclusion"
            },
            {
              "entity_id": "T870",
              "entity": "西洛他唑",
              "entity_type": "Drug",
              "start_idx": 664,
              "end_idx": 668,
              "entity_en": "Cilostazol"
            },
            {
              "entity_id": "T871",
              "entity": "血管再狭窄",
              "entity_type": "Symptom",
              "start_idx": 673,
              "end_idx": 678,
              "entity_en": "Restenosis"
            },
            {
              "entity_id": "T872",
              "entity": "西洛他唑",
              "entity_type": "Drug",
              "start_idx": 686,
              "end_idx": 690,
              "entity_en": "Cilostazol"
            },
            {
              "entity_id": "T873",
              "entity": "头痛",
              "entity_type": "ADE",
              "start_idx": 698,
              "end_idx": 700,
              "entity_en": "Headache"
            },
            {
              "entity_id": "T874",
              "entity": "腹泻",
              "entity_type": "ADE",
              "start_idx": 701,
              "end_idx": 703,
              "entity_en": "diarrhea"
            },
            {
              "entity_id": "T875",
              "entity": "大便异常",
              "entity_type": "ADE",
              "start_idx": 704,
              "end_idx": 708,
              "entity_en": "Abnormal bowel movements"
            },
            {
              "entity_id": "T876",
              "entity": "头晕",
              "entity_type": "ADE",
              "start_idx": 709,
              "end_idx": 711,
              "entity_en": "Dizziness"
            },
            {
              "entity_id": "T877",
              "entity": "心悸",
              "entity_type": "ADE",
              "start_idx": 713,
              "end_idx": 715,
              "entity_en": "Palpitations"
            },
            {
              "entity_id": "T878",
              "entity": "轻微",
              "entity_type": "Level",
              "start_idx": 719,
              "end_idx": 721,
              "entity_en": "slight"
            },
            {
              "entity_id": "T879",
              "entity": "严重",
              "entity_type": "Level",
              "start_idx": 726,
              "end_idx": 728,
              "entity_en": "serious"
            },
            {
              "entity_id": "T880",
              "entity": "心血管事件",
              "entity_type": "ADE",
              "start_idx": 734,
              "end_idx": 739,
              "entity_en": "Cardiovascular events"
            },
            {
              "entity_id": "T881",
              "entity": "心血管",
              "entity_type": "Anatomy",
              "start_idx": 734,
              "end_idx": 737,
              "entity_en": "Cardiovascular"
            }
          ],
          "relations": [
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R323",
              "head_entity_id": "T819",
              "tail_entity_id": "T821"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R324",
              "head_entity_id": "T823",
              "tail_entity_id": "T822"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R325",
              "head_entity_id": "T824",
              "tail_entity_id": "T822"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R326",
              "head_entity_id": "T826",
              "tail_entity_id": "T822"
            },
            {
              "relation_type": "Pathogenesis_Disease",
              "relation_id": "R327",
              "head_entity_id": "T825",
              "tail_entity_id": "T822"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R328",
              "head_entity_id": "T827",
              "tail_entity_id": "T828"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R329",
              "head_entity_id": "T827",
              "tail_entity_id": "T830"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R330",
              "head_entity_id": "T827",
              "tail_entity_id": "T832"
            },
            {
              "relation_type": "Operation_Disease",
              "relation_id": "R331",
              "head_entity_id": "T829",
              "tail_entity_id": "T828"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R332",
              "head_entity_id": "T831",
              "tail_entity_id": "T830"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R333",
              "head_entity_id": "T833",
              "tail_entity_id": "T832"
            },
            {
              "relation_type": "Duration_Drug",
              "relation_id": "R334",
              "head_entity_id": "T834",
              "tail_entity_id": "T835"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R335",
              "head_entity_id": "T835",
              "tail_entity_id": "T838"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R336",
              "head_entity_id": "T837",
              "tail_entity_id": "T835"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R337",
              "head_entity_id": "T836",
              "tail_entity_id": "T835"
            },
            {
              "relation_type": "Duration_Drug",
              "relation_id": "R338",
              "head_entity_id": "T841",
              "tail_entity_id": "T842"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R339",
              "head_entity_id": "T842",
              "tail_entity_id": "T845"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R340",
              "head_entity_id": "T842",
              "tail_entity_id": "T847"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R341",
              "head_entity_id": "T842",
              "tail_entity_id": "T860"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R342",
              "head_entity_id": "T842",
              "tail_entity_id": "T863"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R343",
              "head_entity_id": "T843",
              "tail_entity_id": "T842"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R344",
              "head_entity_id": "T857",
              "tail_entity_id": "T842"
            },
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R345",
              "head_entity_id": "T844",
              "tail_entity_id": "T842"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R346",
              "head_entity_id": "T854",
              "tail_entity_id": "T845"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R347",
              "head_entity_id": "T850",
              "tail_entity_id": "T845"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R348",
              "head_entity_id": "T851",
              "tail_entity_id": "T845"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R349",
              "head_entity_id": "T853",
              "tail_entity_id": "T845"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R350",
              "head_entity_id": "T849",
              "tail_entity_id": "T845"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R351",
              "head_entity_id": "T848",
              "tail_entity_id": "T847"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R352",
              "head_entity_id": "T854",
              "tail_entity_id": "T847"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R353",
              "head_entity_id": "T849",
              "tail_entity_id": "T847"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R354",
              "head_entity_id": "T861",
              "tail_entity_id": "T860"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R355",
              "head_entity_id": "T864",
              "tail_entity_id": "T863"
            },
            {
              "relation_type": "Operation_Disease",
              "relation_id": "R356",
              "head_entity_id": "T865",
              "tail_entity_id": "T866"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R357",
              "head_entity_id": "T867",
              "tail_entity_id": "T866"
            },
            {
              "relation_type": "Drug_Disease",
              "relation_id": "R358",
              "head_entity_id": "T868",
              "tail_entity_id": "T866"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R359",
              "head_entity_id": "T871",
              "tail_entity_id": "T866"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R360",
              "head_entity_id": "T869",
              "tail_entity_id": "T867"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R361",
              "head_entity_id": "T869",
              "tail_entity_id": "T868"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R362",
              "head_entity_id": "T873",
              "tail_entity_id": "T872"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R363",
              "head_entity_id": "T874",
              "tail_entity_id": "T872"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R364",
              "head_entity_id": "T875",
              "tail_entity_id": "T872"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R365",
              "head_entity_id": "T876",
              "tail_entity_id": "T872"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R366",
              "head_entity_id": "T877",
              "tail_entity_id": "T872"
            },
            {
              "relation_type": "ADE_Drug",
              "relation_id": "R367",
              "head_entity_id": "T880",
              "tail_entity_id": "T872"
            }
          ],
          "sentence_en": "Cilostazol is a potent phosphodiester III inhibitor, which was recommended as a first-line drug for the treatment of intermittent claudication by the Trans-Atlantic Collaboration (TASC) II guidelines in 2007. In the treatment of diabetic foot, cilostazol can inhibit platelet aggregation and prevent thrombosis; on the other hand, it can also increase blood flow in narrowed arteries and improve blood collection in the affected limbs by dilating blood vessels. The use of cilostazol can significantly delay the occurrence of amputation in diabetic patients and improve the ischemia of lower limb arteries in patients with diabetic foot. Generally speaking, 24 weeks of cilostazol (100 mg, twice a day) treatment can effectively prevent diabetic foot ulcers; after 8 weeks of cilostazol (100 mg, twice a day) treatment, the transcutaneous oxygen partial pressure, intermittent claudication, limb coldness and pain in patients with type 2 diabetes lower limb ischemia were significantly improved and better than aspirin. The painless claudication distance was significantly improved after giving cilostazol 100 mg and 50 mg, twice a day (WMD=31.41m, 95%CI: 22.38~40.45m, P<0.00001; WMD=19.89m, 95%CI: 9.44~30.34m, P=0.0002), and the maximum claudication distance was also significantly improved (WMD=43.12m, 95%CI: CI: 18.28~67.96m, P=0.0007; WMD=32.00m, 95%CI: 14.17~49.83m, P=0.0004), indicating that cilostazol can improve the walking distance of patients with lower extremity atherosclerotic disease (LEAD), but there is currently insufficient evidence to prove that taking cilostazol can reduce all-cause mortality and cardiovascular events or improve patients' quality of life. In addition, LEAD patients who underwent minimally invasive endovascular treatment (balloon dilatation and stent implantation) had less reocclusion with cilostazol than with ticlopidine (OR=0.32, 95%CI: 0.13~0.76, P=0.01), and cilostazol treatment was an independent predictor of preventing vascular restenosis. The main adverse reactions of cilostazol include headache, diarrhea, abnormal stool, dizziness and palpitations, but the symptoms are mild and tolerable. Serious adverse events including cardiovascular events and mortality are not increased compared with placebo, but the long-term effectiveness is still unclear."
        },
        {
          "sentence_id": "1",
          "sentence": "西洛他唑的推荐剂量为50~100mg/次，2次/d。",
          "start_idx": 766,
          "end_idx": 792,
          "entities": [
            {
              "entity_id": "T882",
              "entity": "西洛他唑",
              "entity_type": "Drug",
              "start_idx": 0,
              "end_idx": 4,
              "entity_en": "Cilostazol"
            },
            {
              "entity_id": "T883",
              "entity": "50~100mg/次",
              "entity_type": "Amount",
              "start_idx": 10,
              "end_idx": 20,
              "entity_en": "50-100 mg/time"
            },
            {
              "entity_id": "T884",
              "entity": "2次/d",
              "entity_type": "Frequency",
              "start_idx": 21,
              "end_idx": 25,
              "entity_en": "2 times/day"
            }
          ],
          "relations": [
            {
              "relation_type": "Frequency_Drug",
              "relation_id": "R368",
              "head_entity_id": "T884",
              "tail_entity_id": "T882"
            },
            {
              "relation_type": "Amount_Drug",
              "relation_id": "R369",
              "head_entity_id": "T883",
              "tail_entity_id": "T882"
            }
          ],
          "sentence_en": "The recommended dose of cilostazol is 50~100 mg/time, twice/day."
        },
        {
          "sentence_id": "2",
          "sentence": " ",
          "start_idx": 792,
          "end_idx": 793,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "Cilostazol is a potent phosphodiester III inhibitor, which was recommended as a first-line drug for the treatment of intermittent claudication by the Trans-Atlantic Collaboration (TASC) II guidelines in 2007. In the treatment of diabetic foot, cilostazol can inhibit platelet aggregation and prevent thrombosis; on the other hand, it can also increase blood flow in narrowed arteries and improve blood collection in the affected limbs by dilating blood vessels. The use of cilostazol can significantly delay the occurrence of amputation in diabetic patients and improve the ischemia of lower limb arteries in patients with diabetic foot. Generally speaking, 24 weeks of cilostazol (100 mg, twice a day) treatment can effectively prevent diabetic foot ulcers; after 8 weeks of cilostazol (100 mg, twice a day) treatment, the transcutaneous oxygen partial pressure, intermittent claudication, limb coldness and pain in patients with type 2 diabetes lower limb ischemia were significantly improved and better than aspirin. The painless claudication distance was significantly improved after giving cilostazol 100 mg and 50 mg, twice a day (WMD=31.41m, 95%CI: 22.38~40.45m, P<0.00001; WMD=19.89m, 95%CI: 9.44~30.34m, P=0.0002), and the maximum claudication distance was also significantly improved (WMD=43.12m, 95%CI: CI: 18.28~67.96m, P=0.0007; WMD=32.00m, 95%CI: 14.17~49.83m, P=0.0004), indicating that cilostazol can improve the walking distance of patients with lower extremity atherosclerotic disease (LEAD), but there is currently insufficient evidence to prove that taking cilostazol can reduce all-cause mortality and cardiovascular events or improve patients' quality of life. In addition, LEAD patients who underwent minimally invasive endovascular treatment (balloon dilatation and stent implantation) had less reocclusion with cilostazol than with ticlopidine (OR=0.32, 95%CI: 0.13~0.76, P=0.01), and cilostazol treatment was an independent predictor of preventing vascular restenosis. The main adverse reactions of cilostazol include headache, diarrhea, abnormal stool, dizziness and palpitations, but the symptoms are mild and tolerable. Serious adverse events including cardiovascular events and mortality did not increase compared with placebo, but the long-term effectiveness is still unclear. The recommended dose of cilostazol is 50~100mg/time, twice/day."
    },
    {
      "paragraph_id": "22",
      "paragraph": "5.血管影像检查：包括动脉彩色多普勒超声检查、CT血管造影(CTA) 、磁共振血管造影(MRA) 和数字减影血管造影(DSA)血管彩色多普勒检查具有无创、简便的特点，可以了解动脉硬化斑块状况及有无动脉狭窄或闭塞，适用于血管病变大范围筛查。 CTA和MR A具有成像清晰的特点，可以显示血管有无狭窄或闭塞，但准确率低于DSA。对于肾功能正常者，CTA目前可作为糖尿病足下肢血管病变的首选影像学检查手段。DSA仍是诊断下肢血管病变的金标准，可以准确显示动脉堵塞状况及侧支循环建立情况，对外科治疗方案的选择有重要作用。 ",
      "sentences": [
        {
          "sentence_id": "0",
          "sentence": "5.血管影像检查：包括动脉彩色多普勒超声检查、CT血管造影(CTA) 、磁共振血管造影(MRA) 和数字减影血管造影(DSA)血管彩色多普勒检查具有无创、简便的特点，可以了解动脉硬化斑块状况及有无动脉狭窄或闭塞，适用于血管病变大范围筛查。 CTA和MR A具有成像清晰的特点，可以显示血管有无狭窄或闭塞，但准确率低于DSA。对于肾功能正常者，CTA目前可作为糖尿病足下肢血管病变的首选影像学检查手段。DSA仍是诊断下肢血管病变的金标准，可以准确显示动脉堵塞状况及侧支循环建立情况，对外科治疗方案的选择有重要作用。",
          "start_idx": 0,
          "end_idx": 256,
          "entities": [
            {
              "entity_id": "T885",
              "entity": "血管影像检查",
              "entity_type": "Test",
              "start_idx": 2,
              "end_idx": 8,
              "entity_en": "Vascular imaging"
            },
            {
              "entity_id": "T886",
              "entity": "动脉彩色多普勒超声检查",
              "entity_type": "Test",
              "start_idx": 11,
              "end_idx": 22,
              "entity_en": "Arterial color Doppler ultrasonography"
            },
            {
              "entity_id": "T887",
              "entity": "CT血管造影(CTA)",
              "entity_type": "Test",
              "start_idx": 23,
              "end_idx": 34,
              "entity_en": "CT angiography (CTA)"
            },
            {
              "entity_id": "T888",
              "entity": "磁共振血管造影(MRA)",
              "entity_type": "Test",
              "start_idx": 36,
              "end_idx": 48,
              "entity_en": "Magnetic resonance angiography (MRA)"
            },
            {
              "entity_id": "T889",
              "entity": "数字减影血管造影(DSA)",
              "entity_type": "Test",
              "start_idx": 50,
              "end_idx": 63,
              "entity_en": "Digital Subtraction Angiography (DSA)"
            },
            {
              "entity_id": "T890",
              "entity": "血管彩色多普勒检查",
              "entity_type": "Test",
              "start_idx": 63,
              "end_idx": 72,
              "entity_en": "Vascular color Doppler examination"
            },
            {
              "entity_id": "T891",
              "entity": "动脉硬化斑块",
              "entity_type": "Disease",
              "start_idx": 87,
              "end_idx": 93,
              "entity_en": "Atherosclerotic plaque"
            },
            {
              "entity_id": "T892",
              "entity": "动脉",
              "entity_type": "Anatomy",
              "start_idx": 87,
              "end_idx": 89,
              "entity_en": "artery"
            },
            {
              "entity_id": "T893",
              "entity": "动脉狭窄或闭塞",
              "entity_type": "Symptom",
              "start_idx": 98,
              "end_idx": 105,
              "entity_en": "Arterial narrowing or blockage"
            },
            {
              "entity_id": "T894",
              "entity": "动脉",
              "entity_type": "Anatomy",
              "start_idx": 98,
              "end_idx": 100,
              "entity_en": "artery"
            },
            {
              "entity_id": "T895",
              "entity": "血管病变",
              "entity_type": "Disease",
              "start_idx": 109,
              "end_idx": 113,
              "entity_en": "Vascular disease"
            },
            {
              "entity_id": "T896",
              "entity": "血管",
              "entity_type": "Anatomy",
              "start_idx": 109,
              "end_idx": 111,
              "entity_en": "Blood vessel"
            },
            {
              "entity_id": "T897",
              "entity": "CTA",
              "entity_type": "Test",
              "start_idx": 120,
              "end_idx": 123,
              "entity_en": "CTA"
            },
            {
              "entity_id": "T898",
              "entity": "MR A",
              "entity_type": "Test",
              "start_idx": 124,
              "end_idx": 128,
              "entity_en": "MR A"
            },
            {
              "entity_id": "T899",
              "entity": "DSA",
              "entity_type": "Test",
              "start_idx": 158,
              "end_idx": 161,
              "entity_en": "DSA"
            },
            {
              "entity_id": "T900",
              "entity": "CTA",
              "entity_type": "Test",
              "start_idx": 171,
              "end_idx": 174,
              "entity_en": "CTA"
            },
            {
              "entity_id": "T901",
              "entity": "糖尿病足",
              "entity_type": "Disease",
              "start_idx": 179,
              "end_idx": 183,
              "entity_en": "Diabetic foot"
            },
            {
              "entity_id": "T902",
              "entity": "足",
              "entity_type": "Anatomy",
              "start_idx": 182,
              "end_idx": 183,
              "entity_en": "foot"
            },
            {
              "entity_id": "T903",
              "entity": "下肢血管病变",
              "entity_type": "Disease",
              "start_idx": 183,
              "end_idx": 189,
              "entity_en": "Lower extremity vascular disease"
            },
            {
              "entity_id": "T904",
              "entity": "下肢血管",
              "entity_type": "Anatomy",
              "start_idx": 183,
              "end_idx": 187,
              "entity_en": "Lower limb blood vessels"
            },
            {
              "entity_id": "T905",
              "entity": "影像学检查",
              "entity_type": "Test",
              "start_idx": 192,
              "end_idx": 197,
              "entity_en": "Imaging tests"
            },
            {
              "entity_id": "T906",
              "entity": "DSA",
              "entity_type": "Test",
              "start_idx": 200,
              "end_idx": 203,
              "entity_en": "DSA"
            },
            {
              "entity_id": "T907",
              "entity": "下肢血管病变",
              "entity_type": "Disease",
              "start_idx": 207,
              "end_idx": 213,
              "entity_en": "Lower extremity vascular disease"
            },
            {
              "entity_id": "T908",
              "entity": "下肢血管",
              "entity_type": "Anatomy",
              "start_idx": 207,
              "end_idx": 211,
              "entity_en": "Lower limb blood vessels"
            },
            {
              "entity_id": "T909",
              "entity": "动脉堵塞",
              "entity_type": "Symptom",
              "start_idx": 224,
              "end_idx": 228,
              "entity_en": "Blocked arteries"
            },
            {
              "entity_id": "T910",
              "entity": "动脉",
              "entity_type": "Anatomy",
              "start_idx": 224,
              "end_idx": 226,
              "entity_en": "artery"
            }
          ],
          "relations": [
            {
              "relation_type": "Test_Disease",
              "relation_id": "R370",
              "head_entity_id": "T885",
              "tail_entity_id": "T895"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R371",
              "head_entity_id": "T885",
              "tail_entity_id": "T891"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R372",
              "head_entity_id": "T886",
              "tail_entity_id": "T895"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R373",
              "head_entity_id": "T886",
              "tail_entity_id": "T891"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R374",
              "head_entity_id": "T887",
              "tail_entity_id": "T895"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R375",
              "head_entity_id": "T887",
              "tail_entity_id": "T891"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R376",
              "head_entity_id": "T888",
              "tail_entity_id": "T895"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R377",
              "head_entity_id": "T888",
              "tail_entity_id": "T891"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R378",
              "head_entity_id": "T889",
              "tail_entity_id": "T895"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R379",
              "head_entity_id": "T889",
              "tail_entity_id": "T891"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R380",
              "head_entity_id": "T890",
              "tail_entity_id": "T895"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R381",
              "head_entity_id": "T890",
              "tail_entity_id": "T891"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R382",
              "head_entity_id": "T892",
              "tail_entity_id": "T891"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R383",
              "head_entity_id": "T893",
              "tail_entity_id": "T895"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R384",
              "head_entity_id": "T896",
              "tail_entity_id": "T895"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R385",
              "head_entity_id": "T900",
              "tail_entity_id": "T901"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R386",
              "head_entity_id": "T900",
              "tail_entity_id": "T903"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R387",
              "head_entity_id": "T902",
              "tail_entity_id": "T901"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R388",
              "head_entity_id": "T905",
              "tail_entity_id": "T901"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R389",
              "head_entity_id": "T904",
              "tail_entity_id": "T903"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R390",
              "head_entity_id": "T905",
              "tail_entity_id": "T903"
            },
            {
              "relation_type": "Test_Disease",
              "relation_id": "R391",
              "head_entity_id": "T906",
              "tail_entity_id": "T907"
            },
            {
              "relation_type": "Anatomy_Disease",
              "relation_id": "R392",
              "head_entity_id": "T908",
              "tail_entity_id": "T907"
            },
            {
              "relation_type": "Symptom_Disease",
              "relation_id": "R393",
              "head_entity_id": "T909",
              "tail_entity_id": "T907"
            }
          ],
          "sentence_en": "5. Vascular imaging examination: including arterial color Doppler ultrasound examination, CT angiography (CTA), magnetic resonance angiography (MRA) and digital subtraction angiography (DSA). Vascular color Doppler examination is non-invasive and simple. It can understand the status of arteriosclerotic plaques and whether there is arterial stenosis or occlusion. It is suitable for large-scale screening of vascular lesions. CTA and MR A have the characteristics of clear imaging and can show whether there is stenosis or occlusion of blood vessels, but the accuracy is lower than DSA. For those with normal renal function, CTA can currently be used as the preferred imaging examination method for diabetic foot lower limb vascular lesions. DSA is still the gold standard for diagnosing lower limb vascular lesions. It can accurately show the status of arterial blockage and the establishment of collateral circulation, and plays an important role in the selection of surgical treatment options."
        },
        {
          "sentence_id": "1",
          "sentence": " ",
          "start_idx": 256,
          "end_idx": 257,
          "entities": [],
          "relations": [],
          "sentence_en": " "
        }
      ],
      "paragraph_en": "5. Vascular imaging examination: including arterial color Doppler ultrasound examination, CT angiography (CTA), magnetic resonance angiography (MRA) and digital subtraction angiography (DSA). Vascular color Doppler examination is non-invasive and simple. It can understand the status of arteriosclerotic plaques and whether there is arterial stenosis or occlusion. It is suitable for large-scale screening of vascular lesions. CTA and MR A have the characteristics of clear imaging and can show whether there is stenosis or occlusion of blood vessels, but the accuracy is lower than DSA. For those with normal renal function, CTA can currently be used as the preferred imaging examination method for diabetic foot lower limb vascular lesions. DSA is still the gold standard for diagnosing lower limb vascular lesions. It can accurately show the status of arterial blockage and the establishment of collateral circulation, and plays an important role in the selection of surgical treatment options."
    }
  ]
}